[
  {
    "id": 157671,
    "drug": {
      "current_status": "MARKETED",
      "id": 22912,
      "drug_code": 85449,
      "updated_date": "2025-12-03T00:31:48-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258296,
          "ingredient": {
            "id": 144,
            "ingredient_code": 182,
            "en_name": "DIPHENHYDRAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diphénhydramine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02369567",
      "brand_name": "DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, USP",
      "brand_name_fr": "CHLORHYDRATE DE DIPHÉNHYDRAMINE INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102639001"
    },
    "created_date": "2022-04-01T00:00:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02369567",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "R06AA",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-03-29T00:00:00-04:00",
    "actual_end_date": "2022-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-18T15:32:05-04:00",
    "status": "resolved",
    "en_comments": "Due to unforeseen circumstances, we have encountered a supply interruption.",
    "fr_comments": "En raison de circonstances imprévues, nous allons éprouver une interruption d’approvisionnemen",
    "en_drug_brand_name": "DIPHENHYDRAMINE HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "DiphenhydrAMINE Hydrochloride Injection",
    "fr_drug_brand_name": "Chlorhydrate de DiphenhydrAMINE injectable",
    "fr_drug_common_name": "Chlorhydrate de DiphenhydrAMINE injectable",
    "en_ingredients": "DIPHENHYDRAMINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diphénhydramine",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157676,
    "drug": {
      "current_status": "MARKETED",
      "id": 11612,
      "drug_code": 68609,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254325,
          "ingredient": {
            "id": 2934,
            "ingredient_code": 1216,
            "en_name": "MILRINONE",
            "fr_name": "Milrinone (Lactate de milrinone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02244622",
      "brand_name": "MILRINONE LACTATE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131285001"
    },
    "created_date": "2022-04-01T00:19:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244622",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "C01CE",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "estimated_end_date": "2022-04-30T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-05-02T07:09:18-04:00",
    "status": "resolved",
    "en_comments": "Effective Apr. 1, 2022, allocation of Milrinone Lactate Injection, USP 10mL increased to cover 100% of 10mL demand plus 50% of 20mL demand. Allocations of 20mL will be reduced to 50%.",
    "fr_comments": "À compter du 1er avril 2022, l'allocation de lactate de milrinone injectable, USP 10 ml a augmenté pour couvrir 100 % de la demande de 10 ml plus 50 % de la demande de 20 ml. Les allocations de 20 mL seront réduites à 50 %.",
    "en_drug_brand_name": "MILRINONE LACTATE INJECTION, USP",
    "en_drug_common_name": "Milrinone Lactate Injection, USP",
    "fr_drug_brand_name": "LACTATE DE MILRINONE INJECTABLE, USP",
    "fr_drug_common_name": "Lactate de milrinone injectable, USP",
    "en_ingredients": "MILRINONE",
    "fr_ingredients": "Lactate de milrinone",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "20mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157692,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11194,
      "drug_code": 6753,
      "updated_date": "2025-05-15T03:30:26-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8281002,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00594636",
      "brand_name": "STATEX TABLET 25MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63970",
      "number_of_ais": "1",
      "ai_group_no": "0104545005"
    },
    "created_date": "2022-04-01T12:03:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00594636",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-01T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-02T05:00:04-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "STATEX TABLET 25MG",
    "en_drug_common_name": "Statex",
    "fr_drug_brand_name": "Statex 25mg comprimés",
    "fr_drug_common_name": "Statex",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 tabs",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157695,
    "drug": {
      "current_status": "MARKETED",
      "id": 17156,
      "drug_code": 78185,
      "updated_date": "2025-05-15T02:31:57-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256055,
          "ingredient": {
            "id": 2418,
            "ingredient_code": 11458,
            "en_name": "LATANOPROST",
            "fr_name": "Latanoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02296527",
      "brand_name": "APO-LATANOPROST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132916002"
    },
    "created_date": "2022-04-01T13:49:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02296527",
    "company_name": "APOTEX INC",
    "atc_number": "S01EE",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2022-09-23T00:00:00-04:00",
    "actual_start_date": "2022-03-29T00:00:00-04:00",
    "actual_end_date": "2022-09-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-23T17:13:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LATANOPROST",
    "en_drug_common_name": "LATANOPROST",
    "fr_drug_brand_name": "APO-LATANOPROST",
    "fr_drug_common_name": "LATANOPROST",
    "en_ingredients": "LATANOPROST",
    "fr_ingredients": "Latanoprost",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "2.5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157698,
    "drug": {
      "current_status": "MARKETED",
      "id": 9488,
      "drug_code": 6297,
      "updated_date": "2025-05-15T02:30:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250873,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00655767",
      "brand_name": "APO-LORAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62760",
      "number_of_ais": "1",
      "ai_group_no": "0110731002"
    },
    "created_date": "2022-04-01T13:52:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00655767",
    "company_name": "APOTEX INC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2022-05-13T00:00:00-04:00",
    "actual_start_date": "2022-03-29T00:00:00-04:00",
    "actual_end_date": "2022-05-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-13T21:03:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LORAZEPAM TAB 2MG",
    "en_drug_common_name": "LORAZEPAM",
    "fr_drug_brand_name": "APO-LORAZEPAM",
    "fr_drug_common_name": "LORAZEPAM",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157701,
    "drug": {
      "current_status": "MARKETED",
      "id": 15966,
      "drug_code": 76747,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255702,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281813",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783004"
    },
    "created_date": "2022-04-01T13:54:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281813",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-04-29T00:00:00-04:00",
    "actual_start_date": "2022-03-29T00:00:00-04:00",
    "actual_end_date": "2022-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-29T12:26:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157704,
    "drug": {
      "current_status": "MARKETED",
      "id": 12534,
      "drug_code": 71247,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254605,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247013",
      "brand_name": "APO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2022-04-01T13:59:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247013",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-04-29T00:00:00-04:00",
    "actual_start_date": "2022-03-29T00:00:00-04:00",
    "actual_end_date": "2022-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-29T12:27:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "APO-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157710,
    "drug": {
      "current_status": "MARKETED",
      "id": 22152,
      "drug_code": 84529,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257932,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360322",
      "brand_name": "ZYTRAM XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694007"
    },
    "created_date": "2022-04-01T14:47:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360322",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-01T00:00:00-04:00",
    "estimated_end_date": "2022-11-25T00:00:00-05:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-11-24T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Delay in component.\r\nDelay in shipping the finished good",
    "fr_comments": "Retard dans le composant.\r\nRetard dans l’expédition du produit fini.",
    "en_drug_brand_name": "ZYTRAM XL",
    "en_drug_common_name": "Tramadol Hydrochloride Controlled Release Tablets",
    "fr_drug_brand_name": "ZYTRAM XL",
    "fr_drug_common_name": "Comprimés de chlorhydrate de tramadol à libération contrôlée",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157713,
    "drug": {
      "current_status": "MARKETED",
      "id": 16396,
      "drug_code": 77190,
      "updated_date": "2025-12-03T00:31:10-05:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255846,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286440",
      "brand_name": "ZYTRAM XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694001"
    },
    "created_date": "2022-04-01T14:51:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286440",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-01T00:00:00-04:00",
    "estimated_end_date": "2022-09-09T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-08-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-08-27T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Delay in component.\r\nDelay in shipping the finished good.",
    "fr_comments": "Retard dans le composant.\r\nRetard dans l’expédition du produit fini.",
    "en_drug_brand_name": "ZYTRAM XL",
    "en_drug_common_name": "Tramadol Hydrochloride Controlled Release Tablets",
    "fr_drug_brand_name": "ZYTRAM XL",
    "fr_drug_common_name": "Comprimés de chlorhydrate de tramadol à libération contrôlée",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157716,
    "drug": {
      "current_status": "MARKETED",
      "id": 16398,
      "drug_code": 77191,
      "updated_date": "2025-12-03T00:31:10-05:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255847,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286459",
      "brand_name": "ZYTRAM XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694004"
    },
    "created_date": "2022-04-01T14:53:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286459",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-01T00:00:00-04:00",
    "estimated_end_date": "2023-02-06T00:00:00-05:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2023-02-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-02-03T13:49:09-05:00",
    "status": "resolved",
    "en_comments": "Delay in component.\r\nDelay in shipping the finished good.",
    "fr_comments": "Retard dans le composant.\r\nRetard dans l’expédition du produit fini.",
    "en_drug_brand_name": "ZYTRAM XL",
    "en_drug_common_name": "Tramadol Hydrochloride Controlled Release Tablets",
    "fr_drug_brand_name": "ZYTRAM XL",
    "fr_drug_common_name": "Comprimés de chlorhydrate de tramadol à libération contrôlée",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157723,
    "drug": {
      "current_status": "MARKETED",
      "id": 32008,
      "drug_code": 9509,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251174,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00786543",
      "brand_name": "DILAUDID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68694",
      "number_of_ais": "1",
      "ai_group_no": "0108698005"
    },
    "created_date": "2022-04-01T14:58:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786543",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-01T00:00:00-04:00",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-07T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DILAUDID",
    "en_drug_common_name": "Hydromorphone hydrochloride",
    "fr_drug_brand_name": "DILAUDID",
    "fr_drug_common_name": "chlorhydrate d’Hydromorphone",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157737,
    "drug": {
      "current_status": "MARKETED",
      "id": 15596,
      "drug_code": 76283,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255592,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277182",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548010"
    },
    "created_date": "2022-04-01T15:02:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277182",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-04-01T00:00:00-04:00",
    "estimated_end_date": "2022-04-11T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-07T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "BIPHENTIN",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157748,
    "drug": {
      "current_status": "MARKETED",
      "id": 15598,
      "drug_code": 76284,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255593,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277190",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548011"
    },
    "created_date": "2022-04-01T15:04:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277190",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-04-01T00:00:00-04:00",
    "estimated_end_date": "2022-09-23T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-09-23T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "BIPHENTIN",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157763,
    "drug": {
      "current_status": "MARKETED",
      "id": 8426,
      "drug_code": 5864,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250846,
          "ingredient": {
            "id": 1328,
            "ingredient_code": 8138,
            "en_name": "SULFASALAZINE",
            "fr_name": "Sulfasalazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00598488",
      "brand_name": "PMS-SULFASALAZINE-E.C. TAB 500MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61650",
      "number_of_ais": "1",
      "ai_group_no": "0106101001"
    },
    "created_date": "2022-04-01T17:03:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00598488",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A07EC",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2022-04-28T00:00:00-04:00",
    "actual_start_date": "2022-03-31T00:00:00-04:00",
    "actual_end_date": "2022-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-29T13:38:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SULFASALAZINE-E.C. TAB 500MG",
    "en_drug_common_name": "SULFASALAZINE-E.C.",
    "fr_drug_brand_name": "PMS-SULFASALAZINE-E.C. TAB 500MG",
    "fr_drug_common_name": "SULFASALAZINE-E.C",
    "en_ingredients": "SULFASALAZINE",
    "fr_ingredients": "Sulfasalazine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157772,
    "drug": {
      "current_status": "DORMANT",
      "id": 28356,
      "drug_code": 90493,
      "updated_date": "2025-05-15T06:55:51-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369070,
          "ingredient": {
            "id": 3068,
            "ingredient_code": 13233,
            "en_name": "ADEFOVIR DIPIVOXIL",
            "fr_name": "Adéfovir dipivoxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420333",
      "brand_name": "AA-ADEFOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149364001"
    },
    "created_date": "2022-04-01T17:29:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420333",
    "company_name": "AA PHARMA INC",
    "atc_number": "J05AF",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2022-06-30T00:00:00-04:00",
    "actual_start_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-07-02T14:42:35-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "AA-ADEFOVIR",
    "en_drug_common_name": "APO-ADEFOVIR DIPIVOXIL",
    "fr_drug_brand_name": "APO-ADEFOVIR DIPIVOXIL",
    "fr_drug_common_name": "APO-ADEFOVIR DIPIVOXIL",
    "en_ingredients": "ADEFOVIR DIPIVOXIL",
    "fr_ingredients": "Adéfovir dipivoxil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157803,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3864,
      "drug_code": 19437,
      "updated_date": "2025-05-15T03:45:35-04:00",
      "company": {
        "id": 496,
        "created_date": "2017-03-09T13:22:49-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 12204,
        "mfr_code": "",
        "name": "ASTELLAS PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "675 COCHRANE DRIVE, WEST TOWER, SUITE 650",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 0B8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8303071,
          "ingredient": {
            "id": 1558,
            "ingredient_code": 4732,
            "en_name": "ADENOSINE",
            "fr_name": "Adénosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02145820",
      "brand_name": "ADENOCARD INJECTION -PRE-FILLED SYRINGE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81734",
      "number_of_ais": "1",
      "ai_group_no": "0113219001"
    },
    "created_date": "2022-04-01T18:33:59-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02145820",
    "company_name": "ASTELLAS PHARMA CANADA INC",
    "atc_number": "C01EB",
    "atc_description": "OTHER CARDIAC PREPARATIONS",
    "discontinuation_date": "2022-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-01T18:36:45-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ADENOCARD INJECTION -PRE-FILLED SYRINGE",
    "en_drug_common_name": "Adenosine injection USP",
    "fr_drug_brand_name": "ADENOCARD INJECTION -PRE-FILLED SYRINGE",
    "fr_drug_common_name": "Adénosine",
    "en_ingredients": "ADENOSINE",
    "fr_ingredients": "Adénosine",
    "drug_strength": "3MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "6mg/2ml and 12mg/4ml pre-filled syringes",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157808,
    "drug": {
      "current_status": "DORMANT",
      "id": 10932,
      "drug_code": 6687,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366423,
          "ingredient": {
            "id": 206,
            "ingredient_code": 8618,
            "en_name": "ERYTHROMYCIN",
            "fr_name": "Érythromycine (Stéarate d'érythromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00682020",
      "brand_name": "ERYTHRO-BASE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63846",
      "number_of_ais": "1",
      "ai_group_no": "0105708003"
    },
    "created_date": "2022-04-01T18:48:25-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00682020",
    "company_name": "AA PHARMA INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "discontinuation_date": "2022-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-02T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ERYTHRO-BASE",
    "en_drug_common_name": "ERETHRO-BASE",
    "fr_drug_brand_name": "ERETHRO BASE",
    "fr_drug_common_name": "ERETHRO BASE",
    "en_ingredients": "ERYTHROMYCIN",
    "fr_ingredients": "Érythromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157813,
    "drug": {
      "current_status": "MARKETED",
      "id": 6726,
      "drug_code": 44186,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253160,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "647",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172747",
      "brand_name": "OMNIPAQUE 300",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9820",
      "number_of_ais": "1",
      "ai_group_no": "0116846004"
    },
    "created_date": "2022-04-01T20:35:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172747",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2022-04-04T00:00:00-04:00",
    "estimated_end_date": "2022-04-18T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-04-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-19T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNIPAQUE 300",
    "en_drug_common_name": "iohexol injection USP",
    "fr_drug_brand_name": "Omnipaque 300",
    "fr_drug_common_name": "injection d'iohexol USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "647MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVASCULAR\r\nSUBARACHNOIDAL",
    "drug_route_fr": "Intravasculaire\r\nSous-arachnoÏdienne",
    "drug_package_quantity": "500 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157872,
    "drug": {
      "current_status": "MARKETED",
      "id": 9090,
      "drug_code": 61817,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8253574,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238400",
      "brand_name": "PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100662004"
    },
    "created_date": "2022-04-04T16:11:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238400",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "actual_start_date": "2022-04-04T00:00:00-04:00",
    "actual_end_date": "2024-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-12-04T12:56:53-05:00",
    "status": "resolved",
    "en_comments": "No demand for the drug.",
    "fr_comments": "Aucune demande pour le produit.",
    "en_drug_brand_name": "PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%",
    "en_drug_common_name": "Phenylephrine Hydrochloride Injection USP",
    "fr_drug_brand_name": "Phenylephrine Hydrochloride Injection USP",
    "fr_drug_common_name": "Injection de chlorhydrate de phényléphrine USP",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de phényléphrine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 5mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157901,
    "drug": {
      "current_status": "MARKETED",
      "id": 50670,
      "drug_code": 94535,
      "updated_date": "2025-05-15T02:35:38-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262165,
          "ingredient": {
            "id": 3272,
            "ingredient_code": 18175,
            "en_name": "SOLIFENACIN SUCCINATE",
            "fr_name": "Succinate de solifénacine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02458241",
      "brand_name": "SOLIFENACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151584001"
    },
    "created_date": "2022-04-05T15:23:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02458241",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2022-09-15T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-03-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-20T16:29:29-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SOLIFENACIN",
    "en_drug_common_name": "SOLIFENACIN",
    "fr_drug_brand_name": "SOLIFENACIN",
    "fr_drug_common_name": "SOLIFENACIN",
    "en_ingredients": "SOLIFENACIN SUCCINATE",
    "fr_ingredients": "Succinate de solifénacine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157908,
    "drug": {
      "current_status": "MARKETED",
      "id": 60428,
      "drug_code": 95239,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262509,
          "ingredient": {
            "id": 3124,
            "ingredient_code": 13311,
            "en_name": "VARDENAFIL",
            "fr_name": "Vardénafil (Chlorhydrate de vardénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02464225",
      "brand_name": "MYLAN-VARDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150003002"
    },
    "created_date": "2022-04-05T17:01:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464225",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2022-04-20T00:00:00-04:00",
    "estimated_end_date": "2022-07-20T00:00:00-04:00",
    "actual_start_date": "2022-04-11T00:00:00-04:00",
    "actual_end_date": "2022-07-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-29T12:21:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-VARDENAFIL",
    "en_drug_common_name": "VARDENAFIL",
    "fr_drug_brand_name": "MYLAN-VARDENAFIL",
    "fr_drug_common_name": "VARDENAFIL",
    "en_ingredients": "VARDENAFIL",
    "fr_ingredients": "VARDENAFIL",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157911,
    "drug": {
      "current_status": "MARKETED",
      "id": 1522,
      "drug_code": 13302,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251750,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251749,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1600",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251748,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01985205",
      "brand_name": "CREON MINIMICROSPHERES 25",
      "brand_name_fr": "CREON MINIMICROSPHERES 25",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74650",
      "number_of_ais": "3",
      "ai_group_no": "0302964041"
    },
    "created_date": "2022-04-05T17:04:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01985205",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "estimated_end_date": "2022-04-12T00:00:00-04:00",
    "actual_start_date": "2022-03-28T00:00:00-04:00",
    "actual_end_date": "2022-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-04-13T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Globally allocated SKU",
    "fr_comments": "Globally allocated SKU",
    "en_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "en_drug_common_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_common_name": "CREON MINIMICROSPHERES 25",
    "en_ingredients": "PROTEASE\r\nAMYLASE\r\nLIPASE",
    "fr_ingredients": "Protéase\r\nAmylase\r\nLipase",
    "drug_strength": "1600UNIT\r\n25500UNIT\r\n25000UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "25",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157914,
    "drug": {
      "current_status": "MARKETED",
      "id": 9672,
      "drug_code": 63443,
      "updated_date": "2025-12-03T00:30:42-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253729,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239942",
      "brand_name": "CELEBREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043002"
    },
    "created_date": "2022-04-05T18:12:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239942",
    "company_name": "UPJOHN CANADA ULC",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2022-05-12T00:00:00-04:00",
    "estimated_end_date": "2022-06-03T00:00:00-04:00",
    "actual_start_date": "2022-05-12T00:00:00-04:00",
    "actual_end_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-04T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Celebrex 100mg to remain fully available during this period.",
    "fr_comments": "Celebrex 100mg demeurera disponible à cette période.",
    "en_drug_brand_name": "CELEBREX",
    "en_drug_common_name": "Celebrex 200mg",
    "fr_drug_brand_name": "CELEBREX",
    "fr_drug_common_name": "Celebrex 200mg",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "BTL 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157953,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 100122,
      "drug_code": 98375,
      "updated_date": "2020-04-03T06:54:24-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8358520,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02493764",
      "brand_name": "SANDOZ TRAMADOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694006"
    },
    "created_date": "2022-04-05T20:32:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02493764",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-06-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-18T05:00:22-04:00",
    "status": "resolved",
    "en_comments": "Product discontinued",
    "fr_comments": "Produit discontinué",
    "en_drug_brand_name": "SANDOZ TRAMADOL",
    "en_drug_common_name": "TRAMADOL",
    "fr_drug_brand_name": "SANDOZ TRAMADOL",
    "fr_drug_common_name": "TRAMADOL",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157956,
    "drug": {
      "current_status": "MARKETED",
      "id": 12436,
      "drug_code": 71020,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254578,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246820",
      "brand_name": "SANDOZ METFORMIN FC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2022-04-05T20:35:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246820",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2022-04-29T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-21T01:12:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ METFORMIN FC",
    "en_drug_common_name": "METFORMIN FC",
    "fr_drug_brand_name": "SANDOZ METFORMIN FC",
    "fr_drug_common_name": "METFORMIN FC",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "360FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157959,
    "drug": {
      "current_status": "MARKETED",
      "id": 17914,
      "drug_code": 78993,
      "updated_date": "2025-05-15T02:32:05-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256292,
          "ingredient": {
            "id": 2958,
            "ingredient_code": 12699,
            "en_name": "ALFUZOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'alfuzosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02304678",
      "brand_name": "SANDOZ ALFUZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146806001"
    },
    "created_date": "2022-04-05T20:38:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02304678",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-11T01:14:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ALFUZOSIN",
    "en_drug_common_name": "ALFUZOSIN",
    "fr_drug_brand_name": "SANDOZ ALFUZOSIN",
    "fr_drug_common_name": "ALFUZOSIN",
    "en_ingredients": "ALFUZOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'alfuzosine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157964,
    "drug": {
      "current_status": "MARKETED",
      "id": 19684,
      "drug_code": 81039,
      "updated_date": "2025-12-03T00:31:26-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256872,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324970",
      "brand_name": "SANDOZ ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2022-04-05T20:39:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324970",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-06-17T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-06-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-18T05:00:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "SANDOZ ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157967,
    "drug": {
      "current_status": "MARKETED",
      "id": 23924,
      "drug_code": 86585,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258611,
          "ingredient": {
            "id": 2882,
            "ingredient_code": 12126,
            "en_name": "ENTACAPONE",
            "fr_name": "Entacapone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380005",
      "brand_name": "SANDOZ ENTACAPONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143623001"
    },
    "created_date": "2022-04-05T20:41:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380005",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N04BX",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-04-29T01:10:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ENTACAPONE",
    "en_drug_common_name": "ENTACAPONE",
    "fr_drug_brand_name": "SANDOZ ENTACAPONE",
    "fr_drug_common_name": "ENTACAPONE",
    "en_ingredients": "ENTACAPONE",
    "fr_ingredients": "Entacapone",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 157992,
    "drug": {
      "current_status": "MARKETED",
      "id": 25802,
      "drug_code": 88178,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259305,
          "ingredient": {
            "id": 2704,
            "ingredient_code": 11893,
            "en_name": "ABACAVIR",
            "fr_name": "Abacavir (Sulfate d'abacavir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396769",
      "brand_name": "APO-ABACAVIR",
      "brand_name_fr": "APO-ABACAVIR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137623001"
    },
    "created_date": "2022-04-06T12:40:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396769",
    "company_name": "APOTEX INC",
    "atc_number": "J05AF",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2022-08-12T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-08-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-11T12:35:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ABACAVIR",
    "en_drug_common_name": "ABACAVIR",
    "fr_drug_brand_name": "APO-ABACAVIR",
    "fr_drug_common_name": "ABACAVIR",
    "en_ingredients": "ABACAVIR",
    "fr_ingredients": "ABACAVIR",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158046,
    "drug": {
      "current_status": "MARKETED",
      "id": 2518,
      "drug_code": 160,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8250127,
          "ingredient": {
            "id": 1200,
            "ingredient_code": 6941,
            "en_name": "PAPAVERINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de papavérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "65",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "2",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00009881",
      "brand_name": "PAPAVERINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "05872",
      "number_of_ais": "1",
      "ai_group_no": "0107115001"
    },
    "created_date": "2022-04-06T13:26:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00009881",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A03AD",
    "atc_description": "DRUGS FOR FUNCTIONAL BOWEL DISORDERS",
    "actual_start_date": "2022-02-11T00:00:00-05:00",
    "actual_end_date": "2022-08-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2022-09-27T17:42:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PAPAVERINE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "PAPAVERINE HCL",
    "fr_drug_brand_name": "PAPAVERINE HYDROCHLORIDE INJECTION USP",
    "fr_drug_common_name": "PAPAVERINE HCL",
    "en_ingredients": "PAPAVERINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de papavérine",
    "drug_strength": "65MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "2ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158050,
    "drug": {
      "current_status": "MARKETED",
      "id": 12998,
      "drug_code": 72248,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254748,
          "ingredient": {
            "id": 1902,
            "ingredient_code": 7387,
            "en_name": "VASOPRESSIN",
            "fr_name": "Vasopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02247938",
      "brand_name": "VASOPRESSIN INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106469001"
    },
    "created_date": "2022-04-06T13:31:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247938",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2022-08-18T00:00:00-04:00",
    "actual_end_date": "2022-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-09-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VASOPRESSIN INJECTION USP",
    "en_drug_common_name": "VASOPRESSIN",
    "fr_drug_brand_name": "VASOPRESSIN INJECTION USP",
    "fr_drug_common_name": "VASOPRESSIN",
    "en_ingredients": "VASOPRESSIN",
    "fr_ingredients": "Vasopressine",
    "drug_strength": "20UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire\r\nSous-cutanée\r\nIntramusculaire",
    "drug_package_quantity": "5ML 1LIVI",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158073,
    "drug": {
      "current_status": "MARKETED",
      "id": 100813,
      "drug_code": 99216,
      "updated_date": "2020-08-04T23:50:49-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265438,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02502593",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "CHLORHYDRATE DE VANCOMYCIN POUR INJECTION, USP",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315003"
    },
    "created_date": "2022-04-06T19:00:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02502593",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "J01XA",
    "atc_description": "OTHER ANTIBACTERIALS",
    "estimated_end_date": "2022-05-31T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T21:24:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "vancomycin hydrochloride",
    "fr_drug_brand_name": "Chlorhydrate de vancomycine pour injection, USP",
    "fr_drug_common_name": "chlorhydrate de vancomycine",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "vancomycine (chlorhydrate de vancomycine)",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 vials",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158076,
    "drug": {
      "current_status": "MARKETED",
      "id": 100622,
      "drug_code": 98981,
      "updated_date": "2020-07-07T01:50:59-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265211,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02500108",
      "brand_name": "JAMP CINACALCET TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282002"
    },
    "created_date": "2022-04-06T19:04:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02500108",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "estimated_end_date": "2022-06-03T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T21:05:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP CINACALCET TABLETS",
    "en_drug_common_name": "Cinacalcet Tablets",
    "fr_drug_brand_name": "JAMP Cinacalcet Tablets",
    "fr_drug_common_name": "Comprimés de cinacalcet",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "Cinacalcet (Chlorhydrate de cinacalcet)",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158079,
    "drug": {
      "current_status": "MARKETED",
      "id": 100623,
      "drug_code": 98982,
      "updated_date": "2020-07-07T01:50:59-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265212,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02500116",
      "brand_name": "JAMP CINACALCET TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282003"
    },
    "created_date": "2022-04-06T19:07:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02500116",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "estimated_end_date": "2022-06-03T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T21:05:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP CINACALCET TABLETS",
    "en_drug_common_name": "Cinacalcet",
    "fr_drug_brand_name": "JAMP Cinacalcet Tablets",
    "fr_drug_common_name": "Comprimés de cinacalcet",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "Cinacalcet (Chlorhydrate de cinacalcet)",
    "drug_strength": "90MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158082,
    "drug": {
      "current_status": "DORMANT",
      "id": 63356,
      "drug_code": 94530,
      "updated_date": "2025-12-03T02:32:40-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369421,
          "ingredient": {
            "id": 2676,
            "ingredient_code": 11857,
            "en_name": "EFAVIRENZ",
            "fr_name": "Éfavirenz"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02458233",
      "brand_name": "JAMP-EFAVIRENZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137031005"
    },
    "created_date": "2022-04-06T19:11:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02458233",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "J05AG",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2022-06-23T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-07-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-20T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-EFAVIRENZ",
    "en_drug_common_name": "Efavirenz tablets, USP",
    "fr_drug_brand_name": "JAMP-Efavirenz",
    "fr_drug_common_name": "Comprimés d'efavirenz, USP",
    "en_ingredients": "EFAVIRENZ",
    "fr_ingredients": "Éfavirenz",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158085,
    "drug": {
      "current_status": "MARKETED",
      "id": 21870,
      "drug_code": 84235,
      "updated_date": "2025-05-15T02:32:49-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257822,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02357224",
      "brand_name": "JAMP-FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2022-04-06T19:13:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02357224",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2022-07-29T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-07-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-02T19:54:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-FINASTERIDE",
    "en_drug_common_name": "JAMP-Finasteride",
    "fr_drug_brand_name": "JAMP-Finasteride",
    "fr_drug_common_name": "Comprimés de finastéride USP",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158088,
    "drug": {
      "current_status": "MARKETED",
      "id": 22072,
      "drug_code": 84454,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257905,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359529",
      "brand_name": "JAMP-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332006"
    },
    "created_date": "2022-04-06T19:15:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359529",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-11-10T00:00:00-05:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-24T15:20:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-RISPERIDONE",
    "en_drug_common_name": "Risperidone Tablets",
    "fr_drug_brand_name": "JAMP-Risperidone",
    "fr_drug_common_name": "Comprimés de rispéridone",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158091,
    "drug": {
      "current_status": "MARKETED",
      "id": 22072,
      "drug_code": 84454,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257905,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359529",
      "brand_name": "JAMP-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332006"
    },
    "created_date": "2022-04-06T19:17:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359529",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-11-10T00:00:00-05:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-24T15:23:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-RISPERIDONE",
    "en_drug_common_name": "Risperidone Tablets",
    "fr_drug_brand_name": "JAMP-Risperidone",
    "fr_drug_common_name": "Comprimés de rispéridone",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158094,
    "drug": {
      "current_status": "MARKETED",
      "id": 22078,
      "drug_code": 84457,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257908,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359553",
      "brand_name": "JAMP-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332004"
    },
    "created_date": "2022-04-06T19:19:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359553",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-05-01T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-05-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-17T21:59:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-RISPERIDONE",
    "en_drug_common_name": "Risperidone Tablets",
    "fr_drug_brand_name": "JAMP-Risperidone",
    "fr_drug_common_name": "Comprimés de rispéridone",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "2.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158097,
    "drug": {
      "current_status": "MARKETED",
      "id": 22078,
      "drug_code": 84457,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257908,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359553",
      "brand_name": "JAMP-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332004"
    },
    "created_date": "2022-04-06T19:20:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359553",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-05-01T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-05-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-17T21:59:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-RISPERIDONE",
    "en_drug_common_name": "Risperidone Tablets",
    "fr_drug_brand_name": "JAMP-Risperidone",
    "fr_drug_common_name": "Comprimés de rispéridone",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "2.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158100,
    "drug": {
      "current_status": "MARKETED",
      "id": 22080,
      "drug_code": 84458,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257909,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359561",
      "brand_name": "JAMP-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332002"
    },
    "created_date": "2022-04-06T19:22:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359561",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-05-31T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-05-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T21:20:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-RISPERIDONE",
    "en_drug_common_name": "Risperidone Tablets",
    "fr_drug_brand_name": "JAMP-Risperidone",
    "fr_drug_common_name": "Comprimés de rispéridone",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "3.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158103,
    "drug": {
      "current_status": "MARKETED",
      "id": 67185,
      "drug_code": 97563,
      "updated_date": "2020-04-03T06:02:55-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263881,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02485389",
      "brand_name": "JAMP RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521003"
    },
    "created_date": "2022-04-06T19:24:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485389",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T20:48:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP RIVASTIGMINE",
    "en_drug_common_name": "Rivastigmine Hydrogen Tartrate Capsules",
    "fr_drug_brand_name": "JAMP Rivastigmine",
    "fr_drug_common_name": "Capsules de tartrate hydrogéné de rivastigmine",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine",
    "drug_strength": "4.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 capsules (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158106,
    "drug": {
      "current_status": "MARKETED",
      "id": 67186,
      "drug_code": 97564,
      "updated_date": "2020-04-03T06:02:55-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263882,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02485397",
      "brand_name": "JAMP RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521004"
    },
    "created_date": "2022-04-06T19:25:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485397",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T20:49:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP RIVASTIGMINE",
    "en_drug_common_name": "Rivastigmine Hydrogen Tartrate Capsules",
    "fr_drug_brand_name": "JAMP Rivastigmine",
    "fr_drug_common_name": "Capsules de tartrate hydrogéné de rivastigmine",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine",
    "drug_strength": "6MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 capsules (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158109,
    "drug": {
      "current_status": "MARKETED",
      "id": 31178,
      "drug_code": 93340,
      "updated_date": "2025-05-15T02:35:08-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261547,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02447800",
      "brand_name": "JAMP-TIMOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131275002"
    },
    "created_date": "2022-04-06T19:27:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02447800",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-17T21:28:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-TIMOLOL",
    "en_drug_common_name": "Timolol Maleate Ophthalmic Solution",
    "fr_drug_brand_name": "JAMP-Timolol",
    "fr_drug_common_name": "Solution ophtalmique de maléate de timolol",
    "en_ingredients": "TIMOLOL",
    "fr_ingredients": "Timolol (maléate de timolol)",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158112,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28350,
      "drug_code": 90489,
      "updated_date": "2025-05-15T04:22:07-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354342,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02420309",
      "brand_name": "JAMP-VANCOMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315009"
    },
    "created_date": "2022-04-06T19:31:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420309",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "J01XA",
    "atc_description": "OTHER ANTIBACTERIALS",
    "estimated_end_date": "2022-12-31T00:00:00-05:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T21:23:48-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP-VANCOMYCIN",
    "en_drug_common_name": "Vancomycin hydrochloride for injection, USp",
    "fr_drug_brand_name": "JAMP-Vancomycin",
    "fr_drug_common_name": "Chlorhydrate de vancomycine pour injection, USP",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "Vancomycine (chlorhydrate de vancomycine)",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nPOWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution\r\nPoudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 1 g",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158115,
    "drug": {
      "current_status": "MARKETED",
      "id": 28226,
      "drug_code": 90364,
      "updated_date": "2025-05-15T02:34:11-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8260242,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8260241,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02419106",
      "brand_name": "COMBIVENT RESPIMAT",
      "brand_name_fr": "",
      "descriptor": "FOR ORAL INHALATION. FOR USE ONLY WITH COMBIVENT RESPIMAT INHALER",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0232902002"
    },
    "created_date": "2022-04-06T19:39:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02419106",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "R03AL",
    "atc_description": "ADRENERGICS, INHALANTS",
    "anticipated_start_date": "2022-04-07T00:00:00-04:00",
    "estimated_end_date": "2022-04-26T00:00:00-04:00",
    "actual_start_date": "2022-04-07T00:00:00-04:00",
    "actual_end_date": "2022-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-04-23T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Unanticipated stock out due primarily to transportation delay of replenishment order",
    "fr_comments": "Rupture de stock imprévue due principalement au retard de transport de la commande de réapprovisionnement",
    "en_drug_brand_name": "COMBIVENT RESPIMAT",
    "en_drug_common_name": "COMBIVENT RESPIMAT 4ML/60 PUFF",
    "fr_drug_brand_name": "COMBIVENT RESPIMAT",
    "fr_drug_common_name": "COMBIVENT RESPIMAT 4ML/60 PUFF",
    "en_ingredients": "SALBUTAMOL\r\nIPRATROPIUM BROMIDE",
    "fr_ingredients": "Salbutamol\r\nBromure d'ipratropium",
    "drug_strength": "100MCG\r\n20MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "4ML/600 PUFF",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158118,
    "drug": {
      "current_status": "MARKETED",
      "id": 24854,
      "drug_code": 87385,
      "updated_date": "2025-05-15T02:33:33-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258988,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258987,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388308",
      "brand_name": "JAMP-ACET-TRAMADOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250601001"
    },
    "created_date": "2022-04-06T19:45:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388308",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2023-04-17T00:00:00-04:00",
    "actual_start_date": "2022-03-31T00:00:00-04:00",
    "actual_end_date": "2023-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-25T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-ACET-TRAMADOL",
    "en_drug_common_name": "Acetaminophen and Tramadol Hydrochloride Tablets",
    "fr_drug_brand_name": "JAMP-Acet-Tramadol",
    "fr_drug_common_name": "Comprimés de chlorhydrate de tramadol et d'acétaminophène",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE\r\nACETAMINOPHEN",
    "fr_ingredients": "Chlorhydrate de tramadol\r\nAcétaminophène",
    "drug_strength": "37.5MG\r\n325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158121,
    "drug": {
      "current_status": "MARKETED",
      "id": 24854,
      "drug_code": 87385,
      "updated_date": "2025-05-15T02:33:33-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258988,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258987,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388308",
      "brand_name": "JAMP-ACET-TRAMADOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250601001"
    },
    "created_date": "2022-04-06T20:01:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388308",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2023-04-17T00:00:00-04:00",
    "actual_start_date": "2022-03-31T00:00:00-04:00",
    "actual_end_date": "2023-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-25T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-ACET-TRAMADOL",
    "en_drug_common_name": "Acetaminophen and Tramadol Hydrochloride Tablets",
    "fr_drug_brand_name": "JAMP-Acet-Tramadol",
    "fr_drug_common_name": "Comprimés de chlorhydrate de tramadol et d'acétaminophène",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE\r\nACETAMINOPHEN",
    "fr_ingredients": "Chlorhydrate de tramadol\r\nAcétaminophène",
    "drug_strength": "37.5MG\r\n325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 tablets (Blister pack)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158124,
    "drug": {
      "current_status": "DORMANT",
      "id": 101142,
      "drug_code": 99642,
      "updated_date": "2020-11-09T00:55:07-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369774,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02507005",
      "brand_name": "JAMP TRAMADOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694006"
    },
    "created_date": "2022-04-06T20:09:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02507005",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-11-10T00:00:00-05:00",
    "actual_start_date": "2022-03-31T00:00:00-04:00",
    "actual_end_date": "2022-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-11-09T17:50:24-05:00",
    "status": "resolved",
    "en_comments": "Change from prescription scheduling to narcotic sheduling (Health Canada regulation). Inventory available at wholesaler.",
    "fr_comments": "Passage de l'inscription du produit de prescription à produit narcotique (Règlementation de Santé Canada). Inventaire disponible chez le grossiste.",
    "en_drug_brand_name": "JAMP TRAMADOL",
    "en_drug_common_name": "Tramadol Hydrochloride Tablets",
    "fr_drug_brand_name": "JAMP Tramadol",
    "fr_drug_common_name": "Comprimés de chlorhydrate de tramadol",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158129,
    "drug": {
      "current_status": "MARKETED",
      "id": 22580,
      "drug_code": 85094,
      "updated_date": "2025-12-03T00:31:47-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258128,
          "ingredient": {
            "id": 108,
            "ingredient_code": 4991,
            "en_name": "FOLIC ACID",
            "fr_name": "Acide folique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366061",
      "brand_name": "JAMP-FOLIC ACID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108418001"
    },
    "created_date": "2022-04-06T20:15:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366061",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "B03BB",
    "atc_description": "VITAMIN B12 AND FOLIC ACID",
    "anticipated_start_date": "2022-04-05T00:00:00-04:00",
    "estimated_end_date": "2024-11-15T00:00:00-05:00",
    "actual_end_date": "2024-07-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-07-20T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Limited quantity available",
    "fr_comments": "Quantité limitée disponible",
    "en_drug_brand_name": "JAMP-FOLIC ACID",
    "en_drug_common_name": "Folic Acid Tablets USP",
    "fr_drug_brand_name": "JAMP-ACIDE FOLIQUE 5mg",
    "fr_drug_common_name": "Comprimés d'acide folique USP",
    "en_ingredients": "FOLIC ACID",
    "fr_ingredients": "Acide folique",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 tablets (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158132,
    "drug": {
      "current_status": "MARKETED",
      "id": 67204,
      "drug_code": 97849,
      "updated_date": "2020-04-03T06:02:59-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264095,
          "ingredient": {
            "id": 3686,
            "ingredient_code": 20636,
            "en_name": "LACOSAMIDE",
            "fr_name": "Lacosamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02488396",
      "brand_name": "JAMP-LACOSAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152810002"
    },
    "created_date": "2022-04-06T20:21:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02488396",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2022-04-05T00:00:00-04:00",
    "estimated_end_date": "2022-05-31T00:00:00-04:00",
    "actual_end_date": "2022-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T21:10:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-LACOSAMIDE",
    "en_drug_common_name": "Lacosamide tablets",
    "fr_drug_brand_name": "JAMP-LACOSAMIDE",
    "fr_drug_common_name": "Comprimés de lacosamide",
    "en_ingredients": "LACOSAMIDE",
    "fr_ingredients": "Lacosamide",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158137,
    "drug": {
      "current_status": "MARKETED",
      "id": 102096,
      "drug_code": 100707,
      "updated_date": "2021-08-09T05:14:37-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266405,
          "ingredient": {
            "id": 3284,
            "ingredient_code": 918,
            "en_name": "MIDODRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de midodrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02517701",
      "brand_name": "JAMP MIDODRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123066001"
    },
    "created_date": "2022-04-06T20:25:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02517701",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2022-04-05T00:00:00-04:00",
    "estimated_end_date": "2022-06-17T00:00:00-04:00",
    "actual_end_date": "2022-06-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-19T20:01:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP MIDODRINE",
    "en_drug_common_name": "Midodrine Hydrohcloride Tablets USP",
    "fr_drug_brand_name": "JAMP Midodrine",
    "fr_drug_common_name": "Comprimés de chlorhydrate de midodrine USP",
    "en_ingredients": "MIDODRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de midodrine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158140,
    "drug": {
      "current_status": "MARKETED",
      "id": 102097,
      "drug_code": 100708,
      "updated_date": "2021-08-09T05:14:37-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266406,
          "ingredient": {
            "id": 3284,
            "ingredient_code": 918,
            "en_name": "MIDODRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de midodrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02517728",
      "brand_name": "JAMP MIDODRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123066002"
    },
    "created_date": "2022-04-06T20:28:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02517728",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2022-04-05T00:00:00-04:00",
    "estimated_end_date": "2022-06-17T00:00:00-04:00",
    "actual_end_date": "2022-06-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-19T20:00:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP MIDODRINE",
    "en_drug_common_name": "Midodrine hydrochloride Tablets USP",
    "fr_drug_brand_name": "JAMP Midodrine",
    "fr_drug_common_name": "Comprimés de chlorhydrate de midodrine USP",
    "en_ingredients": "MIDODRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de midodrine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158143,
    "drug": {
      "current_status": "MARKETED",
      "id": 28336,
      "drug_code": 90479,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260274,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420198",
      "brand_name": "JAMP-OMEPRAZOLE DR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2022-04-06T20:32:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420198",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2022-04-05T00:00:00-04:00",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_end_date": "2022-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-17T22:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-OMEPRAZOLE DR",
    "en_drug_common_name": "Omeprazole magnesium delayed release tablets",
    "fr_drug_brand_name": "JAMP-Omeprazole DR",
    "fr_drug_common_name": "Comprimés d'oméprazole magnésien à libération retardée",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158233,
    "drug": {
      "current_status": "MARKETED",
      "id": 17396,
      "drug_code": 78458,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256132,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299194",
      "brand_name": "RALIVIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694005"
    },
    "created_date": "2022-04-07T19:03:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299194",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-06-16T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-06-15T13:50:47-04:00",
    "status": "resolved",
    "en_comments": "Product has been re-classified as a Control Substance",
    "fr_comments": "Product has been re-classified as a Control Substance",
    "en_drug_brand_name": "RALIVIA",
    "en_drug_common_name": "RALIVIA",
    "fr_drug_brand_name": "RALIVIA",
    "fr_drug_common_name": "RALIVIA",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158236,
    "drug": {
      "current_status": "MARKETED",
      "id": 17398,
      "drug_code": 78459,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256133,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299208",
      "brand_name": "RALIVIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694003"
    },
    "created_date": "2022-04-07T19:05:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299208",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-06-16T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-06-02T18:51:41-04:00",
    "status": "resolved",
    "en_comments": "Product has been re-classified as a Control Substance",
    "fr_comments": "Product has been re-classified as a Control Substance",
    "en_drug_brand_name": "RALIVIA",
    "en_drug_common_name": "RALIVIA",
    "fr_drug_brand_name": "RALIVIA",
    "fr_drug_common_name": "RALIVIA",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "N/A",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158239,
    "drug": {
      "current_status": "MARKETED",
      "id": 17400,
      "drug_code": 78460,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256134,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299216",
      "brand_name": "RALIVIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694001"
    },
    "created_date": "2022-04-07T19:07:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299216",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-06-16T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-06-02T18:52:28-04:00",
    "status": "resolved",
    "en_comments": "Product has been re-classified as a Control Substance",
    "fr_comments": "Product has been re-classified as a Control Substance",
    "en_drug_brand_name": "RALIVIA",
    "en_drug_common_name": "RALIVIA",
    "fr_drug_brand_name": "RALIVIA",
    "fr_drug_common_name": "RALIVIA",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "N/A",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158242,
    "drug": {
      "current_status": "MARKETED",
      "id": 5428,
      "drug_code": 35784,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252836,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02194058",
      "brand_name": "ARISTOCORT R",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H3071",
      "number_of_ais": "1",
      "ai_group_no": "0106310002"
    },
    "created_date": "2022-04-07T19:09:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02194058",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D07AB",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2022-06-16T00:00:00-04:00",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_end_date": "2022-06-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-06-15T13:56:10-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ARISTOCORT R",
    "en_drug_common_name": "ARISTOCORT R",
    "fr_drug_brand_name": "ARISTOCORT R",
    "fr_drug_common_name": "ARISTOCORT R",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Acétonide  de triamcinolone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30g",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158249,
    "drug": {
      "current_status": "MARKETED",
      "id": 5110,
      "drug_code": 31096,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252785,
          "ingredient": {
            "id": 1900,
            "ingredient_code": 4957,
            "en_name": "ACETYLCHOLINE CHLORIDE",
            "fr_name": "Chlorure d'acétylcholine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02133326",
      "brand_name": "MIOCHOL-E",
      "brand_name_fr": "",
      "descriptor": "WITH DILUENT",
      "pediatric_flag": false,
      "accession_number": "F8164",
      "number_of_ais": "1",
      "ai_group_no": "0108463001"
    },
    "created_date": "2022-04-07T19:12:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02133326",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01EB",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2022-06-24T00:00:00-04:00",
    "estimated_end_date": "2022-10-10T00:00:00-04:00",
    "actual_start_date": "2022-06-27T00:00:00-04:00",
    "actual_end_date": "2022-10-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-10-12T19:04:16-04:00",
    "status": "resolved",
    "en_comments": "production delay",
    "fr_comments": "délai en production",
    "en_drug_brand_name": "MIOCHOL-E",
    "en_drug_common_name": "MIOCHOL-E",
    "fr_drug_brand_name": "MIOCHOL-E",
    "fr_drug_common_name": "MIOCHOL-E",
    "en_ingredients": "ACETYLCHOLINE CHLORIDE",
    "fr_ingredients": "Chlorure d'acétylcholine",
    "drug_strength": "20MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "2ml 12/bx",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158256,
    "drug": {
      "current_status": "MARKETED",
      "id": 23192,
      "drug_code": 85765,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258369,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02372533",
      "brand_name": "OXYNEO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552007"
    },
    "created_date": "2022-04-07T19:17:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02372533",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-07T00:00:00-04:00",
    "estimated_end_date": "2022-06-23T00:00:00-04:00",
    "actual_start_date": "2022-04-07T00:00:00-04:00",
    "actual_end_date": "2022-06-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-18T05:00:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OXYNEO",
    "en_drug_common_name": "Oxycodone Hydrochloride Controlled Release Tablets",
    "fr_drug_brand_name": "OxyNeo",
    "fr_drug_common_name": "Comprimés de chlorhydrate d’oxycodone à libération contrôlée",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158261,
    "drug": {
      "current_status": "MARKETED",
      "id": 23200,
      "drug_code": 85769,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258373,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02372584",
      "brand_name": "OXYNEO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552006"
    },
    "created_date": "2022-04-07T19:30:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02372584",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-07T00:00:00-04:00",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-04-07T00:00:00-04:00",
    "actual_end_date": "2022-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-28T15:34:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OXYNEO",
    "en_drug_common_name": "Oxycodone Hydrochloride Controlled Release Tablets",
    "fr_drug_brand_name": "OxyNeo",
    "fr_drug_common_name": "Comprimés de chlorhydrate d’oxycodone à libération contrôlée",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158293,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20826,
      "drug_code": 82693,
      "updated_date": "2025-05-15T04:15:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348232,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341417",
      "brand_name": "PMS-FENTANYL MTX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302012"
    },
    "created_date": "2022-04-07T20:02:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02341417",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2022-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-07T20:02:38-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-FENTANYL MTX",
    "en_drug_common_name": "FENTANYL MTX",
    "fr_drug_brand_name": "PMS-FENTANYL MTX",
    "fr_drug_common_name": "FENTANYL MTX",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158296,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20824,
      "drug_code": 82692,
      "updated_date": "2025-05-15T04:15:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348231,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341409",
      "brand_name": "PMS-FENTANYL MTX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302013"
    },
    "created_date": "2022-04-07T20:03:30-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02341409",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2022-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-07T20:03:39-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-FENTANYL MTX",
    "en_drug_common_name": "FENTANYL MTX",
    "fr_drug_brand_name": "PMS-FENTANYL MTX",
    "fr_drug_common_name": "FENTANYL MTX",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "75MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158299,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20822,
      "drug_code": 82691,
      "updated_date": "2025-12-03T01:27:20-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348230,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341395",
      "brand_name": "PMS-FENTANYL MTX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302002"
    },
    "created_date": "2022-04-07T20:04:37-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02341395",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2022-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-07T20:04:46-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-FENTANYL MTX",
    "en_drug_common_name": "FENTANYL MTX",
    "fr_drug_brand_name": "PMS-FENTANYL MTX",
    "fr_drug_common_name": "FENTANYL MTX",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "50MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158304,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20820,
      "drug_code": 82690,
      "updated_date": "2025-05-15T04:15:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348229,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341387",
      "brand_name": "PMS-FENTANYL MTX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302014"
    },
    "created_date": "2022-04-07T20:06:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02341387",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2022-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-07T20:06:31-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-FENTANYL MTX",
    "en_drug_common_name": "FENTANYL MTX",
    "fr_drug_brand_name": "FENTANYL MTX",
    "fr_drug_common_name": "FENTANYL MTX",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "25MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158307,
    "drug": {
      "current_status": "MARKETED",
      "id": 11186,
      "drug_code": 67514,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254203,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243596",
      "brand_name": "ASMANEX TWISTHALER",
      "brand_name_fr": "",
      "descriptor": "FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732004"
    },
    "created_date": "2022-04-07T20:10:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243596",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2022-04-22T00:00:00-04:00",
    "estimated_end_date": "2022-05-13T00:00:00-04:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2022-05-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-05-09T14:17:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ASMANEX TWISTHALER",
    "en_drug_common_name": "mometasone furoate dry powder inhaler",
    "fr_drug_brand_name": "ASMANEX TWISTHALER",
    "fr_drug_common_name": "furoate de mométasone inhalateur de poudre sèche",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "400MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158318,
    "drug": {
      "current_status": "MARKETED",
      "id": 23930,
      "drug_code": 86588,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258614,
          "ingredient": {
            "id": 3778,
            "ingredient_code": 21178,
            "en_name": "FESOTERODINE FUMARATE",
            "fr_name": "Fumarate de Fésotérodine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380048",
      "brand_name": "TOVIAZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153091002"
    },
    "created_date": "2022-04-07T20:53:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380048",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2022-05-30T00:00:00-04:00",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2022-05-26T00:00:00-04:00",
    "actual_end_date": "2022-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-01T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Toviaz 4mg remains available",
    "fr_comments": "Toviaz 4mg est disponible",
    "en_drug_brand_name": "TOVIAZ",
    "en_drug_common_name": "Toviaz",
    "fr_drug_brand_name": "TOVIAZ",
    "fr_drug_common_name": "Toviaz",
    "en_ingredients": "FESOTERODINE FUMARATE",
    "fr_ingredients": "Fumarate de Fésotérodine",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158321,
    "drug": {
      "current_status": "MARKETED",
      "id": 13302,
      "drug_code": 72897,
      "updated_date": "2025-05-15T02:31:30-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254825,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248542",
      "brand_name": "REMERON RD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928001"
    },
    "created_date": "2022-04-07T20:59:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248542",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2022-05-20T00:00:00-04:00",
    "estimated_end_date": "2022-05-27T00:00:00-04:00",
    "actual_start_date": "2022-05-10T00:00:00-04:00",
    "actual_end_date": "2022-05-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-05-24T17:40:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "REMERON RD",
    "en_drug_common_name": "(mirtazapine) Orally Disintegrating Tablets",
    "fr_drug_brand_name": "REMERON RD",
    "fr_drug_common_name": "Comprimés à désintégration orale mirtazapine",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158324,
    "drug": {
      "current_status": "MARKETED",
      "id": 22440,
      "drug_code": 84835,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8258046,
          "ingredient": {
            "id": 3706,
            "ingredient_code": 20449,
            "en_name": "FOSAPREPITANT",
            "fr_name": "Fosaprépitant (Fosaprépitant diméglumine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02363356",
      "brand_name": "EMEND IV",
      "brand_name_fr": "",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152547002"
    },
    "created_date": "2022-04-07T23:26:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02363356",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A04AD",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "anticipated_start_date": "2022-04-14T00:00:00-04:00",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2022-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-20T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "EMEND IV",
    "en_drug_common_name": "fosaprepitant for injection",
    "fr_drug_brand_name": "EMEND IV",
    "fr_drug_common_name": "fosaprépitant pour injection",
    "en_ingredients": "FOSAPREPITANT",
    "fr_ingredients": "fosaprépitant",
    "drug_strength": "150MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 dose vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158336,
    "drug": {
      "current_status": "MARKETED",
      "id": 7124,
      "drug_code": 48231,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253240,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02229873",
      "brand_name": "APO-ACETAMINOPHEN CAPLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102009001"
    },
    "created_date": "2022-04-08T12:25:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229873",
    "company_name": "APOTEX INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-13T20:59:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACETAMINOPHEN CAPLETS",
    "en_drug_common_name": "ACETAMINOPHEN",
    "fr_drug_brand_name": "APO-ACETAMINOPHEN CAPLETS",
    "fr_drug_common_name": "ACETAMINOPHEN",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158339,
    "drug": {
      "current_status": "MARKETED",
      "id": 6228,
      "drug_code": 43018,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253024,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02207621",
      "brand_name": "APO-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9274",
      "number_of_ais": "1",
      "ai_group_no": "0115506002"
    },
    "created_date": "2022-04-08T12:27:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02207621",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-13T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "APO-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158342,
    "drug": {
      "current_status": "MARKETED",
      "id": 6230,
      "drug_code": 43019,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253025,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02207648",
      "brand_name": "APO-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9275",
      "number_of_ais": "1",
      "ai_group_no": "0115506004"
    },
    "created_date": "2022-04-08T12:40:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02207648",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-13T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "APO-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158345,
    "drug": {
      "current_status": "MARKETED",
      "id": 6234,
      "drug_code": 43020,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253026,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02207656",
      "brand_name": "APO-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9276",
      "number_of_ais": "1",
      "ai_group_no": "0115506005"
    },
    "created_date": "2022-04-08T12:44:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02207656",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-25T12:06:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "APO-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158348,
    "drug": {
      "current_status": "MARKETED",
      "id": 56778,
      "drug_code": 95586,
      "updated_date": "2025-05-15T02:36:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262687,
          "ingredient": {
            "id": 3486,
            "ingredient_code": 11359,
            "en_name": "CEFEPIME",
            "fr_name": "Céfépime (Chlorhydrate de céfépime)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02467496",
      "brand_name": "APO-CEFEPIME",
      "brand_name_fr": "APO-CEFEPIME",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150504004"
    },
    "created_date": "2022-04-08T12:48:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467496",
    "company_name": "APOTEX INC",
    "atc_number": "J01DE",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2022-08-26T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-08-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-24T11:51:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CEFEPIME",
    "en_drug_common_name": "CEFEPIME",
    "fr_drug_brand_name": "APO-CEFEPIME",
    "fr_drug_common_name": "CEFEPIME",
    "en_ingredients": "CEFEPIME",
    "fr_ingredients": "CEFEPIME",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "20 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158353,
    "drug": {
      "current_status": "MARKETED",
      "id": 16782,
      "drug_code": 77739,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255930,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292025",
      "brand_name": "APO-FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885003"
    },
    "created_date": "2022-04-08T12:52:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292025",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2022-05-13T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-05-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-13T21:02:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FAMCICLOVIR",
    "en_drug_common_name": "FAMCICLOVIR",
    "fr_drug_brand_name": "APO-FAMCICLOVIR",
    "fr_drug_common_name": "FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "125MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158358,
    "drug": {
      "current_status": "MARKETED",
      "id": 21676,
      "drug_code": 84058,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257743,
          "ingredient": {
            "id": 3134,
            "ingredient_code": 12429,
            "en_name": "IMATINIB",
            "fr_name": "Imatinib (Mésylate d'imatinib)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355337",
      "brand_name": "APO-IMATINIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145503002"
    },
    "created_date": "2022-04-08T12:56:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02355337",
    "company_name": "APOTEX INC",
    "atc_number": "L01EA",
    "estimated_end_date": "2022-06-03T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-02T20:54:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-IMATINIB",
    "en_drug_common_name": "IMATINIB",
    "fr_drug_brand_name": "APO-IMATINIB",
    "fr_drug_common_name": "IMATINIB",
    "en_ingredients": "IMATINIB",
    "fr_ingredients": "IMATINIB",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158361,
    "drug": {
      "current_status": "MARKETED",
      "id": 21678,
      "drug_code": 84059,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257744,
          "ingredient": {
            "id": 3134,
            "ingredient_code": 12429,
            "en_name": "IMATINIB",
            "fr_name": "Imatinib (Mésylate d'imatinib)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355345",
      "brand_name": "APO-IMATINIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145503003"
    },
    "created_date": "2022-04-08T12:59:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02355345",
    "company_name": "APOTEX INC",
    "atc_number": "L01EA",
    "estimated_end_date": "2022-06-10T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-03T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-IMATINIB",
    "en_drug_common_name": "IMATINIB",
    "fr_drug_brand_name": "APO-IMATINIB",
    "fr_drug_common_name": "IMATINIB",
    "en_ingredients": "IMATINIB",
    "fr_ingredients": "IMATINIB",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158364,
    "drug": {
      "current_status": "MARKETED",
      "id": 13322,
      "drug_code": 72917,
      "updated_date": "2025-05-15T02:31:30-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254836,
          "ingredient": {
            "id": 116,
            "ingredient_code": 9880,
            "en_name": "METRONIDAZOLE",
            "fr_name": "Métronidazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248562",
      "brand_name": "APO-METRONIDAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102572003"
    },
    "created_date": "2022-04-08T13:03:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248562",
    "company_name": "APOTEX INC",
    "atc_number": "P01AB",
    "atc_description": "AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS.",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-14T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METRONIDAZOLE",
    "en_drug_common_name": "METRONIDAZOLE",
    "fr_drug_brand_name": "APO-METRONIDAZOLE",
    "fr_drug_common_name": "METRONIDAZOLE",
    "en_ingredients": "METRONIDAZOLE",
    "fr_ingredients": "Métronidazole",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158367,
    "drug": {
      "current_status": "DORMANT",
      "id": 25502,
      "drug_code": 87940,
      "updated_date": "2025-12-03T02:32:32-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368842,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394243",
      "brand_name": "APO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121002"
    },
    "created_date": "2022-04-08T13:06:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394243",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-05-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-13T21:09:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "APO-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158370,
    "drug": {
      "current_status": "MARKETED",
      "id": 20618,
      "drug_code": 82362,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257287,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337975",
      "brand_name": "APO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2022-04-08T13:10:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337975",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-04-27T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-22T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "APO-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158373,
    "drug": {
      "current_status": "MARKETED",
      "id": 9640,
      "drug_code": 63385,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253725,
          "ingredient": {
            "id": 1002,
            "ingredient_code": 11385,
            "en_name": "TERBINAFINE",
            "fr_name": "Terbinafine (Chlorhydrate de terbinafine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239893",
      "brand_name": "APO-TERBINAFINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132855002"
    },
    "created_date": "2022-04-08T13:14:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239893",
    "company_name": "APOTEX INC",
    "atc_number": "D01BA",
    "atc_description": "ANTIFUNGALS FOR SYSTEMIC USE",
    "estimated_end_date": "2022-06-10T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-13T00:43:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TERBINAFINE",
    "en_drug_common_name": "TERBINAFINE",
    "fr_drug_brand_name": "APO-TERBINAFINE",
    "fr_drug_common_name": "TERBINAFINE",
    "en_ingredients": "TERBINAFINE",
    "fr_ingredients": "Terbinafine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158376,
    "drug": {
      "current_status": "MARKETED",
      "id": 11754,
      "drug_code": 69136,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254363,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8254362,
          "ingredient": {
            "id": 2000,
            "ingredient_code": 11282,
            "en_name": "SALMETEROL",
            "fr_name": "Salmétérol (Xinafoate de salmétérol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02245126",
      "brand_name": "ADVAIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0238341005"
    },
    "created_date": "2022-04-08T13:31:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245126",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2022-05-18T00:00:00-04:00",
    "actual_start_date": "2022-04-08T00:00:00-04:00",
    "actual_end_date": "2022-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-05-18T13:56:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ADVAIR 125",
    "en_drug_common_name": "fluticasone propionate and salmeterol pressurised inhalation, suspension",
    "fr_drug_brand_name": "ADVAIR 125",
    "fr_drug_common_name": "propionate de fluticasone et salmétérol en suspension pressurisée pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE\r\nSALMETEROL",
    "fr_ingredients": "Propionate de fluticasone; Salmétérol (Xinafoate de salmétérol)",
    "drug_strength": "125MCG\r\n25MCG",
    "drug_dosage_form": "AEROSOL, METERED DOSE",
    "drug_dosage_form_fr": "Aérosol, dose mesurée",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "1x120",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158379,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10602,
      "drug_code": 6619,
      "updated_date": "2025-12-03T01:02:00-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8280751,
          "ingredient": {
            "id": 346,
            "ingredient_code": 5054,
            "en_name": "TRETINOIN",
            "fr_name": "Trétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.01",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00657204",
      "brand_name": "STIEVA-A",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63691",
      "number_of_ais": "1",
      "ai_group_no": "0112395003"
    },
    "created_date": "2022-04-08T13:35:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00657204",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "D10AD",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-04-06T00:00:00-04:00",
    "actual_end_date": "2022-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-05-18T13:57:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STIEVA-A",
    "en_drug_common_name": "Tretinoin cream",
    "fr_drug_brand_name": "STIEVA-A",
    "fr_drug_common_name": "Crème de trétinoïne",
    "en_ingredients": "TRETINOIN",
    "fr_ingredients": "Trétinoïne",
    "drug_strength": "0.01%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "25G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158388,
    "drug": {
      "current_status": "MARKETED",
      "id": 102306,
      "drug_code": 101003,
      "updated_date": "2021-10-08T05:17:01-04:00",
      "company": {
        "id": 5379,
        "created_date": "2017-10-07T01:00:14-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17221,
        "mfr_code": "",
        "name": "JAZZ PHARMACEUTICALS IRELAND LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5TH  FLOOR, WATERLOO EXCHANGE, WATERLOO RD.",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "DUBLIN",
        "postal_code": "D04 E5W7",
        "post_office_box": "",
        "contact_information": "Medical Information T: +1 800 520 5568 ; E: medinfo-ca@jazzpharma.com"
      },
      "drug_ingredients": [
        {
          "id": 8266626,
          "ingredient": {
            "id": 36054,
            "ingredient_code": 23662,
            "en_name": "LURBINECTEDIN",
            "fr_name": "Lurbinectédine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02520834",
      "brand_name": "ZEPZELCA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0163176001"
    },
    "created_date": "2022-04-08T15:34:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02520834",
    "company_name": "JAZZ PHARMACEUTICALS IRELAND LIMITED",
    "atc_number": "L01XX",
    "anticipated_start_date": "2022-04-30T00:00:00-04:00",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-08-03T19:10:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZEPZELCA",
    "en_drug_common_name": "lurbinectedin",
    "fr_drug_brand_name": "Zepzelca",
    "fr_drug_common_name": "lurbinectedin",
    "fr_ingredients": "lurbinectedin",
    "drug_strength": "4MG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158393,
    "drug": {
      "current_status": "DORMANT",
      "id": 5358,
      "drug_code": 3492,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 590,
        "created_date": "2017-03-09T13:22:56-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4086,
        "mfr_code": "DUI07",
        "name": "DUCHESNAY INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "950 MICHELE-BOHEC BLVD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 5E2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366155,
          "ingredient": {
            "id": 126,
            "ingredient_code": 7531,
            "en_name": "HYDROCORTISONE ACETATE",
            "fr_name": "Acétate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8366154,
          "ingredient": {
            "id": 46,
            "ingredient_code": 6343,
            "en_name": "PRAMOXINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de pramoxine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00363014",
      "brand_name": "PROCTOFOAM-HC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54534",
      "number_of_ais": "2",
      "ai_group_no": "0211084001"
    },
    "created_date": "2022-04-08T16:25:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00363014",
    "company_name": "DUCHESNAY INC",
    "atc_number": "C05AA",
    "atc_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
    "hc_updated_date": "2024-03-28T16:44:01-04:00",
    "anticipated_start_date": "2022-05-31T00:00:00-04:00",
    "estimated_end_date": "2026-04-30T00:00:00-04:00",
    "actual_start_date": "2022-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-03-05T13:09:33-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "PROCTOFOAM HC",
    "en_drug_common_name": "PROCTOFOAM HC",
    "fr_drug_brand_name": "PROCTOFOAM HC",
    "fr_drug_common_name": "PROCTOFOAM HC",
    "en_ingredients": "PRAMOXINE HYDROCHLORIDE\r\nHYDROCORTISONE ACETATE",
    "fr_ingredients": "Chlorhydrate de pramoxime\r\nAcétate d'hydrocortisone",
    "drug_strength": "1%\r\n1%",
    "drug_dosage_form": "AEROSOL",
    "drug_dosage_form_fr": "Aérosol",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "22.4g",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158396,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21074,
      "drug_code": 83320,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8348673,
          "ingredient": {
            "id": 2292,
            "ingredient_code": 11081,
            "en_name": "ROPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ropivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02347830",
      "brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORHYDRATE DE ROPIVACAÏNE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133273005"
    },
    "created_date": "2022-04-08T17:44:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347830",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2022-04-15T00:00:00-04:00",
    "actual_end_date": "2022-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "ROPIVACAINE HYDROCHLORIDE INJECTION USP",
    "fr_drug_brand_name": "Chlorhydrate de Ropivacaïne Injectable USP",
    "fr_drug_common_name": "Chlorhydrate de Ropivacaïne Injectable USP",
    "en_ingredients": "ROPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ropivacaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nEPIDURAL",
    "drug_route_fr": "Épidurale\r\nÉpidurale",
    "drug_package_quantity": "10 x 20mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158399,
    "drug": {
      "current_status": "MARKETED",
      "id": 24194,
      "drug_code": 86821,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258707,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02382350",
      "brand_name": "MIDAZOLAM INJECTION USP",
      "brand_name_fr": "MIDOZOLAM INJECTABLE US",
      "descriptor": "PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2022-04-08T17:46:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382350",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2022-04-15T00:00:00-04:00",
    "actual_end_date": "2022-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-17T16:58:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION USP",
    "en_drug_common_name": "MIDAZOLAM INJECTION USP",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION USP",
    "fr_drug_common_name": "MIDAZOLAM INJECTION USP",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 1mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158428,
    "drug": {
      "current_status": "MARKETED",
      "id": 18718,
      "drug_code": 79986,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256546,
          "ingredient": {
            "id": 2564,
            "ingredient_code": 11770,
            "en_name": "NARATRIPTAN",
            "fr_name": "Naratriptan (Chlorhydrate de naratriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314304",
      "brand_name": "TEVA-NARATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131121002"
    },
    "created_date": "2022-04-08T20:28:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314304",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2022-04-30T00:00:00-04:00",
    "actual_start_date": "2022-04-08T00:00:00-04:00",
    "actual_end_date": "2022-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-17T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NARATRIPTAN",
    "en_drug_common_name": "TEVA-NARATRIPTAN",
    "fr_drug_brand_name": "TEVA-NARATRIPTAN 2.5MG",
    "fr_drug_common_name": "TEVA-NARATRIPTAN 2.5MG",
    "en_ingredients": "NARATRIPTAN",
    "fr_ingredients": "NARATRIPTAN 2.5MG",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "8",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158445,
    "drug": {
      "current_status": "MARKETED",
      "id": 101107,
      "drug_code": 99592,
      "updated_date": "2020-11-09T00:55:05-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8265698,
          "ingredient": {
            "id": 2920,
            "ingredient_code": 12335,
            "en_name": "INSULIN ASPART",
            "fr_name": "Insuline asparte"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02506564",
      "brand_name": "TRURAPI",
      "brand_name_fr": "",
      "descriptor": "CARTRIDGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144802001"
    },
    "created_date": "2022-04-08T20:35:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02506564",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AB",
    "atc_description": "INSULINS AND ANALOGUES",
    "anticipated_start_date": "2022-04-11T00:00:00-04:00",
    "estimated_end_date": "2022-04-08T00:00:00-04:00",
    "actual_end_date": "2022-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-04-08T20:45:08-04:00",
    "status": "avoided_shortage",
    "en_comments": "Transportation delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Délai de transportation. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "TRURAPI",
    "en_drug_common_name": "insulin aspart injection",
    "fr_drug_brand_name": "TRURAPI",
    "fr_drug_common_name": "insuline asparte injectable",
    "en_ingredients": "INSULIN ASPART",
    "fr_ingredients": "Insuline asparte",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "SoloSTAR",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158457,
    "drug": {
      "current_status": "MARKETED",
      "id": 101108,
      "drug_code": 99593,
      "updated_date": "2020-11-09T00:55:05-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8265699,
          "ingredient": {
            "id": 2920,
            "ingredient_code": 12335,
            "en_name": "INSULIN ASPART",
            "fr_name": "Insuline asparte"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02506572",
      "brand_name": "TRURAPI",
      "brand_name_fr": "",
      "descriptor": "MULTIDOSE PREFILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144802001"
    },
    "created_date": "2022-04-08T20:46:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02506572",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AB",
    "atc_description": "INSULINS AND ANALOGUES",
    "estimated_end_date": "2022-05-13T00:00:00-04:00",
    "actual_start_date": "2022-04-11T00:00:00-04:00",
    "actual_end_date": "2022-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-13T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Transportation delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Délai de transportation. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "TRURAPI",
    "en_drug_common_name": "insulin aspart injection",
    "fr_drug_brand_name": "TRURAPI",
    "fr_drug_common_name": "insuline asparte injectable",
    "en_ingredients": "INSULIN ASPART",
    "fr_ingredients": "Insuline asparte",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "SoloSTAR",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158479,
    "drug": {
      "current_status": "MARKETED",
      "id": 49981,
      "drug_code": 94502,
      "updated_date": "2025-05-15T02:35:36-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8262149,
          "ingredient": {
            "id": 3280,
            "ingredient_code": 12477,
            "en_name": "TRAVOPROST",
            "fr_name": "Travoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.003",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02457997",
      "brand_name": "IZBA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145801002"
    },
    "created_date": "2022-04-11T17:50:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457997",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01EE",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2022-04-11T00:00:00-04:00",
    "estimated_end_date": "2022-05-09T00:00:00-04:00",
    "actual_start_date": "2022-04-11T00:00:00-04:00",
    "actual_end_date": "2022-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-11T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Delay related to packaging component",
    "fr_comments": "Retard lié au composant d'emballage",
    "en_drug_brand_name": "IZBA",
    "en_drug_common_name": "IZBA 0.003% SOLN. 5ML",
    "fr_drug_brand_name": "IZBA",
    "fr_drug_common_name": "IZBA 0.003% SOLN. 5ML",
    "en_ingredients": "TRAVOPROST",
    "fr_ingredients": "Travoprost",
    "drug_strength": "0.003%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158484,
    "drug": {
      "current_status": "MARKETED",
      "id": 4786,
      "drug_code": 259,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8250139,
          "ingredient": {
            "id": 106,
            "ingredient_code": 8519,
            "en_name": "POLYMYXIN B SULFATE",
            "fr_name": "Sulfate de polymyxine b"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250138,
          "ingredient": {
            "id": 56,
            "ingredient_code": 8638,
            "en_name": "NEOMYCIN",
            "fr_name": "Néomycine (Sulfate de néomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250137,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "00042676",
      "brand_name": "MAXITROL",
      "brand_name_fr": "",
      "descriptor": "SUSPENSION",
      "pediatric_flag": false,
      "accession_number": "09947",
      "number_of_ais": "3",
      "ai_group_no": "0305643001"
    },
    "created_date": "2022-04-11T18:06:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00042676",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01CA",
    "atc_description": "ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB",
    "anticipated_start_date": "2022-05-09T00:00:00-04:00",
    "estimated_end_date": "2022-06-14T00:00:00-04:00",
    "actual_end_date": "2022-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-17T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAXITROL",
    "en_drug_common_name": "MAXITROL SUSP. 5ML",
    "fr_drug_brand_name": "MAXITROL",
    "fr_drug_common_name": "MAXITROL SUSP. 5ML",
    "en_ingredients": "POLYMYXIN B SULFATE\r\nNEOMYCIN\r\nDEXAMETHASONE",
    "fr_ingredients": "Sulfate de polymyxine b\r\nNéomycine\r\nDexaméthasone",
    "drug_strength": "6000UNIT\r\n3.5MG\r\n0.1%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158487,
    "drug": {
      "current_status": "MARKETED",
      "id": 13010,
      "drug_code": 72310,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254752,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "SACHET",
          "base": false
        }
      ],
      "din": "02247997",
      "brand_name": "SINGULAIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823003"
    },
    "created_date": "2022-04-11T18:45:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247997",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "anticipated_start_date": "2022-05-20T00:00:00-04:00",
    "estimated_end_date": "2023-01-13T00:00:00-05:00",
    "actual_start_date": "2022-05-05T00:00:00-04:00",
    "actual_end_date": "2023-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-10T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Other formats remain available.",
    "fr_comments": "Les autres formats sont encore disponibles.",
    "en_drug_brand_name": "SINGULAIR",
    "en_drug_common_name": "montelukast granules for oral use",
    "fr_drug_brand_name": "SINGULAIR",
    "fr_drug_common_name": "granulés de montélukast pour administration orale",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "montélukast",
    "drug_strength": "4MG",
    "drug_dosage_form": "GRANULES",
    "drug_dosage_form_fr": "Granules",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158491,
    "drug": {
      "current_status": "MARKETED",
      "id": 6728,
      "drug_code": 44187,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253161,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "755",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172755",
      "brand_name": "OMNIPAQUE 350",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9821",
      "number_of_ais": "1",
      "ai_group_no": "0116846006"
    },
    "created_date": "2022-04-11T18:51:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172755",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2022-04-12T00:00:00-04:00",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-12T00:00:00-04:00",
    "actual_end_date": "2022-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-22T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNIPAQUE 350",
    "en_drug_common_name": "iohexol injection USP",
    "fr_drug_brand_name": "Omnipaque 350",
    "fr_drug_common_name": "injection d'iohexol USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "755MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVASCULAR\r\nINTRAVASCULAR",
    "drug_route_fr": "Intravasculaire\r\nIntravasculaire",
    "drug_package_quantity": "500 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158494,
    "drug": {
      "current_status": "MARKETED",
      "id": 100757,
      "drug_code": 99139,
      "updated_date": "2020-08-04T23:50:46-04:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265356,
          "ingredient": {
            "id": 1728,
            "ingredient_code": 8833,
            "en_name": "SUCCINYLCHOLINE CHLORIDE",
            "fr_name": "Chlorure de succinylcholine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02501783",
      "brand_name": "SUCCINYLCHOLINE CHLORIDE INJECTION, USP",
      "brand_name_fr": "CHLORURE DE SUCCINYLCHOLINE INJECTABLE USP",
      "descriptor": "MULTI-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105141001"
    },
    "created_date": "2022-04-11T20:04:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02501783",
    "company_name": "DR REDDY'S LABORATORIES LTD",
    "atc_number": "M03AB",
    "atc_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
    "anticipated_start_date": "2022-04-11T00:00:00-04:00",
    "estimated_end_date": "2022-10-31T00:00:00-04:00",
    "actual_start_date": "2022-04-11T00:00:00-04:00",
    "actual_end_date": "2022-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-10-31T20:33:37-04:00",
    "status": "resolved",
    "en_comments": "Please contact customer service 1-855-550-5528 (Monday to Friday from: 9:00 am to 5:00 pm ET).",
    "fr_comments": "Veuillez contacter le service à la clientèle au 1-855-550-5528 (du lundi au vendredi de 9 h 00 à 17 h 00 HE).",
    "en_drug_brand_name": "SUCCINYLCHOLINE CHLORIDE INJECTION, USP",
    "en_drug_common_name": "Succinylcholine Chloride Injection",
    "fr_drug_brand_name": "CHLORURE DE SUCCINYLCHOLINE INJECTABLE USP",
    "fr_drug_common_name": "CHLORURE DE SUCCINYLCHOLINE INJECTABLE",
    "en_ingredients": "SUCCINYLCHOLINE CHLORIDE",
    "fr_ingredients": "Chlorure de succinylcholine",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 mL Multi Dose Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158497,
    "drug": {
      "current_status": "MARKETED",
      "id": 5808,
      "drug_code": 3891,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8250580,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250579,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "42000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250578,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10800",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00502790",
      "brand_name": "COTAZYM ECS 8",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "55867",
      "number_of_ais": "3",
      "ai_group_no": "0302964031"
    },
    "created_date": "2022-04-11T20:09:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00502790",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "anticipated_start_date": "2022-04-29T00:00:00-04:00",
    "estimated_end_date": "2022-05-13T00:00:00-04:00",
    "actual_start_date": "2022-04-28T00:00:00-04:00",
    "actual_end_date": "2022-05-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-05-09T13:04:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COTAZYM ECS 8",
    "en_drug_common_name": "PANCRELIPASE DELAYED-RELEASE CAPSULES",
    "fr_drug_brand_name": "COTAZYM E.C.S.",
    "fr_drug_common_name": "CAPSULES DE PANCRÉLIPASE À LIBÉRATION RETARDÉE",
    "en_ingredients": "PROTEASE\r\nAMYLASE\r\nLIPASE",
    "fr_ingredients": "Protéase\r\nAmylase\r\nLipase",
    "drug_strength": "45000UNIT\r\n42000UNIT\r\n10800UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158518,
    "drug": {
      "current_status": "MARKETED",
      "id": 30566,
      "drug_code": 92621,
      "updated_date": "2025-05-15T02:34:48-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8261216,
          "ingredient": {
            "id": 2970,
            "ingredient_code": 12724,
            "en_name": "INSULIN GLARGINE",
            "fr_name": "Insuline glargine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02441829",
      "brand_name": "TOUJEO SOLOSTAR",
      "brand_name_fr": "",
      "descriptor": "1.5ML (450 IU) PREFILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147062002"
    },
    "created_date": "2022-04-12T03:06:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02441829",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AE",
    "atc_description": "INSULINS AND ANALOGUES",
    "estimated_end_date": "2022-05-02T00:00:00-04:00",
    "actual_start_date": "2022-04-08T00:00:00-04:00",
    "actual_end_date": "2022-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-04-27T02:59:04-04:00",
    "status": "resolved",
    "en_comments": "Transportation delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Délai de transportation. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "TOUJEO SOLOSTAR",
    "en_drug_common_name": "insulin glargine injection",
    "fr_drug_brand_name": "TOUJEO SoloSTAR",
    "fr_drug_common_name": "insuline glargine injectable",
    "en_ingredients": "INSULIN GLARGINE",
    "fr_ingredients": "Insuline glargine",
    "drug_strength": "300UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "5 x 1.5 mL pen",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158553,
    "drug": {
      "current_status": "MARKETED",
      "id": 18688,
      "drug_code": 79955,
      "updated_date": "2025-12-03T00:31:20-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256536,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314037",
      "brand_name": "SPC-ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618001"
    },
    "created_date": "2022-04-12T15:13:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314037",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2022-07-06T00:00:00-04:00",
    "estimated_end_date": "2023-10-15T00:00:00-04:00",
    "actual_start_date": "2022-09-09T00:00:00-04:00",
    "actual_end_date": "2024-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-09T21:13:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-ROPINIROLE",
    "en_drug_common_name": "ROPINIROLE",
    "fr_drug_brand_name": "RAN-ROPINIROLE",
    "fr_drug_common_name": "ROPINIROLE",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158598,
    "drug": {
      "current_status": "MARKETED",
      "id": 55427,
      "drug_code": 95437,
      "updated_date": "2025-05-15T02:35:55-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262599,
          "ingredient": {
            "id": 1230,
            "ingredient_code": 1209,
            "en_name": "ACITRETIN",
            "fr_name": "Acitrétine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466074",
      "brand_name": "TARO-ACITRETIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122473002"
    },
    "created_date": "2022-04-12T15:49:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466074",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D05BB",
    "atc_description": "ANTIPSORIATICS FOR SYSTEMIC USE",
    "estimated_end_date": "2022-04-15T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-04-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T14:12:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-ACITRETIN",
    "en_drug_common_name": "ACITRETIN",
    "fr_drug_brand_name": "TARO-ACITRETIN",
    "fr_drug_common_name": "ACITRETIN",
    "en_ingredients": "ACITRETIN",
    "fr_ingredients": "Acitrétine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158601,
    "drug": {
      "current_status": "MARKETED",
      "id": 27482,
      "drug_code": 8972,
      "updated_date": "2025-05-15T02:30:42-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251115,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00716618",
      "brand_name": "BETADERM CRM 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "67692",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2022-04-12T15:51:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716618",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-04-15T00:00:00-04:00",
    "actual_start_date": "2022-03-24T00:00:00-04:00",
    "actual_end_date": "2022-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T14:10:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BETADERM CRM 0.05%",
    "en_drug_common_name": "BETADERM",
    "fr_drug_brand_name": "TARO-BETADERM CREAM .05%",
    "fr_drug_common_name": "BETADERM",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "454",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158608,
    "drug": {
      "current_status": "MARKETED",
      "id": 30664,
      "drug_code": 9270,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251140,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00716642",
      "brand_name": "BETADERM ONT 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68222",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2022-04-12T15:57:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716642",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-03-17T00:00:00-04:00",
    "actual_end_date": "2022-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T14:08:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BETADERM ONT 0.05%",
    "en_drug_common_name": "BETADERM",
    "fr_drug_brand_name": "TARO-BETADERM OINT 0.05%",
    "fr_drug_common_name": "BETADERM",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "454",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158611,
    "drug": {
      "current_status": "MARKETED",
      "id": 53021,
      "drug_code": 94454,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262117,
          "ingredient": {
            "id": 2586,
            "ingredient_code": 11787,
            "en_name": "CAPECITABINE",
            "fr_name": "Capécitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457490",
      "brand_name": "TARO-CAPECITABINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134120001"
    },
    "created_date": "2022-04-12T17:01:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457490",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2022-11-11T00:00:00-05:00",
    "actual_start_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-11-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-16T03:40:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CAPECITABINE",
    "en_drug_common_name": "CAPECITABINE",
    "fr_drug_brand_name": "TARO-CAPECITABINE",
    "fr_drug_common_name": "CAPECITABINE",
    "en_ingredients": "CAPECITABINE",
    "fr_ingredients": "Capécitabine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158614,
    "drug": {
      "current_status": "MARKETED",
      "id": 11866,
      "drug_code": 69610,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254398,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245523",
      "brand_name": "TARO-CLOBETASOL CREAM USP, 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2022-04-12T17:05:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245523",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-09-09T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-09-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-16T15:06:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL CREAM USP, 0.05%",
    "en_drug_common_name": "CLOBETASOL",
    "fr_drug_brand_name": "TARO-CLOBETASOL",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158617,
    "drug": {
      "current_status": "MARKETED",
      "id": 11868,
      "drug_code": 69611,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254399,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245524",
      "brand_name": "TARO-CLOBETASOL OINTMENT USP, 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2022-04-12T17:06:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245524",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-09-09T00:00:00-04:00",
    "actual_start_date": "2022-04-05T00:00:00-04:00",
    "actual_end_date": "2022-08-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-16T15:08:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL OINTMENT USP, 0.05%",
    "en_drug_common_name": "CLOBETASOL",
    "fr_drug_brand_name": "TARO-CLOBETASOL OINT",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158620,
    "drug": {
      "current_status": "MARKETED",
      "id": 11868,
      "drug_code": 69611,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254399,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245524",
      "brand_name": "TARO-CLOBETASOL OINTMENT USP, 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2022-04-12T17:08:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245524",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-04-06T00:00:00-04:00",
    "actual_end_date": "2022-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-01T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL OINTMENT USP, 0.05%",
    "en_drug_common_name": "CLOBETASOL",
    "fr_drug_brand_name": "TARO-CLOBETASOL OINT",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158623,
    "drug": {
      "current_status": "MARKETED",
      "id": 11868,
      "drug_code": 69611,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254399,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245524",
      "brand_name": "TARO-CLOBETASOL OINTMENT USP, 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2022-04-12T17:10:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245524",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-03-11T00:00:00-05:00",
    "actual_end_date": "2022-06-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T13:52:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL OINTMENT USP, 0.05%",
    "en_drug_common_name": "CLOBETASOL",
    "fr_drug_brand_name": "TARO-CLOBETASOL OINT",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "454",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158626,
    "drug": {
      "current_status": "MARKETED",
      "id": 11866,
      "drug_code": 69610,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254398,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245523",
      "brand_name": "TARO-CLOBETASOL CREAM USP, 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2022-04-12T17:11:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245523",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-04-11T00:00:00-04:00",
    "actual_end_date": "2022-08-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T13:50:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL CREAM USP, 0.05%",
    "en_drug_common_name": "CLOBETASOL",
    "fr_drug_brand_name": "TARO-CLOBETASOL CREAM",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "454",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158644,
    "drug": {
      "current_status": "MARKETED",
      "id": 63466,
      "drug_code": 97594,
      "updated_date": "2025-05-15T02:37:30-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263906,
          "ingredient": {
            "id": 1938,
            "ingredient_code": 4893,
            "en_name": "CALCITRIOL",
            "fr_name": "Calcitriol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02485710",
      "brand_name": "TARO-CALCITRIOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113628001"
    },
    "created_date": "2022-04-12T18:29:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485710",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "A11CC",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "estimated_end_date": "2022-04-15T00:00:00-04:00",
    "actual_start_date": "2022-04-08T00:00:00-04:00",
    "actual_end_date": "2022-08-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T13:49:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CALCITRIOL",
    "en_drug_common_name": "CALCITRIOL",
    "fr_drug_brand_name": "TARO-CALCITRIOL",
    "fr_drug_common_name": "CALCITRIOL",
    "en_ingredients": "CALCITRIOL",
    "fr_ingredients": "Calcitriol",
    "drug_strength": "0.25MCG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158647,
    "drug": {
      "current_status": "MARKETED",
      "id": 53021,
      "drug_code": 94454,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262117,
          "ingredient": {
            "id": 2586,
            "ingredient_code": 11787,
            "en_name": "CAPECITABINE",
            "fr_name": "Capécitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457490",
      "brand_name": "TARO-CAPECITABINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134120001"
    },
    "created_date": "2022-04-12T18:33:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457490",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2022-11-11T00:00:00-05:00",
    "actual_start_date": "2022-02-25T00:00:00-05:00",
    "actual_end_date": "2022-11-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-04T01:01:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CAPECITABINE",
    "en_drug_common_name": "CAPECITABINE",
    "fr_drug_brand_name": "TARO-CAPECITABINE",
    "fr_drug_common_name": "CAPECITABINE",
    "en_ingredients": "CAPECITABINE",
    "fr_ingredients": "Capécitabine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158650,
    "drug": {
      "current_status": "MARKETED",
      "id": 11866,
      "drug_code": 69610,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254398,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245523",
      "brand_name": "TARO-CLOBETASOL CREAM USP, 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2022-04-12T18:36:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245523",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-04-11T00:00:00-04:00",
    "actual_end_date": "2022-08-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T13:46:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL CREAM USP, 0.05%",
    "en_drug_common_name": "CLOBETASOL",
    "fr_drug_brand_name": "TARO-CLOBETASOL CREAM",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "454",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158653,
    "drug": {
      "current_status": "MARKETED",
      "id": 27502,
      "drug_code": 8974,
      "updated_date": "2025-05-15T02:30:42-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251117,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00716731",
      "brand_name": "TARO-DOCUSATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "67694",
      "number_of_ais": "1",
      "ai_group_no": "0104351002"
    },
    "created_date": "2022-04-12T18:38:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716731",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "A06AA",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-08T00:00:00-04:00",
    "actual_end_date": "2022-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T13:44:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-DOCUSATE",
    "en_drug_common_name": "DOCUSATE SODIUM",
    "fr_drug_brand_name": "TARO - DOCUSATE SODIUM CAPS",
    "fr_drug_common_name": "DOCUSATE SODIUM",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158658,
    "drug": {
      "current_status": "MARKETED",
      "id": 22670,
      "drug_code": 85196,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258174,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02367157",
      "brand_name": "TARO-MOMETASONE CREAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732001"
    },
    "created_date": "2022-04-12T18:45:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367157",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-04-15T00:00:00-04:00",
    "actual_start_date": "2022-04-08T00:00:00-04:00",
    "actual_end_date": "2022-08-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T13:42:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-MOMETASONE CREAM",
    "en_drug_common_name": "MOMETASONE",
    "fr_drug_brand_name": "TARO-MOMETASONE CREAM",
    "fr_drug_common_name": "MOMETASONE",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158661,
    "drug": {
      "current_status": "MARKETED",
      "id": 14810,
      "drug_code": 75180,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255314,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02266385",
      "brand_name": "TARO-MOMETASONE LOTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732001"
    },
    "created_date": "2022-04-12T18:48:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02266385",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-03-31T00:00:00-04:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T13:41:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-MOMETASONE LOTION",
    "en_drug_common_name": "MOMETASONE",
    "fr_drug_brand_name": "TARO-MOMETASONE LOTION",
    "fr_drug_common_name": "MOMETASONE",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "75",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158664,
    "drug": {
      "current_status": "MARKETED",
      "id": 15820,
      "drug_code": 76560,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255666,
          "ingredient": {
            "id": 1124,
            "ingredient_code": 1832,
            "en_name": "MUPIROCIN",
            "fr_name": "Mupirocine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02279983",
      "brand_name": "TARO-MUPIROCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117081001"
    },
    "created_date": "2022-04-12T18:50:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279983",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D06AX",
    "atc_description": "ANTIBIOTICS FOR TOPICAL USE",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-08T00:00:00-04:00",
    "actual_end_date": "2022-08-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T13:39:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-MUPIROCIN",
    "en_drug_common_name": "MUPIROCIN",
    "fr_drug_brand_name": "TARO-MUPIROCIN OINT",
    "fr_drug_common_name": "MUPIROCIN",
    "en_ingredients": "MUPIROCIN",
    "fr_ingredients": "Mupirocine",
    "drug_strength": "2%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158667,
    "drug": {
      "current_status": "MARKETED",
      "id": 30764,
      "drug_code": 92823,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261329,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443554",
      "brand_name": "TARO-TEMOZOLOMIDE",
      "brand_name_fr": "TARO-TÉMOZOLOMIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781004"
    },
    "created_date": "2022-04-12T18:52:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443554",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-03-04T00:00:00-05:00",
    "actual_end_date": "2022-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-25T13:37:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE",
    "fr_drug_brand_name": "TARO-TEMOZOLOMIDE 250mg",
    "fr_drug_common_name": "TEMOZOLOMIDE",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158670,
    "drug": {
      "current_status": "MARKETED",
      "id": 28450,
      "drug_code": 90578,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260314,
          "ingredient": {
            "id": 878,
            "ingredient_code": 7469,
            "en_name": "TESTOSTERONE UNDECANOATE",
            "fr_name": "Undécanoate de testostérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02421186",
      "brand_name": "TARO-TESTOSTERONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120414001"
    },
    "created_date": "2022-04-12T18:54:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02421186",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "G03BA",
    "atc_description": "ANDROGENS",
    "estimated_end_date": "2022-04-15T00:00:00-04:00",
    "actual_start_date": "2022-03-03T00:00:00-05:00",
    "actual_end_date": "2022-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-05T20:49:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-TESTOSTERONE",
    "en_drug_common_name": "TESTOSTERONE",
    "fr_drug_brand_name": "TARO-TESTOSTERONE",
    "fr_drug_common_name": "TESTOSTERONE",
    "en_ingredients": "TESTOSTERONE UNDECANOATE",
    "fr_ingredients": "Undécanoate de testostérone",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158673,
    "drug": {
      "current_status": "MARKETED",
      "id": 31358,
      "drug_code": 93657,
      "updated_date": "2025-12-03T00:32:59-05:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261670,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02450429",
      "brand_name": "TARO-TRAMADOL ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694005"
    },
    "created_date": "2022-04-12T18:58:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450429",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-09-23T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-09-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-16T15:15:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-TRAMADOL ER",
    "en_drug_common_name": "TRAMADOL",
    "fr_drug_brand_name": "TARO-TRAMADOL",
    "fr_drug_common_name": "TRAMODOL",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158676,
    "drug": {
      "current_status": "MARKETED",
      "id": 31360,
      "drug_code": 93658,
      "updated_date": "2025-12-03T00:32:59-05:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261671,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02450437",
      "brand_name": "TARO-TRAMADOL ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694003"
    },
    "created_date": "2022-04-12T19:03:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450437",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-09-23T00:00:00-04:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-09-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-16T15:14:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-TRAMADOL ER",
    "en_drug_common_name": "TRAMADOL",
    "fr_drug_brand_name": "TARO-TRAMADOL",
    "fr_drug_common_name": "TRAMODOL",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158679,
    "drug": {
      "current_status": "MARKETED",
      "id": 31362,
      "drug_code": 93659,
      "updated_date": "2025-12-03T00:32:59-05:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261672,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02450445",
      "brand_name": "TARO-TRAMADOL ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694001"
    },
    "created_date": "2022-04-12T19:06:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450445",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2023-02-24T00:00:00-05:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2023-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-28T22:24:29-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-TRAMADOL ER",
    "en_drug_common_name": "TRAMADOL",
    "fr_drug_brand_name": "TARO-TRAMADOL",
    "fr_drug_common_name": "TRAMODOL",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158682,
    "drug": {
      "current_status": "MARKETED",
      "id": 31938,
      "drug_code": 9448,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251168,
          "ingredient": {
            "id": 54,
            "ingredient_code": 8523,
            "en_name": "GRAMICIDIN",
            "fr_name": "Gramicidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251167,
          "ingredient": {
            "id": 56,
            "ingredient_code": 8638,
            "en_name": "NEOMYCIN",
            "fr_name": "Néomycine (Sulfate de néomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": true
        },
        {
          "id": 8251166,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251165,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "00717002",
      "brand_name": "VIADERM KC CRM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68586",
      "number_of_ais": "4",
      "ai_group_no": "0405625002"
    },
    "created_date": "2022-04-12T19:07:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00717002",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07CB",
    "atc_description": "CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",
    "estimated_end_date": "2022-09-09T00:00:00-04:00",
    "actual_start_date": "2022-08-02T00:00:00-04:00",
    "actual_end_date": "2022-09-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-16T15:12:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VIADERM KC CRM",
    "en_drug_common_name": "VIADERM KC",
    "fr_drug_brand_name": "TARO-VIADERM KC CREAM",
    "fr_drug_common_name": "VIADERM KC",
    "en_ingredients": "NYSTATIN\r\nGRAMICIDIN\r\nNEOMYCIN\r\nTRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Nystatine\r\nGramicidine\r\nNéomycine\r\nAcétonide  de triamcinolone",
    "drug_strength": "100000UNIT\r\n0.25MG\r\n2.5MG\r\n1MG",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158687,
    "drug": {
      "current_status": "MARKETED",
      "id": 2640,
      "drug_code": 1628,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250286,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250285,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250284,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250283,
          "ingredient": {
            "id": 8,
            "ingredient_code": 1074,
            "en_name": "SODIUM LACTATE",
            "fr_name": "Lactate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "310",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00061085",
      "brand_name": "LACTATED RINGER'S INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "42170",
      "number_of_ais": "4",
      "ai_group_no": "0400132001"
    },
    "created_date": "2022-04-12T20:20:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00061085",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BB",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2022-04-14T00:00:00-04:00",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-21T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LACTATED RINGER'S INJECTION, USP",
    "en_drug_common_name": "Lactated Ringer's Injection USP",
    "fr_drug_brand_name": "Lactated Ringer's Injection USP",
    "fr_drug_common_name": "Lactated Ringer's Injection USP",
    "en_ingredients": "CALCIUM CHLORIDE\r\nPOTASSIUM CHLORIDE\r\nSODIUM LACTATE\r\nSODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de calcium\r\nChlorure de potassium\r\nLactate de sodium\r\nChlorure de sodium",
    "drug_strength": "20MG\r\n30MG\r\n310MG\r\n600MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158702,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17270,
      "drug_code": 78323,
      "updated_date": "2025-05-15T04:12:47-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8344388,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02297906",
      "brand_name": "SANDOZ PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541001"
    },
    "created_date": "2022-04-13T04:03:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02297906",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2022-04-12T00:00:00-04:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-21T01:03:13-04:00",
    "status": "resolved",
    "en_comments": "Dicontinued",
    "en_drug_brand_name": "SANDOZ PIOGLITAZONE",
    "en_drug_common_name": "PIOGLITAZONE",
    "fr_drug_brand_name": "SANDOZ PIOGLITAZONE",
    "fr_drug_common_name": "PIOGLITAZONE",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "PIOGLITAZONE",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90TAB BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158706,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7092,
      "drug_code": 4806,
      "updated_date": "2025-05-15T03:27:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8277336,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00544884",
      "brand_name": "CODEINE PHOSPHATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58792",
      "number_of_ais": "1",
      "ai_group_no": "0104398004"
    },
    "created_date": "2022-04-13T04:05:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00544884",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "R05DA",
    "atc_description": "COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS",
    "actual_start_date": "2022-04-12T00:00:00-04:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-21T01:07:23-04:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontinué",
    "en_drug_brand_name": "CODEINE PHOSPHATE INJECTION USP",
    "en_drug_common_name": "CODEINE PHOSPHATE",
    "fr_drug_brand_name": "CODEINE PHOSPHATE INJECTION USP",
    "fr_drug_common_name": "CODEINE PHOSPHATE",
    "en_ingredients": "CODEINE PHOSPHATE",
    "fr_ingredients": "Phosphate de codéine",
    "drug_strength": "30MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire\r\nSous-cutanée\r\nIntramusculaire",
    "drug_package_quantity": "1ML 10LIAM",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158717,
    "drug": {
      "current_status": "MARKETED",
      "id": 11666,
      "drug_code": 68782,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254338,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244792",
      "brand_name": "SANDOZ MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545010"
    },
    "created_date": "2022-04-13T04:17:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244792",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2023-02-03T00:00:00-05:00",
    "actual_start_date": "2022-08-18T00:00:00-04:00",
    "actual_end_date": "2023-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-09T18:48:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MORPHINE SR",
    "en_drug_common_name": "MORPHINE SR",
    "fr_drug_brand_name": "SANDOZ MORPHINE SR",
    "fr_drug_common_name": "MORPHINE SR",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100PRT BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158741,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 31420,
      "drug_code": 93740,
      "updated_date": "2025-05-15T04:24:27-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8356558,
          "ingredient": {
            "id": 4130,
            "ingredient_code": 22679,
            "en_name": "GRAZOPREVIR",
            "fr_name": "Grazoprévir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8356557,
          "ingredient": {
            "id": 4132,
            "ingredient_code": 22680,
            "en_name": "ELBASVIR",
            "fr_name": "Elbasvir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02451131",
      "brand_name": "ZEPATIER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257730001"
    },
    "created_date": "2022-04-13T20:03:13-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02451131",
    "company_name": "MERCK CANADA INC",
    "atc_number": "J05AP",
    "discontinuation_date": "2022-08-16T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-08-17T19:13:58-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ZEPATIER",
    "en_drug_common_name": "Elbasvir / Grazoprevir",
    "fr_drug_brand_name": "ZEPATIER",
    "fr_drug_common_name": "Elbasvir / Grazoprevir",
    "en_ingredients": "GRAZOPREVIR\r\nELBASVIR",
    "fr_ingredients": "Grazoprévir\r\nElbasvir",
    "drug_strength": "100MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28TAB",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158756,
    "drug": {
      "current_status": "MARKETED",
      "id": 626,
      "drug_code": 11370,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251518,
          "ingredient": {
            "id": 418,
            "ingredient_code": 8344,
            "en_name": "CEFTAZIDIME",
            "fr_name": "Ceftazidime (Ceftazidime pentahydratée)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00886971",
      "brand_name": "CEFTAZIDIME FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72032",
      "number_of_ais": "1",
      "ai_group_no": "0116900004"
    },
    "created_date": "2022-04-13T20:57:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00886971",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01DD",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "anticipated_start_date": "2022-04-30T00:00:00-04:00",
    "estimated_end_date": "2022-06-01T00:00:00-04:00",
    "actual_start_date": "2022-04-30T00:00:00-04:00",
    "actual_end_date": "2022-05-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-24T15:50:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFTAZIDIME FOR INJECTION, USP",
    "en_drug_common_name": "Ceftazidime for Injection, USP",
    "fr_drug_brand_name": "Ceftazidime pour injection, USP",
    "fr_drug_common_name": "Ceftazidime pour injection, USP",
    "en_ingredients": "CEFTAZIDIME",
    "fr_ingredients": "Ceftazidime",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "20mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158759,
    "drug": {
      "current_status": "MARKETED",
      "id": 628,
      "drug_code": 11371,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251519,
          "ingredient": {
            "id": 418,
            "ingredient_code": 8344,
            "en_name": "CEFTAZIDIME",
            "fr_name": "Ceftazidime (Ceftazidime pentahydratée)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00886963",
      "brand_name": "CEFTAZIDIME FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72033",
      "number_of_ais": "1",
      "ai_group_no": "0116900003"
    },
    "created_date": "2022-04-13T20:58:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00886963",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01DD",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "anticipated_start_date": "2022-04-30T00:00:00-04:00",
    "estimated_end_date": "2022-06-01T00:00:00-04:00",
    "actual_end_date": "2022-05-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-24T15:50:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFTAZIDIME FOR INJECTION, USP",
    "en_drug_common_name": "Ceftazidime for Injection, USP",
    "fr_drug_brand_name": "Ceftazidime pour injection, USP",
    "fr_drug_common_name": "Ceftazidime pour injection, USP",
    "en_ingredients": "CEFTAZIDIME",
    "fr_ingredients": "Ceftazidime",
    "drug_strength": "6G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158762,
    "drug": {
      "current_status": "MARKETED",
      "id": 27216,
      "drug_code": 89462,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259813,
          "ingredient": {
            "id": 3122,
            "ingredient_code": 11309,
            "en_name": "CEFTRIAXONE",
            "fr_name": "Ceftriaxone (Ceftriaxone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "BAG",
          "base": false
        }
      ],
      "din": "02409968",
      "brand_name": "CEFTRIAXONE FOR INJECTION",
      "brand_name_fr": "CEFTRIAXONE POUR INJECTION",
      "descriptor": "SMARTPACK BULK PACKAGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117292009"
    },
    "created_date": "2022-04-13T21:00:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02409968",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01DD",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2022-04-30T00:00:00-04:00",
    "actual_start_date": "2022-02-01T00:00:00-05:00",
    "actual_end_date": "2022-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-02T07:08:59-04:00",
    "status": "resolved",
    "en_comments": ".",
    "fr_comments": "Sous 100% allocation",
    "en_drug_brand_name": "CEFTRIAXONE FOR INJECTION",
    "en_drug_common_name": "CefTRIAXone for Injection",
    "fr_drug_brand_name": "CefTRIAXone pour injection en SmartPak® de 100 g",
    "fr_drug_common_name": "CefTRIAXone pour injection en SmartPak® de 100 g",
    "en_ingredients": "CEFTRIAXONE",
    "fr_ingredients": "CefTRIAXone",
    "drug_strength": "100G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158765,
    "drug": {
      "current_status": "MARKETED",
      "id": 25294,
      "drug_code": 87773,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259168,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02392453",
      "brand_name": "HEPARIN SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE. 0.5ML SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596002"
    },
    "created_date": "2022-04-13T21:01:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392453",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2023-03-01T00:00:00-05:00",
    "actual_start_date": "2023-01-05T00:00:00-05:00",
    "actual_end_date": "2023-02-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-03-01T16:14:59-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we have encountered a supply interruption on our Heparin Sodium Injection, USP 10 000 USP units/mL SD Vial 0.5 mL effective immediately until March 1, 2023.",
    "fr_comments": "Fresenius Kabi Canada a le regret de vous informer qu’en raison de circonstances imprévues, nous allons éprouver une interruption d’approvisionnement touchant notre préparation d’Héparine sodique injectable, USP 10 000 unités USP/mL, fiole DU, 0,5 mL, à compter immédiatement jusqu’au 1 mars 2023.",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION, USP",
    "en_drug_common_name": "Heparin Sodium Injection, USP",
    "fr_drug_brand_name": "Héparine sodique injectable, USP",
    "fr_drug_common_name": "Héparine sodique injectable, USP",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "0.5mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158768,
    "drug": {
      "id": 10848,
      "drug_code": 66736,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254095,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242904",
      "brand_name": "MIDAZOLAM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "MUTI-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935002"
    },
    "created_date": "2022-04-13T21:03:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242904",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2022-02-02T00:00:00-05:00",
    "actual_end_date": "2022-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-08-04T15:07:15-04:00",
    "status": "resolved",
    "en_comments": "On 100% allocation",
    "fr_comments": "Sous 100 % allocation",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "Midazolam Injection",
    "fr_drug_brand_name": "Midazolam injectable",
    "fr_drug_common_name": "Midazolam injectable",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158771,
    "drug": {
      "current_status": "MARKETED",
      "id": 10850,
      "drug_code": 66737,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254096,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242905",
      "brand_name": "MIDAZOLAM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "MULTI-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2022-04-13T21:04:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242905",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-01T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "On 100% allocation",
    "fr_comments": "Sous 100 % allocation",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "Midazolam Injection",
    "fr_drug_brand_name": "Midazolam injectable",
    "fr_drug_common_name": "Midazolam injectable",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "2 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158774,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 99175,
      "drug_code": 95407,
      "updated_date": "2020-04-03T06:53:26-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357430,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "36",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8357429,
          "ingredient": {
            "id": 3416,
            "ingredient_code": 11242,
            "en_name": "TAZOBACTAM",
            "fr_name": "Tazobactam (Tazobactam sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02465833",
      "brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
      "brand_name_fr": "PRPIPÉRACILLINE ET TAZOBACTAM POUR INJECTION",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0225919008"
    },
    "created_date": "2022-04-13T21:06:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02465833",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2022-04-30T00:00:00-04:00",
    "actual_start_date": "2022-01-10T00:00:00-05:00",
    "actual_end_date": "2022-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-02T07:09:39-04:00",
    "status": "resolved",
    "en_comments": "On 100% allocation",
    "fr_comments": "Sous 100 % allocation",
    "en_drug_brand_name": "PIPERACILLIN AND TAZOBACTAM FOR INJECTION",
    "en_drug_common_name": "Piperacillin and Tazobactam for Injection",
    "fr_drug_brand_name": "Pipéracilline et Tazobactam pour injection",
    "fr_drug_common_name": "Pipéracilline et Tazobactam pour injection",
    "en_ingredients": "TAZOBACTAM\r\nPIPERACILLIN",
    "fr_ingredients": "Pipéracilline et Tazobactam",
    "drug_strength": "4.5G\r\n36G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "200 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158777,
    "drug": {
      "current_status": "MARKETED",
      "id": 3868,
      "drug_code": 19442,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252489,
          "ingredient": {
            "id": 158,
            "ingredient_code": 5319,
            "en_name": "POTASSIUM PHOSPHATE DIBASIC",
            "fr_name": "Phosphate de potassium dibasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "236",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252488,
          "ingredient": {
            "id": 160,
            "ingredient_code": 6337,
            "en_name": "POTASSIUM PHOSPHATE MONOBASIC",
            "fr_name": "Phosphate de potassium monobasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "224",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139545",
      "brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81739",
      "number_of_ais": "2",
      "ai_group_no": "0207483001"
    },
    "created_date": "2022-04-13T21:11:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139545",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2022-11-23T00:00:00-05:00",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-11-03T17:04:08-04:00",
    "status": "resolved",
    "en_comments": "On 100% allocation. Supply interruption effective September 1, 2022 until November 23, 2022 with coverage available using 50mL format. Please see communication for further details.",
    "fr_comments": "Sur 100 % allocation. Interruption de l'approvisionnement en vigueur du 1er septembre 2022 au 23 novembre 2022 avec une couverture disponible en format 50 ml. Veuillez consulter la communication pour plus de détails.",
    "en_drug_brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
    "en_drug_common_name": "Potassium Phosphates Injection, USP",
    "fr_drug_brand_name": "Phosphates de potassium injectables",
    "fr_drug_common_name": "Phosphates de potassium injectables",
    "en_ingredients": "POTASSIUM PHOSPHATE DIBASIC\r\nPOTASSIUM PHOSPHATE MONOBASIC",
    "fr_ingredients": "Phosphate de potassium dibasique\r\nPhosphate de potassium monobasique",
    "drug_strength": "236MG\r\n224MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "15 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158780,
    "drug": {
      "current_status": "MARKETED",
      "id": 3868,
      "drug_code": 19442,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252489,
          "ingredient": {
            "id": 158,
            "ingredient_code": 5319,
            "en_name": "POTASSIUM PHOSPHATE DIBASIC",
            "fr_name": "Phosphate de potassium dibasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "236",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252488,
          "ingredient": {
            "id": 160,
            "ingredient_code": 6337,
            "en_name": "POTASSIUM PHOSPHATE MONOBASIC",
            "fr_name": "Phosphate de potassium monobasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "224",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139545",
      "brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81739",
      "number_of_ais": "2",
      "ai_group_no": "0207483001"
    },
    "created_date": "2022-04-13T21:12:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139545",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2022-03-01T00:00:00-05:00",
    "actual_end_date": "2022-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-02T07:13:18-04:00",
    "status": "resolved",
    "en_comments": "On 100% allocation",
    "fr_comments": "Sous 100 % allocation",
    "en_drug_brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
    "en_drug_common_name": "Potassium Phosphates Injection, USP",
    "fr_drug_brand_name": "Phosphates de potassium injectables",
    "fr_drug_common_name": "Phosphates de potassium injectables",
    "en_ingredients": "POTASSIUM PHOSPHATE DIBASIC\r\nPOTASSIUM PHOSPHATE MONOBASIC",
    "fr_ingredients": "Phosphate de potassium dibasique\r\nPhosphate de potassium monobasique",
    "drug_strength": "236MG\r\n224MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158783,
    "drug": {
      "current_status": "MARKETED",
      "id": 59699,
      "drug_code": 92374,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261082,
          "ingredient": {
            "id": 2292,
            "ingredient_code": 11081,
            "en_name": "ROPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ropivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02439379",
      "brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133273001"
    },
    "created_date": "2022-04-13T21:18:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439379",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2022-10-01T00:00:00-04:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-15T14:32:42-04:00",
    "status": "avoided_shortage",
    "en_comments": "On 100% allocation",
    "fr_comments": "Sous 100 % allocation",
    "en_drug_brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
    "en_drug_common_name": "Ropivacaine Hydrochloride Injection",
    "fr_drug_brand_name": "Chlorhydrate de ropivacaïne injectable, USP",
    "fr_drug_common_name": "Chlorhydrate de ropivacaïne injectable",
    "en_ingredients": "ROPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ropivacaïne",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nINFILTRATION\r\nINFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Épidurale\r\nINFILTRATION\r\nINFILTRATION\r\nÉpidurale",
    "drug_package_quantity": "100 mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158786,
    "drug": {
      "current_status": "MARKETED",
      "id": 59699,
      "drug_code": 92374,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261082,
          "ingredient": {
            "id": 2292,
            "ingredient_code": 11081,
            "en_name": "ROPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ropivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02439379",
      "brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133273001"
    },
    "created_date": "2022-04-13T21:20:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439379",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2022-04-04T00:00:00-04:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-15T14:33:06-04:00",
    "status": "resolved",
    "en_comments": "On 100% allocation",
    "fr_comments": "Sous 100 % allocation",
    "en_drug_brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
    "en_drug_common_name": "Ropivacaine Hydrochloride Injection",
    "fr_drug_brand_name": "Chlorhydrate de ropivacaïne injectable, USP",
    "fr_drug_common_name": "Chlorhydrate de ropivacaïne injectable, USP",
    "en_ingredients": "ROPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ropivacaïne",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nINFILTRATION\r\nINFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Épidurale\r\nINFILTRATION\r\nINFILTRATION\r\nÉpidurale",
    "drug_package_quantity": "200 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158789,
    "drug": {
      "current_status": "MARKETED",
      "id": 62314,
      "drug_code": 92377,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261084,
          "ingredient": {
            "id": 2292,
            "ingredient_code": 11081,
            "en_name": "ROPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ropivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02439409",
      "brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133273005"
    },
    "created_date": "2022-04-13T21:22:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439409",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2022-03-01T00:00:00-05:00",
    "actual_end_date": "2022-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-09-01T21:32:31-04:00",
    "status": "resolved",
    "en_comments": "Effective May 2, 2022, contract customers will be allocated 100% of 10mL demand plus 50% of 20mL demand on a mL:mL basis.",
    "fr_comments": "À compter du 2 mai 2022, les clients sous contrat se verront attribuer 100 % de la demande de 10 ml plus 50 % de la demande de 20 ml sur une base ml/ml.",
    "en_drug_brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
    "en_drug_common_name": "Ropivacaine Hydrochloride Injection",
    "fr_drug_brand_name": "Chlorhydrate de ropivacaïne injectable, USP",
    "fr_drug_common_name": "Chlorhydrate de ropivacaïne injectable, USP",
    "en_ingredients": "ROPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ropivacaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nEPIDURAL",
    "drug_route_fr": "Épidurale\r\nÉpidurale",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158792,
    "drug": {
      "current_status": "MARKETED",
      "id": 62314,
      "drug_code": 92377,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261084,
          "ingredient": {
            "id": 2292,
            "ingredient_code": 11081,
            "en_name": "ROPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ropivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02439409",
      "brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133273005"
    },
    "created_date": "2022-04-13T21:23:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439409",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2022-08-26T00:00:00-04:00",
    "actual_start_date": "2022-06-01T00:00:00-04:00",
    "actual_end_date": "2022-08-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-08-29T13:21:53-04:00",
    "status": "resolved",
    "en_comments": "Effective June 1, 2022 until Aug 26, 2022 we will be encountering a supply interruption with substitution available using our 10 mg/mL 10mL Ampoule.",
    "fr_comments": "À compter du 1er juin 2022 jusqu'au 26 août 2022, nous rencontrerons une interruption d'approvisionnement avec une substitution disponible en utilisant notre ampoule de 10 mg/mL de 10 ml.",
    "en_drug_brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
    "en_drug_common_name": "Ropivacaine Hydrochloride Injection, USP",
    "fr_drug_brand_name": "Chlorhydrate de ropivacaïne injectable, USP",
    "fr_drug_common_name": "Chlorhydrate de ropivacaïne injectable, USP",
    "en_ingredients": "ROPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ropivacaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nEPIDURAL",
    "drug_route_fr": "Épidurale\r\nÉpidurale",
    "drug_package_quantity": "20mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158795,
    "drug": {
      "current_status": "MARKETED",
      "id": 65433,
      "drug_code": 97681,
      "updated_date": "2025-05-15T02:37:35-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263964,
          "ingredient": {
            "id": 800,
            "ingredient_code": 9197,
            "en_name": "SODIUM BICARBONATE",
            "fr_name": "Bicarbonate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "84",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02486636",
      "brand_name": "SODIUM BICARBONATE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104153005"
    },
    "created_date": "2022-04-13T21:24:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02486636",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2022-08-08T00:00:00-04:00",
    "actual_end_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-06-08T05:43:12-04:00",
    "status": "avoided_shortage",
    "en_comments": "On 100% allocation",
    "fr_comments": "Sous 100 % allocation",
    "en_drug_brand_name": "SODIUM BICARBONATE INJECTION, USP",
    "en_drug_common_name": "Sodium Bicarbonate Injection, USP",
    "fr_drug_brand_name": "Bicarbonate de sodium injectable",
    "fr_drug_common_name": "Bicarbonate de sodium injectable",
    "en_ingredients": "SODIUM BICARBONATE",
    "fr_ingredients": "Bicarbonate de sodium",
    "drug_strength": "84MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158798,
    "drug": {
      "current_status": "MARKETED",
      "id": 3562,
      "drug_code": 18937,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252402,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "234",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139510",
      "brand_name": "SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "81223",
      "number_of_ais": "1",
      "ai_group_no": "0100053008"
    },
    "created_date": "2022-04-13T21:25:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139510",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2022-11-01T00:00:00-04:00",
    "actual_start_date": "2021-10-01T00:00:00-04:00",
    "actual_end_date": "2022-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-10-05T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "We will be encountering a supply interruption on our Sodium Chloride Injection, USP 4mEq/mL Maxivial® 100 mL effective September 1, 2022 until November 1, 2022. Effective September 1, 2022 allocations for our 200 mL will be increased to cover 100% of 200mL demand plus 100% of 100 mL demand on a mL:mL basis. Please see communication for further details.",
    "fr_comments": "Nous allons subir une interruption d’approvisionnement de notre présentation de Chlorure de sodium injectable, USP à 4 mEq/mL en MaxivialMD de 100 mL du 1er septembre 2022 au 1er novembre 2022. À compter du 1 septembre 2022, les allocations seront augmentées pour couvrir 100 % de la demande du 200 mL plus 100 % de la demande du 100 mL sur une base mL:mL. Voir la communication pour plus de détails.",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "Sodium Chloride Injection, USP",
    "fr_drug_brand_name": "Chlorure de sodium  injectable, USP",
    "fr_drug_common_name": "Chlorure de sodium  injectable, USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "234MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158801,
    "drug": {
      "current_status": "MARKETED",
      "id": 3562,
      "drug_code": 18937,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252402,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "234",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139510",
      "brand_name": "SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "81223",
      "number_of_ais": "1",
      "ai_group_no": "0100053008"
    },
    "created_date": "2022-04-13T21:27:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139510",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2021-10-01T00:00:00-04:00",
    "actual_end_date": "2022-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-01T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "On 100% allocation",
    "fr_comments": "Sous 100 % allocation",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "Sodium Chloride Injection, USP",
    "fr_drug_brand_name": "Chlorure de sodium  injectable, USP",
    "fr_drug_common_name": "Chlorure de sodium  injectable, USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "234MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "200 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158804,
    "drug": {
      "current_status": "MARKETED",
      "id": 8142,
      "drug_code": 5402,
      "updated_date": "2025-05-15T02:30:33-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250751,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00533688",
      "brand_name": "TOBRAMYCIN FOR INJECTION",
      "brand_name_fr": "TOBRAMYCINE POUR INJECTION",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60581",
      "number_of_ais": "1",
      "ai_group_no": "0110230006"
    },
    "created_date": "2022-04-13T21:28:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00533688",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "estimated_end_date": "2022-09-20T00:00:00-04:00",
    "actual_start_date": "2022-07-01T00:00:00-04:00",
    "actual_end_date": "2022-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-09-21T16:46:35-04:00",
    "status": "resolved",
    "en_comments": "We regret to advise that our Tobramycin for Injection 1.2 g PBP Vial 50 mL will be encountering a supply interruption effective July 1, 2022 until September 20, 2022.",
    "fr_comments": "Nous avons le regret de vous informer que notre présentation de Tobramycine pour injection à 1,2 g en fioles GFP sera en interruption d’approvisionnement du 1er juillet 2022 au 20e septembre 2022.",
    "en_drug_brand_name": "TOBRAMYCIN FOR INJECTION",
    "en_drug_common_name": "Tobramycin for Injection",
    "fr_drug_brand_name": "Tobramycine pour injection USP",
    "fr_drug_common_name": "Tobramycine pour injection USP",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "1.2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158819,
    "drug": {
      "current_status": "MARKETED",
      "id": 53525,
      "drug_code": 95642,
      "updated_date": "2025-05-15T02:36:03-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262727,
          "ingredient": {
            "id": 3102,
            "ingredient_code": 13090,
            "en_name": "GEFITINIB",
            "fr_name": "Géfitinib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468050",
      "brand_name": "APO-GEFITINIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149783001"
    },
    "created_date": "2022-04-14T12:10:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468050",
    "company_name": "APOTEX INC",
    "atc_number": "L01XE",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2022-06-25T00:00:00-04:00",
    "actual_start_date": "2022-04-12T00:00:00-04:00",
    "actual_end_date": "2022-06-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-24T22:10:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GEFITINIB",
    "en_drug_common_name": "GEFITINIB",
    "fr_drug_brand_name": "APO-GEFITINIB",
    "fr_drug_common_name": "GEFITNIB",
    "en_ingredients": "GEFITINIB",
    "fr_ingredients": "Géfitinib",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158837,
    "drug": {
      "current_status": "MARKETED",
      "id": 9944,
      "drug_code": 6421,
      "updated_date": "2025-12-03T00:30:23-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250893,
          "ingredient": {
            "id": 1816,
            "ingredient_code": 8426,
            "en_name": "PENICILLIN V POTASSIUM",
            "fr_name": "Pénicilline v potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00642215",
      "brand_name": "PEN-VK",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63031",
      "number_of_ais": "1",
      "ai_group_no": "0105897011"
    },
    "created_date": "2022-04-14T15:28:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00642215",
    "company_name": "AA PHARMA INC",
    "atc_number": "J01CE",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2022-06-27T00:00:00-04:00",
    "actual_start_date": "2022-04-13T00:00:00-04:00",
    "actual_end_date": "2022-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-22T18:31:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PEN-VK",
    "en_drug_common_name": "PEN-VK",
    "fr_drug_brand_name": "PEN VK",
    "fr_drug_common_name": "PEN VK",
    "en_ingredients": "PENICILLIN V POTASSIUM",
    "fr_ingredients": "Pénicilline v potassique",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158869,
    "drug": {
      "current_status": "MARKETED",
      "id": 14714,
      "drug_code": 75010,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255283,
          "ingredient": {
            "id": 346,
            "ingredient_code": 5054,
            "en_name": "TRETINOIN",
            "fr_name": "Trétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.04",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02264633",
      "brand_name": "RETIN-A MICRO",
      "brand_name_fr": "",
      "descriptor": "MICROSPHERES GEL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112395006"
    },
    "created_date": "2022-04-14T19:29:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02264633",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D10AD",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_start_date": "2022-04-12T00:00:00-04:00",
    "actual_end_date": "2022-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-06-02T18:54:51-04:00",
    "status": "resolved",
    "en_comments": "other",
    "fr_comments": "autre",
    "en_drug_brand_name": "RETIN-A MICRO",
    "en_drug_common_name": "RETIN-A MICRO",
    "fr_drug_brand_name": "RETIN-A MICRO",
    "fr_drug_common_name": "RETIN-A MICRO",
    "en_ingredients": "TRETINOIN",
    "fr_ingredients": "Trétinoïne",
    "drug_strength": "0.04%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "50g pump",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158874,
    "drug": {
      "current_status": "MARKETED",
      "id": 9014,
      "drug_code": 61553,
      "updated_date": "2025-12-03T00:30:41-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253555,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238162",
      "brand_name": "DIASTAT",
      "brand_name_fr": "",
      "descriptor": "PREFILLED RECTAL DELIVERY SYSTEM",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103614001"
    },
    "created_date": "2022-04-14T19:37:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238162",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2022-07-29T00:00:00-04:00",
    "actual_start_date": "2022-04-07T00:00:00-04:00",
    "actual_end_date": "2022-07-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-08-01T16:34:31-04:00",
    "status": "resolved",
    "en_comments": "Capacity issue in production",
    "fr_comments": "problème de capacité",
    "en_drug_brand_name": "DIASTAT",
    "en_drug_common_name": "DIASTAT",
    "fr_drug_brand_name": "DIASTAT",
    "fr_drug_common_name": "DIASTAT",
    "en_ingredients": "DIAZEPAM",
    "fr_ingredients": "Diazépam",
    "drug_strength": "5MG",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "10mg/2pk",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158877,
    "drug": {
      "current_status": "MARKETED",
      "id": 29334,
      "drug_code": 91339,
      "updated_date": "2025-05-15T02:34:24-04:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260637,
          "ingredient": {
            "id": 622,
            "ingredient_code": 9782,
            "en_name": "DIMENHYDRINATE",
            "fr_name": "Diménhydrinate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02428954",
      "brand_name": "DIMENHYDRINATE INJECTION USP",
      "brand_name_fr": "INJECTION DE DIMENHYDRINATE USP",
      "descriptor": "MUST BE DILUTED FOR I.V. USE, SINGLE-USE AMPOULES, PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102747004"
    },
    "created_date": "2022-04-14T19:42:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02428954",
    "company_name": "TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.",
    "atc_number": "R06AA",
    "estimated_end_date": "2022-05-15T00:00:00-04:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2022-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-07T20:11:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DIMENHYDRINATE INJECTION USP",
    "en_drug_common_name": "DIMENHYDRINATE INJECTION USP",
    "fr_drug_brand_name": "DIMENHYDRINATE INJECTION USP",
    "fr_drug_common_name": "DIMENHYDRINATE INJECTION USP",
    "en_ingredients": "DIMENHYDRINATE",
    "fr_ingredients": "Diménhydrinate",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158881,
    "drug": {
      "current_status": "MARKETED",
      "id": 30000,
      "drug_code": 92056,
      "updated_date": "2025-12-03T00:32:43-05:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260920,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8260919,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.01",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02436221",
      "brand_name": "LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP",
      "brand_name_fr": "INJECTION DE CHLORHYDRATE DE LIDOCAÏNE ET D'ÉPINÉPHRINE USP",
      "descriptor": "MULTIDOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0201284005"
    },
    "created_date": "2022-04-14T19:45:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02436221",
    "company_name": "TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2023-02-16T00:00:00-05:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2023-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-21T14:08:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP",
    "en_drug_common_name": "LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP",
    "fr_drug_brand_name": "LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP",
    "fr_drug_common_name": "LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP",
    "en_ingredients": "EPINEPHRINE\r\nLIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Épinéphrine\r\nChlorhydrate de lidocaïne",
    "drug_strength": "0.01MG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "20mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158884,
    "drug": {
      "current_status": "MARKETED",
      "id": 28544,
      "drug_code": 90668,
      "updated_date": "2025-12-03T00:32:31-05:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260353,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02421984",
      "brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORHYDRATE DE LIDOCAÏNE INJECTABLE USP",
      "descriptor": "WITHOUT PRESERVATIVE. SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101280004"
    },
    "created_date": "2022-04-14T19:51:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02421984",
    "company_name": "TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2022-09-09T00:00:00-04:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2022-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-09-08T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
    "fr_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
    "fr_drug_common_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158887,
    "drug": {
      "current_status": "MARKETED",
      "id": 5888,
      "drug_code": 4114,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 1930,
        "created_date": "2017-03-09T13:26:25-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16088,
        "mfr_code": "",
        "name": "LUPIN PHARMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "550-1111 RUE ST-CHARLES OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LONGUEUIL",
        "postal_code": "J4K 5G4",
        "post_office_box": "",
        "contact_information": "lupin@lsu3pl.ca (Customer service / Service à la clientèle)"
      },
      "drug_ingredients": [
        {
          "id": 8250594,
          "ingredient": {
            "id": 966,
            "ingredient_code": 11447,
            "en_name": "CROMOLYN SODIUM",
            "fr_name": "Cromolyne sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00500895",
      "brand_name": "NALCROM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56686",
      "number_of_ais": "1",
      "ai_group_no": "0108810001"
    },
    "created_date": "2022-04-14T20:32:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00500895",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A07EB",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "actual_start_date": "2022-04-15T00:00:00-04:00",
    "actual_end_date": "2022-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-04T21:52:38-04:00",
    "status": "resolved",
    "en_comments": "Delay in transportation. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Délai de transportation. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "NALCROM",
    "en_drug_common_name": "Sodium Cromoglicate Capsules",
    "fr_drug_brand_name": "NALCROM",
    "fr_drug_common_name": "capsules de cromoglicate disodique",
    "en_ingredients": "CROMOLYN SODIUM",
    "fr_ingredients": "Cromolyne sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottle of 100 capsules",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158890,
    "drug": {
      "current_status": "MARKETED",
      "id": 10354,
      "drug_code": 65484,
      "updated_date": "2025-12-03T00:30:44-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8253915,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8253914,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241819",
      "brand_name": "AVALIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086002"
    },
    "created_date": "2022-04-14T20:40:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241819",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2022-04-19T00:00:00-04:00",
    "actual_end_date": "2021-08-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-08-11T19:56:32-04:00",
    "status": "avoided_shortage",
    "en_comments": "Manufacturing Issue. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Problème de fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "AVALIDE",
    "en_drug_common_name": "Irbesartan and Hydrochlorothiazide Tablets",
    "fr_drug_brand_name": "AVALIDE",
    "fr_drug_common_name": "Comprimés d’irbesartan et d’hydrochlorothiazide",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "12.5MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottle of 90 tablets",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158904,
    "drug": {
      "current_status": "MARKETED",
      "id": 3382,
      "drug_code": 18558,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252340,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02125331",
      "brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80818",
      "number_of_ais": "1",
      "ai_group_no": "0108698010"
    },
    "created_date": "2022-04-15T15:13:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02125331",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-14T00:00:00-04:00",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2022-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-28T15:38:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG",
    "en_drug_common_name": "Hydromorph Contin",
    "fr_drug_brand_name": "HYDROMORPH CONTIN",
    "fr_drug_common_name": "Capsules de chlorhydrate d’HYDROmorphone* à libération contrôlée",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "6MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158907,
    "drug": {
      "current_status": "MARKETED",
      "id": 4272,
      "drug_code": 20171,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252680,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02125366",
      "brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82474",
      "number_of_ais": "1",
      "ai_group_no": "0108698011"
    },
    "created_date": "2022-04-15T15:16:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02125366",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-14T00:00:00-04:00",
    "estimated_end_date": "2022-06-17T00:00:00-04:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2022-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-10T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG",
    "en_drug_common_name": "Hydromorph Contin",
    "fr_drug_brand_name": "HYDROMORPH CONTIN",
    "fr_drug_common_name": "Capsules de chlorhydrate d’HYDROmorphone* à libération contrôlée",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "12MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158910,
    "drug": {
      "current_status": "MARKETED",
      "id": 54628,
      "drug_code": 95927,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262887,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470292",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548014"
    },
    "created_date": "2022-04-15T15:18:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470292",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-04-14T00:00:00-04:00",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2022-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-23T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158913,
    "drug": {
      "current_status": "MARKETED",
      "id": 54630,
      "drug_code": 95928,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262888,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470306",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548015"
    },
    "created_date": "2022-04-15T15:19:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470306",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-04-14T00:00:00-04:00",
    "estimated_end_date": "2022-04-29T00:00:00-04:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2022-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-29T17:32:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "35MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158916,
    "drug": {
      "current_status": "MARKETED",
      "id": 4210,
      "drug_code": 20083,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252625,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216205",
      "brand_name": "TRUSOPT",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "82384",
      "number_of_ais": "1",
      "ai_group_no": "0128558001"
    },
    "created_date": "2022-04-15T15:22:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216205",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01EC",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2022-04-14T00:00:00-04:00",
    "estimated_end_date": "2022-04-29T00:00:00-04:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2022-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-23T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRUSOPT",
    "en_drug_common_name": "Dorzolamide hydrochloride ophthalmic solution",
    "fr_drug_brand_name": "TRUSOPT",
    "fr_drug_common_name": "Collyre de chlorhydrate de dorzolamide",
    "en_ingredients": "DORZOLAMIDE",
    "fr_ingredients": "sterile ophthalmic solution, dorzolamide 2% weight/volume, ophthalmic",
    "drug_strength": "2%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158919,
    "drug": {
      "current_status": "MARKETED",
      "id": 54636,
      "drug_code": 95931,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262891,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470330",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548017"
    },
    "created_date": "2022-04-15T15:24:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470330",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-04-14T00:00:00-04:00",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-14T00:00:00-04:00",
    "actual_end_date": "2022-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-23T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "70MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158951,
    "drug": {
      "current_status": "MARKETED",
      "id": 6626,
      "drug_code": 4389,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 252,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 3893,
        "mfr_code": "CHU08",
        "name": "CHURCH & DWIGHT CANADA CORP",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "635 SECRETARIAT COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5S 0A5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250630,
          "ingredient": {
            "id": 126,
            "ingredient_code": 7531,
            "en_name": "HYDROCORTISONE ACETATE",
            "fr_name": "Acétate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250629,
          "ingredient": {
            "id": 686,
            "ingredient_code": 8746,
            "en_name": "ZINC SULFATE",
            "fr_name": "Sulfate de zinc"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00505773",
      "brand_name": "ANUSOL-HC OINTMENT",
      "brand_name_fr": "ANUSOL-HC ONGUENT",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57483",
      "number_of_ais": "2",
      "ai_group_no": "0214222001"
    },
    "created_date": "2022-04-18T19:49:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00505773",
    "company_name": "CHURCH & DWIGHT CANADA CORP",
    "atc_number": "C05AA",
    "atc_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-18T00:00:00-04:00",
    "actual_end_date": "2022-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-27T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ANUSOL-HC OINTMENT",
    "en_drug_common_name": "Hydrocortisone acetate / Zinc Sulfate",
    "fr_drug_brand_name": "ANUSOL-HC ONGUENT",
    "fr_drug_common_name": "Acétate d'hydrocortisone / Sulfate de zinc",
    "en_ingredients": "ZINC SULFATE\r\nHYDROCORTISONE ACETATE",
    "fr_ingredients": "Sulfate de zinc\r\nAcétate d'hydrocortisone",
    "drug_strength": "0.5%\r\n0.5%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "30g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158956,
    "drug": {
      "current_status": "MARKETED",
      "id": 52979,
      "drug_code": 2390,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250406,
          "ingredient": {
            "id": 558,
            "ingredient_code": 8970,
            "en_name": "ATROPINE SULFATE",
            "fr_name": "Sulfate d'atropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "10",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00328154",
      "brand_name": "ATROPINE SULFATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "10ML PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "49353",
      "number_of_ais": "1",
      "ai_group_no": "0104748003"
    },
    "created_date": "2022-04-18T20:33:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00328154",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "A03BA",
    "atc_description": "BELLADONNAAND DERIVATIVES, PLAIN",
    "estimated_end_date": "2022-08-31T00:00:00-04:00",
    "actual_start_date": "2022-04-27T00:00:00-04:00",
    "actual_end_date": "2022-08-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-08-11T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATROPINE SULFATE INJECTION USP",
    "en_drug_common_name": "ATROPINE SULFATE INJECTION USP",
    "fr_drug_brand_name": "ATROPINE SULFATE INJECTION USP",
    "fr_drug_common_name": "ATROPINE SULFATE INJECTION USP",
    "en_ingredients": "ATROPINE SULFATE",
    "fr_ingredients": "Sulfate d'atropine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 10mL LifeShield syringes",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158970,
    "drug": {
      "current_status": "MARKETED",
      "id": 31466,
      "drug_code": 93784,
      "updated_date": "2025-05-15T02:35:14-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8261722,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261721,
          "ingredient": {
            "id": 4138,
            "ingredient_code": 16100,
            "en_name": "PERINDOPRIL ARGININE",
            "fr_name": "Périndopril arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "14",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02451557",
      "brand_name": "VIACORAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257790003"
    },
    "created_date": "2022-04-19T15:27:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02451557",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "C09BB",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2022-04-30T00:00:00-04:00",
    "actual_start_date": "2022-04-13T00:00:00-04:00",
    "actual_end_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-22T13:05:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VIACORAM",
    "en_drug_common_name": "perindropil arginine/amlodipine",
    "fr_drug_brand_name": "Viacoram",
    "fr_drug_common_name": "perindropil arginine/amlodipine",
    "en_ingredients": "AMLODIPINE\r\nPERINDOPRIL ARGININE",
    "fr_ingredients": "perindropil arginine/amlodipine",
    "drug_strength": "10MG\r\n14MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158975,
    "drug": {
      "current_status": "MARKETED",
      "id": 55339,
      "drug_code": 92848,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8261342,
          "ingredient": {
            "id": 10506,
            "ingredient_code": 22626,
            "en_name": "VILAZODONE HYDROCHLORIDE",
            "fr_name": "CHLORHYDRATE DE VILAZODONE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443740",
      "brand_name": "VIIBRYD",
      "brand_name_fr": "VIIBRYD",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0157110003"
    },
    "created_date": "2022-04-19T15:50:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443740",
    "company_name": "ALLERGAN INC",
    "atc_number": "N06AX",
    "anticipated_start_date": "2022-04-19T00:00:00-04:00",
    "estimated_end_date": "2022-06-03T00:00:00-04:00",
    "actual_start_date": "2022-04-25T00:00:00-04:00",
    "actual_end_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-04T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "20mg Viibryd available",
    "fr_comments": "20mgViibryd disponible",
    "en_drug_brand_name": "VIIBRYD",
    "en_drug_common_name": "40mg VILAZODONE HYDROCHLORIDE",
    "fr_drug_brand_name": "Viibryd",
    "fr_drug_common_name": "comprimés de chlorhydrate de vilazodone",
    "en_ingredients": "VILAZODONE HYDROCHLORIDE",
    "fr_ingredients": "chlorhydrate de vilazodone",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158992,
    "drug": {
      "current_status": "MARKETED",
      "id": 3260,
      "drug_code": 1830,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250326,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250325,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00284106",
      "brand_name": "XYLOCAINE 2% W EPINEPHRINE 1:200000",
      "brand_name_fr": "",
      "descriptor": "20 ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "44825",
      "number_of_ais": "2",
      "ai_group_no": "0201284006"
    },
    "created_date": "2022-04-19T16:55:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00284106",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2022-07-15T00:00:00-04:00",
    "estimated_end_date": "2022-07-30T00:00:00-04:00",
    "actual_start_date": "2022-07-11T00:00:00-04:00",
    "actual_end_date": "2022-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-07-19T13:00:18-04:00",
    "status": "resolved",
    "en_comments": "VR44557CA1\tXYLOCAIN AD20MG:5MCG/ML SDV10X20ML CA AS",
    "en_drug_brand_name": "XYLOCAINE 2% W EPINEPHRINE 1:200000",
    "en_drug_common_name": "lidocaine HCI 2% w/epin. 1:200M 10x20mL SU Vial",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "lidocaine HCI 2% w/epin. 1:200M 10x20mL SU Vial",
    "en_ingredients": "EPINEPHRINE\r\nLIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Épinéphrine\r\nChlorhydrate de lidocaïne",
    "drug_strength": "5MCG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nEPIDURAL",
    "drug_route_fr": "Épidurale\r\nÉpidurale",
    "drug_package_quantity": "10 vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 158995,
    "drug": {
      "current_status": "MARKETED",
      "id": 8416,
      "drug_code": 585,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250158,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00001732",
      "brand_name": "XYLOCAINE 1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "23886",
      "number_of_ais": "1",
      "ai_group_no": "0101280004"
    },
    "created_date": "2022-04-19T16:58:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00001732",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2022-04-28T00:00:00-04:00",
    "actual_start_date": "2022-04-06T00:00:00-04:00",
    "actual_end_date": "2022-04-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-30T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "VR89896CA1\tXYLOCAINE 10MG/ML LIQ AMP 50X10ML CA ASP",
    "en_drug_brand_name": "XYLOCAINE 1%",
    "en_drug_common_name": "lidocaine HCI 1% Plain 50x10mL SU Polyamp® Duofit®",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "lidocaine HCI 1% Plain 50x10mL SU Polyamp® Duofit®",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "50 PE Polyamp",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159004,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27440,
      "drug_code": 89675,
      "updated_date": "2025-05-15T04:21:33-04:00",
      "company": {
        "id": 17068,
        "created_date": "2021-05-07T04:00:05-04:00",
        "updated_date": "2025-05-15T03:22:29-04:00",
        "company_code": 18344,
        "mfr_code": "",
        "name": "TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "105 LINCOLN AVE",
        "province": "NEW JERSEY",
        "country": "UNITED STATES",
        "city": "BUENA",
        "postal_code": "08310",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8353591,
          "ingredient": {
            "id": 2428,
            "ingredient_code": 11461,
            "en_name": "IRINOTECAN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'irinotécan (Chlorhydrate trihydraté d'irinotécan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02412187",
      "brand_name": "IRINOTECAN HYDROCHLORIDE INJECTION",
      "brand_name_fr": "CHLORHYDRATE D'IRINOTÉCAN POUR INJECTION",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132910001"
    },
    "created_date": "2022-04-19T20:01:47-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02412187",
    "company_name": "TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.",
    "atc_number": "L01XX",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "discontinuation_date": "2022-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-20T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "IRINOTECAN HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "IRINOTECAN HYDROCHLORIDE INJECTION",
    "fr_drug_brand_name": "IRINOTECAN HYDROCHLORIDE INJECTION",
    "fr_drug_common_name": "IRINOTECAN HYDROCHLORIDE INJECTION",
    "en_ingredients": "IRINOTECAN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'irinotécan",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION\r\nSOLUTION",
    "drug_dosage_form_fr": "Solution\r\nSolution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159009,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 994,
      "drug_code": 12332,
      "updated_date": "2025-05-15T03:38:45-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8289665,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01947672",
      "brand_name": "ACCUPRIL TAB 10MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73423",
      "number_of_ais": "1",
      "ai_group_no": "0123206002"
    },
    "created_date": "2022-04-20T00:21:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01947672",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "actual_start_date": "2022-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-20T00:22:18-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACCUPRIL TAB 10MG",
    "en_drug_common_name": "ACCUPRIL",
    "fr_drug_brand_name": "ACCUPRIL 10MG",
    "fr_drug_common_name": "ACCUPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRIL",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x90 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159014,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 996,
      "drug_code": 12333,
      "updated_date": "2025-05-15T03:38:45-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8289666,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01947680",
      "brand_name": "ACCUPRIL TAB 20MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73424",
      "number_of_ais": "1",
      "ai_group_no": "0123206003"
    },
    "created_date": "2022-04-20T00:24:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01947680",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "actual_start_date": "2022-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-20T00:24:43-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACCUPRIL TAB 20MG",
    "en_drug_common_name": "ACCUPRIL",
    "fr_drug_brand_name": "ACCUPRIL TAB 20MG",
    "fr_drug_common_name": "ACCUPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRIL",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x90 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159017,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 998,
      "drug_code": 12334,
      "updated_date": "2025-05-15T03:38:45-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8289667,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01947699",
      "brand_name": "ACCUPRIL TAB 40MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73425",
      "number_of_ais": "1",
      "ai_group_no": "0123206004"
    },
    "created_date": "2022-04-20T00:25:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01947699",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "actual_start_date": "2022-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-20T00:25:58-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACCUPRIL TAB 40MG",
    "en_drug_common_name": "ACCUPRIL",
    "fr_drug_brand_name": "ACCUPRIL TAB 40MG",
    "fr_drug_common_name": "ACCUPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRIL",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x90 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159027,
    "drug": {
      "current_status": "MARKETED",
      "id": 29502,
      "drug_code": 91526,
      "updated_date": "2025-05-15T02:34:31-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260701,
          "ingredient": {
            "id": 2880,
            "ingredient_code": 12110,
            "en_name": "LINEZOLID",
            "fr_name": "Linézolide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02430827",
      "brand_name": "LINEZOLID INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143501003"
    },
    "created_date": "2022-04-20T15:07:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02430827",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01XX",
    "atc_description": "OTHER ANTIBACTERIALS",
    "estimated_end_date": "2022-06-24T00:00:00-04:00",
    "actual_start_date": "2022-04-30T00:00:00-04:00",
    "actual_end_date": "2022-06-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-27T16:16:46-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Linezolid Injection 2 mg/mL freeflex® Bag 300 mL effective April 30, 2022 until June 24, 2022. Please note that all available inventory expires April 30, 2022.",
    "fr_comments": "Fresenius Kabi Canada a le regret de vous informer qu’en raison d’un retard de production, nous allons éprouver une interruption d’approvisionnement de notre préparation de Linézolide injectable à 2 mg/mL en sacs freeflexMD de 300 mL du 30 avril 2022 au 24 juin 2022. Veuillez noter que tous les stocks disponibles expirent le 30 avril 2022.",
    "en_drug_brand_name": "LINEZOLID INJECTION",
    "en_drug_common_name": "LINEZOLID INJECTION",
    "fr_drug_brand_name": "Linézolide injectable",
    "fr_drug_common_name": "Linézolide injectable",
    "en_ingredients": "LINEZOLID",
    "fr_ingredients": "Linézolide",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "300 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159045,
    "drug": {
      "current_status": "MARKETED",
      "id": 51283,
      "drug_code": 94884,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262336,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461331",
      "brand_name": "SANDOZ GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934003"
    },
    "created_date": "2022-04-21T00:50:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461331",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2022-05-13T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-05-05T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "en_drug_common_name": "GLICLAZIDE",
    "fr_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "fr_drug_common_name": "GLICLAZIDE",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100MRT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159048,
    "drug": {
      "current_status": "MARKETED",
      "id": 2856,
      "drug_code": 16902,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252171,
          "ingredient": {
            "id": 26,
            "ingredient_code": 10146,
            "en_name": "HALOPERIDOL",
            "fr_name": "Halopéridol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02130300",
      "brand_name": "HALOPERIDOL LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78972",
      "number_of_ais": "1",
      "ai_group_no": "0101774008"
    },
    "created_date": "2022-04-21T00:55:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02130300",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AD",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-09-02T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-09-02T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Product is available on allocation at wholesalers based 100% of historical volume.",
    "fr_comments": "Le produit est disponible sur allocation chez les grossistes en fonction de 100 % du volume historique.",
    "en_drug_brand_name": "HALOPERIDOL LA",
    "en_drug_common_name": "HALOPERIDOL",
    "fr_drug_brand_name": "HALOPERIDOL LA",
    "fr_drug_common_name": "HALOPERIDOL",
    "en_ingredients": "HALOPERIDOL",
    "fr_ingredients": "Halopéridol",
    "drug_strength": "100MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "5ML 1LIV",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159051,
    "drug": {
      "current_status": "MARKETED",
      "id": 1848,
      "drug_code": 13946,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251844,
          "ingredient": {
            "id": 70,
            "ingredient_code": 7617,
            "en_name": "PREDNISOLONE ACETATE",
            "fr_name": "Acétate de prednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01916203",
      "brand_name": "SANDOZ PREDNISOLONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75429",
      "number_of_ais": "1",
      "ai_group_no": "0106295001"
    },
    "created_date": "2022-04-21T00:58:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01916203",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2022-05-29T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-04-29T01:04:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PREDNISOLONE",
    "en_drug_common_name": "PREDNISOLONE",
    "fr_drug_brand_name": "SANDOZ PREDNISOLONE",
    "fr_drug_common_name": "PREDNISOLONE",
    "en_ingredients": "PREDNISOLONE ACETATE",
    "fr_ingredients": "Acétate de prednisolone",
    "drug_strength": "1%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10ML LDP",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159054,
    "drug": {
      "current_status": "MARKETED",
      "id": 25110,
      "drug_code": 87623,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259099,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390833",
      "brand_name": "SANDOZ PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2022-04-21T01:00:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390833",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-05-27T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-05T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "SANDOZ PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100HGC BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159057,
    "drug": {
      "current_status": "MARKETED",
      "id": 13700,
      "drug_code": 73541,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254939,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02250608",
      "brand_name": "SANDOZ MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928002"
    },
    "created_date": "2022-04-21T01:01:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250608",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-05-27T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-25T01:40:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "SANDOZ MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159061,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17270,
      "drug_code": 78323,
      "updated_date": "2025-05-15T04:12:47-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8344388,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02297906",
      "brand_name": "SANDOZ PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541001"
    },
    "created_date": "2022-04-21T01:05:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02297906",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-21T01:05:28-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ PIOGLITAZONE",
    "en_drug_common_name": "PIOGLITAZONE",
    "fr_drug_brand_name": "SANDOZ PIOGLITAZONE",
    "fr_drug_common_name": "PIOGLITAZONE",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "PIOGLITAZONE",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90TAB BO",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159064,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7092,
      "drug_code": 4806,
      "updated_date": "2025-05-15T03:27:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8277336,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00544884",
      "brand_name": "CODEINE PHOSPHATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58792",
      "number_of_ais": "1",
      "ai_group_no": "0104398004"
    },
    "created_date": "2022-04-21T01:06:19-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00544884",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "R05DA",
    "atc_description": "COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS",
    "discontinuation_date": "2022-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-04-21T01:06:38-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "CODEINE PHOSPHATE INJECTION USP",
    "en_drug_common_name": "CODEINE PHOSPHATE",
    "fr_drug_brand_name": "CODEINE PHOSPHATE INJECTION USP",
    "fr_drug_common_name": "CODEINE PHOSPHATE",
    "en_ingredients": "CODEINE PHOSPHATE",
    "fr_ingredients": "Phosphate de codéine",
    "drug_strength": "30MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire\r\nSous-cutanée\r\nIntramusculaire",
    "drug_package_quantity": "1ML 10LIAM",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159079,
    "drug": {
      "current_status": "MARKETED",
      "id": 17968,
      "drug_code": 79097,
      "updated_date": "2025-05-15T02:32:06-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256313,
          "ingredient": {
            "id": 2534,
            "ingredient_code": 11710,
            "en_name": "BRIMONIDINE TARTRATE",
            "fr_name": "Tartrate de brimonidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02305429",
      "brand_name": "SANDOZ BRIMONIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131859001"
    },
    "created_date": "2022-04-21T01:20:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02305429",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01EA",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2022-08-05T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-19T03:58:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ BRIMONIDINE",
    "en_drug_common_name": "BRIMONIDINE",
    "fr_drug_brand_name": "SANDOZ BRIMONIDINE",
    "fr_drug_common_name": "BRIMONIDINE",
    "en_ingredients": "BRIMONIDINE TARTRATE",
    "fr_ingredients": "Tartrate de brimonidine",
    "drug_strength": "0.2%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML LDP",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159082,
    "drug": {
      "current_status": "MARKETED",
      "id": 18662,
      "drug_code": 79937,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256534,
          "ingredient": {
            "id": 1570,
            "ingredient_code": 118,
            "en_name": "MYCOPHENOLATE MOFETIL",
            "fr_name": "Mofétilmycophénolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313855",
      "brand_name": "SANDOZ MYCOPHENOLATE MOFETIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128158002"
    },
    "created_date": "2022-04-21T01:21:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313855",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-04-29T01:03:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MYCOPHENOLATE MOFETIL",
    "en_drug_common_name": "MYCOPHENOLATE MOFETIL",
    "fr_drug_brand_name": "SANDOZ MYCOPHENOLATE MOFETIL",
    "fr_drug_common_name": "MYCOPHENOLATE MOFETIL",
    "en_ingredients": "MYCOPHENOLATE MOFETIL",
    "fr_ingredients": "Mofétilmycophénolate",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50FCT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159091,
    "drug": {
      "current_status": "MARKETED",
      "id": 101856,
      "drug_code": 97891,
      "updated_date": "2021-06-08T05:11:49-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264130,
          "ingredient": {
            "id": 3816,
            "ingredient_code": 21466,
            "en_name": "PIRFENIDONE",
            "fr_name": "Pirfénidone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "267",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02488833",
      "brand_name": "SANDOZ PIRFENIDONE CAPSULES",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153328001"
    },
    "created_date": "2022-04-21T01:29:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02488833",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L04AX",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-29T00:57:55-04:00",
    "status": "resolved",
    "en_comments": "Product is available on allocation at wholesalers, based on 100% of historical volumes.",
    "fr_comments": "Le produit est disponible sur allocation chez les grossistes, selon 100% de l'historique d'achat.",
    "en_drug_brand_name": "SANDOZ PIRFENIDONE CAPSULES",
    "en_drug_common_name": "PIRFENIDONE",
    "fr_drug_brand_name": "SANDOZ PIRFENIDONE CAPSULES",
    "fr_drug_common_name": "PIRFENIDONE",
    "en_ingredients": "PIRFENIDONE",
    "fr_ingredients": "Pirfénidone",
    "drug_strength": "267MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "270HGC BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159096,
    "drug": {
      "current_status": "MARKETED",
      "id": 5402,
      "drug_code": 3553,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8250520,
          "ingredient": {
            "id": 558,
            "ingredient_code": 8970,
            "en_name": "ATROPINE SULFATE",
            "fr_name": "Sulfate d'atropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": ".6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00392693",
      "brand_name": "ATROPINE SULFATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54671",
      "number_of_ais": "1",
      "ai_group_no": "0104748005"
    },
    "created_date": "2022-04-21T01:33:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00392693",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A03BA",
    "atc_description": "BELLADONNAAND DERIVATIVES, PLAIN",
    "anticipated_start_date": "2022-04-20T00:00:00-04:00",
    "estimated_end_date": "2022-07-08T00:00:00-04:00",
    "actual_end_date": "2022-07-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-07-14T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Product is available on allocation at wholesalers, based on 100% of historical volumes.",
    "fr_comments": "Le produit est disponible sur allocation chez les grossistes, basé sur 100% de l’historique des volumes.",
    "en_drug_brand_name": "ATROPINE SULFATE INJECTION USP",
    "en_drug_common_name": "ATROPINE SO4",
    "fr_drug_brand_name": "ATROPINE SULFATE INJECTION USP",
    "fr_drug_common_name": "ATROPINE SO4",
    "en_ingredients": "ATROPINE SULFATE",
    "fr_ingredients": "Sulfate d'atropine",
    "drug_strength": ".6MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1ML 10LIAM",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159100,
    "drug": {
      "current_status": "MARKETED",
      "id": 728,
      "drug_code": 11641,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251560,
          "ingredient": {
            "id": 7231,
            "ingredient_code": 7395,
            "en_name": "NOREPINEPHRINE",
            "fr_name": "Norépinéphrine (Bitartrate de norépinéphrine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00893285",
      "brand_name": "NOREPINEPHRINE BITARTRATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72461",
      "number_of_ais": "1",
      "ai_group_no": "0131301001"
    },
    "created_date": "2022-04-21T01:35:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00893285",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "estimated_end_date": "2022-10-21T00:00:00-04:00",
    "actual_start_date": "2022-09-27T00:00:00-04:00",
    "actual_end_date": "2022-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-10-13T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Product is available on allocation at wholesalers, based on 100% of historical volumes.",
    "fr_comments": "Le produit est disponible sur allocation chez les grossistes, basé sur 100% de l’historique des volumes.",
    "en_drug_brand_name": "NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP",
    "en_drug_common_name": "NOREPINEPHRINE",
    "fr_drug_brand_name": "NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP",
    "fr_drug_common_name": "NOREPINEPHRINE",
    "en_ingredients": "NOREPINEPHRINE",
    "fr_ingredients": "NOREPINEPHRINE",
    "drug_strength": "1MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "4ML 10LIV",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159136,
    "drug": {
      "current_status": "MARKETED",
      "id": 24772,
      "drug_code": 87332,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 10750,
        "created_date": "2018-12-05T03:00:11-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 16507,
        "mfr_code": "",
        "name": "IPSEN BIOPHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 500",
        "street_name": "5050 SATELLITE DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 0G1",
        "post_office_box": "",
        "contact_information": "medinfoandsafetycanada@ipsen.com \r\n1(855) 215-2288"
      },
      "drug_ingredients": [
        {
          "id": 8258944,
          "ingredient": {
            "id": 3798,
            "ingredient_code": 21617,
            "en_name": "ABOBOTULINUMTOXINA",
            "fr_name": "AbobotulinumtoxineA"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02387735",
      "brand_name": "DYSPORT AESTHETIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153614001"
    },
    "created_date": "2022-04-21T12:59:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387735",
    "company_name": "IPSEN BIOPHARMACEUTICALS CANADA INC",
    "atc_number": "M03AX",
    "atc_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
    "hc_updated_date": "2022-04-21T13:00:06-04:00",
    "anticipated_start_date": "2022-05-04T00:00:00-04:00",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-05-04T00:00:00-04:00",
    "actual_end_date": "2022-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-05-21T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Dysport 300u product has seen a significant increase in demand driven by Aesthetic growth. Ipsen are implementing supply capacity improvement projects in order to meet this new growth. During this interim period there will be stock constraints.",
    "en_drug_brand_name": "DYSPORT AESTHETIC",
    "en_drug_common_name": "abobotulinumtoxinA",
    "fr_drug_brand_name": "DYSPORT AESTHETIC",
    "fr_drug_common_name": "abobotulinumtoxinA",
    "en_ingredients": "ABOBOTULINUMTOXINA",
    "fr_ingredients": "AbobotulinumtoxineA",
    "drug_strength": "300UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1 vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159139,
    "drug": {
      "current_status": "MARKETED",
      "id": 6778,
      "drug_code": 44261,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253178,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02182947",
      "brand_name": "METHOTREXATE INJECTION USP",
      "brand_name_fr": "MÉTHOTREXATE INJECTABLE USP",
      "descriptor": "SINGLE USE VIALS. PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "T9985",
      "number_of_ais": "1",
      "ai_group_no": "0107545004"
    },
    "created_date": "2022-04-21T13:00:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182947",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "L01BA",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2022-10-16T00:00:00-04:00",
    "actual_end_date": "2022-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-18T20:17:33-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "METHOTREXATE INJECTION USP",
    "en_drug_common_name": "METHOTREXATE INJECTION USP",
    "fr_drug_brand_name": "METHOTREXATE INJECTION USP",
    "fr_drug_common_name": "METHOTREXATE INJECTION USP",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRATHECAL\r\nINTRAMUSCULAR\r\nINTRA-ARTERIAL\r\nINTRACEREBROVENTRICULAR\r\nINTRACEREBROVENTRICULAR\r\nINTRAVENOUS\r\nINTRATHECAL\r\nINTRAMUSCULAR\r\nINTRA-ARTERIAL",
    "drug_route_fr": "Intraveineuse\r\nIntrathécale\r\nIntramusculaire\r\nIntra-artérielle\r\nIntracérébroventriculaire\r\nIntracérébroventriculaire\r\nIntraveineuse\r\nIntrathécale\r\nIntramusculaire\r\nIntra-artérielle",
    "drug_package_quantity": "5 x 2mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159186,
    "drug": {
      "current_status": "MARKETED",
      "id": 64614,
      "drug_code": 94374,
      "updated_date": "2025-05-15T02:35:29-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262060,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02456753",
      "brand_name": "TEVA-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2022-04-21T14:02:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456753",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-10-20T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-10-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-29T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DULOXETINE",
    "en_drug_common_name": "DULOXETINE HCL 30MG CAPS",
    "fr_drug_brand_name": "TEVA-DULOXETINE HCL 30MG CAPS",
    "fr_drug_common_name": "DULOXETINE HCL 30MG CAPS",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE HCL",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159189,
    "drug": {
      "current_status": "MARKETED",
      "id": 8376,
      "drug_code": 5779,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250828,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250827,
          "ingredient": {
            "id": 582,
            "ingredient_code": 8231,
            "en_name": "BUTALBITAL",
            "fr_name": "Butalbital"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250826,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "330",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00608211",
      "brand_name": "TEVA-TECNAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61499",
      "number_of_ais": "3",
      "ai_group_no": "0301241001"
    },
    "created_date": "2022-04-21T14:04:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00608211",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02BA",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2024-01-10T00:00:00-05:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2024-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-19T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TECNAL",
    "en_drug_common_name": "TECNAL TAB",
    "fr_drug_brand_name": "TEVA-TECNAL TAB",
    "fr_drug_common_name": "TECNAL TAB",
    "en_ingredients": "ACETYLSALICYLIC ACID\r\nCAFFEINE\r\nBUTALBITAL",
    "fr_ingredients": "Acide acétylsalicylique\r\nCaféine\r\nButalbital",
    "drug_strength": "330MG\r\n40MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159192,
    "drug": {
      "current_status": "MARKETED",
      "id": 1810,
      "drug_code": 13888,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251827,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00805009",
      "brand_name": "TEVA-TOPISONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75364",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2022-04-21T14:05:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00805009",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-06-10T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-06-17T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TOPISONE",
    "en_drug_common_name": "TOPISONE 0.05% OINT",
    "fr_drug_brand_name": "TEVA-TOPISONE 0.05% OINT",
    "fr_drug_common_name": "TOPISONE 0.05% OINT",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159195,
    "drug": {
      "current_status": "MARKETED",
      "id": 14444,
      "drug_code": 74709,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255202,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261715",
      "brand_name": "TEVA-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2022-04-21T14:07:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261715",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2022-08-20T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-08-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-20T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE 70MG TABS",
    "fr_drug_brand_name": "TEVA-ALENDRONATE 70MG TABS",
    "fr_drug_common_name": "ALENDRONATE 70MG TABS",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ALENDRONATE",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 pack",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159198,
    "drug": {
      "current_status": "MARKETED",
      "id": 16866,
      "drug_code": 77854,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255956,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293161",
      "brand_name": "TEVA-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2022-04-21T14:08:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293161",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2022-12-10T00:00:00-05:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-11-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-12T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL 75MG TAB",
    "fr_drug_brand_name": "TEVA-CLOPIDOGREL 75MG TAB",
    "fr_drug_common_name": "CLOPIDOGREL 75MG TAB",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159201,
    "drug": {
      "current_status": "MARKETED",
      "id": 51683,
      "drug_code": 88396,
      "updated_date": "2025-05-15T02:33:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259382,
          "ingredient": {
            "id": 3254,
            "ingredient_code": 16516,
            "en_name": "EMTRICITABINE",
            "fr_name": "Emtricitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259381,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02399059",
      "brand_name": "TEVA-EMTRICITABINE/TENOFOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251568001"
    },
    "created_date": "2022-04-21T14:10:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02399059",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2023-06-10T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2023-06-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-21T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-EMTRICITABINE/TENOFOVIR",
    "en_drug_common_name": "EMTRICITABINE/TENOFOVIR 200/300MG",
    "fr_drug_brand_name": "TEVA-EMTRICITABINE/TENOFOVIR 200/300MG",
    "fr_drug_common_name": "EMTRICITABINE/TENOFOVIR 200/300MG",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE\r\nEMTRICITABINE",
    "fr_ingredients": "Fumarate de ténofovir disoproxil\r\nEmtricitabine",
    "drug_strength": "300MG\r\n200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159204,
    "drug": {
      "current_status": "MARKETED",
      "id": 18718,
      "drug_code": 79986,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256546,
          "ingredient": {
            "id": 2564,
            "ingredient_code": 11770,
            "en_name": "NARATRIPTAN",
            "fr_name": "Naratriptan (Chlorhydrate de naratriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314304",
      "brand_name": "TEVA-NARATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131121002"
    },
    "created_date": "2022-04-21T14:11:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314304",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2022-05-31T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-03T18:11:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NARATRIPTAN",
    "en_drug_common_name": "NARATRIPTAN 2.5MG TABS",
    "fr_drug_brand_name": "TEVA-NARATRIPTAN 2.5MG TABS",
    "fr_drug_common_name": "NARATRIPTAN 2.5MG TABS",
    "en_ingredients": "NARATRIPTAN",
    "fr_ingredients": "NARATRIPTAN",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 8",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159207,
    "drug": {
      "current_status": "MARKETED",
      "id": 22220,
      "drug_code": 84626,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257953,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361205",
      "brand_name": "TEVA-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121005"
    },
    "created_date": "2022-04-21T14:13:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361205",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-08-10T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-08-16T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PREGABALIN",
    "en_drug_common_name": "PREGABALIN 150MG CAPS",
    "fr_drug_brand_name": "TEVA-PREGABALIN 150MG CAPS",
    "fr_drug_common_name": "PREGABALIN 150MG CAPS",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159210,
    "drug": {
      "current_status": "MARKETED",
      "id": 13002,
      "drug_code": 72256,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254750,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247946",
      "brand_name": "TEVA-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858003"
    },
    "created_date": "2022-04-21T14:14:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247946",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2022-11-10T00:00:00-05:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-08-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-08-20T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RAMIPRIL",
    "en_drug_common_name": "TEVA-RAMIPRIL 5MG CAPS",
    "fr_drug_brand_name": "TEVA-RAMIPRIL 5MG CAPS",
    "fr_drug_common_name": "RAMIPRIL 5MG CAPS",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159213,
    "drug": {
      "current_status": "MARKETED",
      "id": 21032,
      "drug_code": 83257,
      "updated_date": "2025-05-15T02:32:39-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257462,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257461,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347180",
      "brand_name": "TEVA-TRAMADOL/ACETAMINOPHEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250601001"
    },
    "created_date": "2022-04-21T14:15:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347180",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-08-31T00:00:00-04:00",
    "actual_start_date": "2022-04-20T00:00:00-04:00",
    "actual_end_date": "2022-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-08-19T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TRAMADOL/ACETAMINOPHEN",
    "en_drug_common_name": "TRAMADOL/ACET 37.5/325MG TABS",
    "fr_drug_brand_name": "TEVA-TRAMADOL/ACET 37.5/325MG TABS",
    "fr_drug_common_name": "TRAMADOL/ACET 37.5/325MG TABS",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE\r\nACETAMINOPHEN",
    "fr_ingredients": "Chlorhydrate de tramadol\r\nAcétaminophène",
    "drug_strength": "37.5MG\r\n325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's and PP 6's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159220,
    "drug": {
      "current_status": "MARKETED",
      "id": 13476,
      "drug_code": 73181,
      "updated_date": "2025-12-03T00:30:57-05:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254883,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248812",
      "brand_name": "ADDERALL XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310005"
    },
    "created_date": "2022-04-21T16:41:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248812",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-04-21T00:00:00-04:00",
    "estimated_end_date": "2022-06-24T00:00:00-04:00",
    "actual_end_date": "2022-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-05-05T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ADDERALL XR",
    "en_drug_common_name": "Mixed salts amphetamine",
    "fr_drug_brand_name": "ADDERALL XR",
    "fr_drug_common_name": "Mixed salts amphetamine",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "Mixed salts amphetamine",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottles of 100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159223,
    "drug": {
      "current_status": "MARKETED",
      "id": 5008,
      "drug_code": 2902,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250469,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037915",
      "brand_name": "DEXTROSE INJECTION USP",
      "brand_name_fr": "DEXTROSE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "51941",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2022-04-21T17:54:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037915",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2022-07-11T00:00:00-04:00",
    "estimated_end_date": "2022-07-29T00:00:00-04:00",
    "actual_end_date": "2022-07-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-29T18:38:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXTROSE INJECTION USP",
    "en_drug_common_name": "Dextrose Injection USP",
    "fr_drug_brand_name": "Dextrose injectable USP",
    "fr_drug_common_name": "Dextrose injectable USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "500 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159241,
    "drug": {
      "current_status": "DORMANT",
      "id": 5442,
      "drug_code": 3585,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366188,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "700",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00244988",
      "brand_name": "DEXTROSE INJECTION USP",
      "brand_name_fr": "DEXTROSE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54755",
      "number_of_ais": "1",
      "ai_group_no": "0102181015"
    },
    "created_date": "2022-04-21T18:18:58-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00244988",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "discontinuation_date": "2023-06-19T00:00:00-04:00",
    "anticipated_discontinuation_date": "2023-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Remaining supply expires 7/31/2023.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-07-25T18:54:07-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DEXTROSE INJECTION USP",
    "en_drug_common_name": "Dextrose Injection USP",
    "fr_drug_brand_name": "Dextrose injectable USP",
    "fr_drug_common_name": "Dextrose injectable USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "700MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "2000 mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159244,
    "drug": {
      "current_status": "MARKETED",
      "id": 3380,
      "drug_code": 18556,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252339,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02125323",
      "brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80816",
      "number_of_ais": "1",
      "ai_group_no": "0108698002"
    },
    "created_date": "2022-04-21T19:15:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02125323",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-21T00:00:00-04:00",
    "estimated_end_date": "2022-06-17T00:00:00-04:00",
    "actual_start_date": "2022-04-21T00:00:00-04:00",
    "actual_end_date": "2022-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-10T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG",
    "en_drug_common_name": "Hydromorph Contin",
    "fr_drug_brand_name": "HYDROMORPH CONTIN",
    "fr_drug_common_name": "Capsules de chlorhydrate d’HYDROmorphone* à libération contrôlée",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "3MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159247,
    "drug": {
      "current_status": "MARKETED",
      "id": 14304,
      "drug_code": 74388,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255153,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8255152,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02258692",
      "brand_name": "COSOPT PRESERVATIVE-FREE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0237301001"
    },
    "created_date": "2022-04-21T19:20:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02258692",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2022-04-21T00:00:00-04:00",
    "estimated_end_date": "2022-08-17T00:00:00-04:00",
    "actual_start_date": "2022-04-21T00:00:00-04:00",
    "actual_end_date": "2022-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-08-22T13:53:29-04:00",
    "status": "resolved",
    "en_comments": "resolved",
    "fr_comments": "resolved",
    "en_drug_brand_name": "COSOPT",
    "en_drug_common_name": "Dorzolamide and Timolol Ophthalmic solution",
    "fr_drug_brand_name": "Cosopt",
    "fr_drug_common_name": "collyre de dorzolamide et timolol",
    "en_ingredients": "TIMOLOL\r\nDORZOLAMIDE",
    "fr_ingredients": "ophthalmic solution, 20 mg/mL, 5 mg/mL (as dorzolamide hydrochloride and timolol maleate),\r\nophthalmic",
    "drug_strength": "5MG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "0.2ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159254,
    "drug": {
      "current_status": "MARKETED",
      "id": 9014,
      "drug_code": 61553,
      "updated_date": "2025-12-03T00:30:41-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253555,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238162",
      "brand_name": "DIASTAT",
      "brand_name_fr": "",
      "descriptor": "PREFILLED RECTAL DELIVERY SYSTEM",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103614001"
    },
    "created_date": "2022-04-21T20:25:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238162",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2022-04-25T00:00:00-04:00",
    "estimated_end_date": "2022-11-30T00:00:00-05:00",
    "actual_start_date": "2022-04-22T00:00:00-04:00",
    "actual_end_date": "2022-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2022-11-23T18:18:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DIASTAT",
    "en_drug_common_name": "DIASTAT",
    "fr_drug_brand_name": "DIASTAT",
    "fr_drug_common_name": "DIASTAT",
    "en_ingredients": "DIAZEPAM",
    "fr_ingredients": "Diazépam",
    "drug_strength": "5MG",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "5mg/2pk",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159257,
    "drug": {
      "current_status": "MARKETED",
      "id": 3530,
      "drug_code": 18860,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252392,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148447",
      "brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
      "brand_name_fr": "MINIMS CHLORHYDRATE DE PHÉNYLÉPHRINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81140",
      "number_of_ais": "1",
      "ai_group_no": "0100662002"
    },
    "created_date": "2022-04-21T20:28:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148447",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "S01FB",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "estimated_end_date": "2022-06-18T00:00:00-04:00",
    "actual_start_date": "2022-04-18T00:00:00-04:00",
    "actual_end_date": "2022-06-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-23T17:48:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "en_drug_common_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "fr_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "fr_drug_common_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de phényléphrine",
    "drug_strength": "2.5%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "N/A",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159260,
    "drug": {
      "current_status": "MARKETED",
      "id": 15474,
      "drug_code": 76060,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255537,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02275090",
      "brand_name": "WELLBUTRIN XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140003"
    },
    "created_date": "2022-04-21T20:35:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02275090",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-04-22T00:00:00-04:00",
    "actual_start_date": "2022-04-18T00:00:00-04:00",
    "actual_end_date": "2022-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-04-23T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "WELLBUTRIN XL",
    "en_drug_common_name": "WELLBUTRIN XL",
    "fr_drug_brand_name": "WELLBUTRIN XL",
    "fr_drug_common_name": "WELLBUTRIN XL",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90s",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159313,
    "drug": {
      "current_status": "MARKETED",
      "id": 2226,
      "drug_code": 14735,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8251992,
          "ingredient": {
            "id": 1106,
            "ingredient_code": 6506,
            "en_name": "HYDROXYCHLOROQUINE SULFATE",
            "fr_name": "Sulfate d'hydroxychloroquine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02017709",
      "brand_name": "PLAQUENIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76405",
      "number_of_ais": "1",
      "ai_group_no": "0107403001"
    },
    "created_date": "2022-04-22T20:03:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02017709",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "P01BA",
    "atc_description": "ANTIMALARIALS",
    "anticipated_start_date": "2022-04-29T00:00:00-04:00",
    "estimated_end_date": "2022-07-29T00:00:00-04:00",
    "actual_start_date": "2022-04-29T00:00:00-04:00",
    "actual_end_date": "2022-07-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-08-01T12:21:19-04:00",
    "status": "resolved",
    "en_comments": "Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Délai en approvisionnement. \tLa date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "PLAQUENIL",
    "en_drug_common_name": "Hydroxychloroquine Sulfate Tablets",
    "fr_drug_brand_name": "PLAQUENIL",
    "fr_drug_common_name": "Comprimés de sulfate d’hydroxychloroquine",
    "en_ingredients": "HYDROXYCHLOROQUINE SULFATE",
    "fr_ingredients": "Sulfate d'hydroxychloroquine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottle of 100 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159316,
    "drug": {
      "current_status": "MARKETED",
      "id": 57228,
      "drug_code": 96232,
      "updated_date": "2025-12-03T00:33:42-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8263069,
          "ingredient": {
            "id": 6188,
            "ingredient_code": 22840,
            "en_name": "SARILUMAB",
            "fr_name": "Sarilumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1.14",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02472961",
      "brand_name": "KEVZARA",
      "brand_name_fr": "",
      "descriptor": "1.14 ML PREFILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0158770001"
    },
    "created_date": "2022-04-22T20:15:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02472961",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "L04AC",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2022-08-25T00:00:00-04:00",
    "actual_start_date": "2022-04-18T00:00:00-04:00",
    "actual_end_date": "2022-08-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-08-26T20:31:25-04:00",
    "status": "resolved",
    "en_comments": "Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard de fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "KEVZARA",
    "en_drug_common_name": "sarilumab 1.14 mL pre-filled pen",
    "fr_drug_brand_name": "KEVZARA",
    "fr_drug_common_name": "sarilumab stylo pré-rempli de 1.14 mL",
    "en_ingredients": "SARILUMAB",
    "fr_ingredients": "sarilumab",
    "drug_strength": "150MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "2 pen per carton",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159319,
    "drug": {
      "current_status": "MARKETED",
      "id": 55455,
      "drug_code": 95935,
      "updated_date": "2025-12-03T00:33:36-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8262894,
          "ingredient": {
            "id": 10502,
            "ingredient_code": 22918,
            "en_name": "DUPILUMAB",
            "fr_name": "dupilumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "2",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02470365",
      "brand_name": "DUPIXENT",
      "brand_name_fr": "",
      "descriptor": "PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0159790001"
    },
    "created_date": "2022-04-22T20:49:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470365",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "D11AH",
    "anticipated_start_date": "2022-04-25T00:00:00-04:00",
    "estimated_end_date": "2022-05-06T00:00:00-04:00",
    "actual_end_date": "2022-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-02T19:48:31-04:00",
    "status": "resolved",
    "en_comments": "The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard de fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "DUPIXENT",
    "en_drug_common_name": "dupilumab injection 300 mg single-use syringe",
    "fr_drug_brand_name": "DUPIXENT",
    "fr_drug_common_name": "dupilumab injectable (seringues jetables de 300 mg)",
    "en_ingredients": "DUPILUMAB",
    "fr_ingredients": "dupilumab",
    "drug_strength": "150MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "300 mg/2 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159324,
    "drug": {
      "current_status": "MARKETED",
      "id": 30566,
      "drug_code": 92621,
      "updated_date": "2025-05-15T02:34:48-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8261216,
          "ingredient": {
            "id": 2970,
            "ingredient_code": 12724,
            "en_name": "INSULIN GLARGINE",
            "fr_name": "Insuline glargine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02441829",
      "brand_name": "TOUJEO SOLOSTAR",
      "brand_name_fr": "",
      "descriptor": "1.5ML (450 IU) PREFILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147062002"
    },
    "created_date": "2022-04-22T21:00:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02441829",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AE",
    "atc_description": "INSULINS AND ANALOGUES",
    "anticipated_start_date": "2022-04-25T00:00:00-04:00",
    "estimated_end_date": "2022-05-02T00:00:00-04:00",
    "actual_end_date": "2022-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-04T21:49:36-04:00",
    "status": "resolved",
    "en_comments": "Transportation delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Délai de transportation. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "TOUJEO SOLOSTAR",
    "en_drug_common_name": "insulin glargine injection",
    "fr_drug_brand_name": "TOUJEO SoloSTAR",
    "fr_drug_common_name": "insuline glargine injectable",
    "en_ingredients": "INSULIN GLARGINE",
    "fr_ingredients": "Insuline glargine",
    "drug_strength": "300UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "3 x 1.5 mL pen",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159333,
    "drug": {
      "current_status": "MARKETED",
      "id": 4018,
      "drug_code": 19701,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252558,
          "ingredient": {
            "id": 280,
            "ingredient_code": 8750,
            "en_name": "MAGNESIUM SULFATE",
            "fr_name": "Sulfate de magnésium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139499",
      "brand_name": "MAGNESIUM SULFATE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81997",
      "number_of_ais": "1",
      "ai_group_no": "0105356002"
    },
    "created_date": "2022-04-22T22:06:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139499",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2022-05-01T00:00:00-04:00",
    "estimated_end_date": "2022-12-16T00:00:00-05:00",
    "actual_start_date": "2022-05-01T00:00:00-04:00",
    "actual_end_date": "2022-12-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-20T14:47:53-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to production delays we will be encountering a supply interruption on our Magnesium Sulfate Injection, USP 500 mg/mL SD Vial 10 mL effective May 1, 2022 until December 16, 2022. Effective May 1, 2022 allocations of 50mL will be increased to cover 100% of 50mL demand plus 200% of 10mL demand on a mL:mL basis",
    "fr_comments": "Fresenius Kabi Canada a le regret de vous informer qu’en raison de retards de production, nous allons éprouver une interruption d’approvisionnement qui va toucher notre préparation de Sulfate de magnésium injectable, USP à 500 mg/mL en fioles DU de 10 mL du 1er mai 2022 au 16 decembre 2022. À compter du 1er mai 2022, les allocations de 50 mL seront augmentées pour couvrir 100 % de la demande du 50 mL plus 200 % de la demande du 10 mL sur une base mL:mL",
    "en_drug_brand_name": "MAGNESIUM SULFATE INJECTION",
    "en_drug_common_name": "Magnesium Sulfate Injection",
    "fr_drug_brand_name": "Sulfate de magnésium injectable, USP",
    "fr_drug_common_name": "Sulfate de magnésium injectable",
    "en_ingredients": "MAGNESIUM SULFATE",
    "fr_ingredients": "Sulfate de magnésium",
    "drug_strength": "500MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159348,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27890,
      "drug_code": 90088,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8353993,
          "ingredient": {
            "id": 3916,
            "ingredient_code": 22169,
            "en_name": "TERIFLUNOMIDE",
            "fr_name": "Tériflunomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "14",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02416328",
      "brand_name": "AUBAGIO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154970001"
    },
    "created_date": "2022-04-25T18:19:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02416328",
    "company_name": "SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_start_date": "2022-04-28T00:00:00-04:00",
    "estimated_end_date": "2022-05-11T00:00:00-04:00",
    "actual_end_date": "2022-05-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-04T22:25:38-04:00",
    "status": "resolved",
    "en_comments": "Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard de fabrication. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "AUBAGIO",
    "en_drug_common_name": "Teriflunomide tablets 14 mg",
    "fr_drug_brand_name": "AUBAGIO",
    "fr_drug_common_name": "Comprimés de tériflunomide 14 mg",
    "en_ingredients": "TERIFLUNOMIDE",
    "fr_ingredients": "Tériflunomide",
    "drug_strength": "14MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "14 mg",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159355,
    "drug": {
      "current_status": "MARKETED",
      "id": 3868,
      "drug_code": 19442,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252489,
          "ingredient": {
            "id": 158,
            "ingredient_code": 5319,
            "en_name": "POTASSIUM PHOSPHATE DIBASIC",
            "fr_name": "Phosphate de potassium dibasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "236",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252488,
          "ingredient": {
            "id": 160,
            "ingredient_code": 6337,
            "en_name": "POTASSIUM PHOSPHATE MONOBASIC",
            "fr_name": "Phosphate de potassium monobasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "224",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139545",
      "brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81739",
      "number_of_ais": "2",
      "ai_group_no": "0207483001"
    },
    "created_date": "2022-04-26T04:18:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139545",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2023-05-01T00:00:00-04:00",
    "actual_start_date": "2023-03-01T00:00:00-05:00",
    "actual_end_date": "2023-04-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-13T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Product is on backorder. Effective March 1, 2023, allocations of Potassium Phosphates Injection, USP 3 mmol/mL Phosphorus SD Vial 15 mL to cover 100% of historical monthly demand of 15 mL and 100% of historical monthly demand of 50 mL at a 3:1 ratio. Please see communication for further details.",
    "fr_comments": "Produit en rupture de stock. À compter du 1 mars 2023, les allocations de Phosphates de potassium injectables, USP, 3 mmol/mL (phosphore), fioles DU de 15 mL pour couvrir 100 % de la demande du 15 mL, plus 100 % de la demande du 50 mL selon en ratio de 3:1. Voir la communication pour plus de détails.",
    "en_drug_brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
    "en_drug_common_name": "Potassium Phosphates Injection, USP",
    "fr_drug_brand_name": "Phosphates de potassium injectables, USP",
    "fr_drug_common_name": "Phosphates de potassium injectables, USP",
    "en_ingredients": "POTASSIUM PHOSPHATE DIBASIC\r\nPOTASSIUM PHOSPHATE MONOBASIC",
    "fr_ingredients": "Phosphate de potassium dibasique\r\nPhosphate de potassium monobasique",
    "drug_strength": "236MG\r\n224MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159368,
    "drug": {
      "current_status": "MARKETED",
      "id": 65485,
      "drug_code": 98076,
      "updated_date": "2025-05-15T02:38:12-04:00",
      "company": {
        "id": 140,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 4835,
        "mfr_code": "ODN07",
        "name": "ODAN LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "325 STILLVIEW AVENUE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "POINTE-CLAIRE",
        "postal_code": "H9R 2Y6",
        "post_office_box": "",
        "contact_information": "info@odanlab.com\r\nTel.: 1-800-387-9342\r\nFax: 1-800-329-6326"
      },
      "drug_ingredients": [
        {
          "id": 8264286,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02490706",
      "brand_name": "ODAN CLOBETASOL SPRAY",
      "brand_name_fr": "",
      "descriptor": "SOLUTION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2022-04-26T13:54:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02490706",
    "company_name": "ODAN LABORATORIES LTD",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2022-05-30T00:00:00-04:00",
    "actual_start_date": "2022-04-24T00:00:00-04:00",
    "actual_end_date": "2022-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-06-07T16:06:01-04:00",
    "status": "resolved",
    "en_comments": "Delay in shipping of inactive ingredients",
    "fr_comments": "Délai dans la réception d'ingréfdients non-médicinaux.",
    "en_drug_brand_name": "ODAN CLOBETASOL SPRAY",
    "en_drug_common_name": "Clobetasol Propionate Topical Solution, USP",
    "fr_drug_brand_name": "Odan Clobetasol Vaporisateur",
    "fr_drug_common_name": "Solution topique de propionate de clobétasol, USP",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "59 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159383,
    "drug": {
      "current_status": "MARKETED",
      "id": 7908,
      "drug_code": 51386,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253418,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231934",
      "brand_name": "OXY.IR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552003"
    },
    "created_date": "2022-04-26T14:41:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231934",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-25T00:00:00-04:00",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_start_date": "2022-04-25T00:00:00-04:00",
    "actual_end_date": "2022-06-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-24T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OXY.IR",
    "en_drug_common_name": "Oxycodone Hydrochloride Immediate Release Tablets",
    "fr_drug_brand_name": "Oxy-IR",
    "fr_drug_common_name": "Comprimés de chlorhydrate d’oxycodone à libération immédiate",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159386,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23506,
      "drug_code": 86093,
      "updated_date": "2025-05-15T04:19:33-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8350897,
          "ingredient": {
            "id": 2736,
            "ingredient_code": 20380,
            "en_name": "VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED",
            "fr_name": "Vaccin contre le virus varicelle-zona vivant atténué (souche Oka/Merck)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "19400",
          "strength_unit": "PFU",
          "strength_type": "",
          "dosage_value": "0.65",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02375516",
      "brand_name": "ZOSTAVAX II",
      "brand_name_fr": "",
      "descriptor": "0.65ML SINGLE-DOSE VIAL. REFRIGERATOR STABLE.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152480003"
    },
    "created_date": "2022-04-26T14:45:19-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02375516",
    "company_name": "MERCK CANADA INC",
    "atc_number": "J07BK",
    "atc_description": "VIRAL VACCINES",
    "discontinuation_date": "2022-10-14T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-10-15T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ZOSTAVAX II",
    "en_drug_common_name": "(zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection",
    "fr_drug_brand_name": "ZOSTAVAX II",
    "fr_drug_common_name": "\"(vaccin à virus vivant atténué contre le zona [Oka/Merck], stable au réfrigérateur) poudre pour suspension injectable\"",
    "en_ingredients": "VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED",
    "fr_ingredients": "VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED",
    "drug_strength": "19400PFU",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "1 dose vial",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159388,
    "drug": {
      "current_status": "MARKETED",
      "id": 15594,
      "drug_code": 76282,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255591,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277174",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548009"
    },
    "created_date": "2022-04-26T14:46:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277174",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-04-25T00:00:00-04:00",
    "estimated_end_date": "2022-07-04T00:00:00-04:00",
    "actual_start_date": "2022-04-25T00:00:00-04:00",
    "actual_end_date": "2022-06-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "BIPHENTIN",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159392,
    "drug": {
      "current_status": "MARKETED",
      "id": 99476,
      "drug_code": 96841,
      "updated_date": "2020-04-03T06:53:45-04:00",
      "company": {
        "id": 876,
        "created_date": "2017-03-09T13:23:25-05:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 10225,
        "mfr_code": "",
        "name": "DR. REDDY'S LABORATORIES INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 4000 4TH FLOOR",
        "street_name": "600 COLLEGE ROAD EAST",
        "province": "NEW JERSEY",
        "country": "UNITED STATES",
        "city": "PRINCETON",
        "postal_code": "08540",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263337,
          "ingredient": {
            "id": 3616,
            "ingredient_code": 11885,
            "en_name": "ALITRETINOIN",
            "fr_name": "Alitrétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02477432",
      "brand_name": "HANZEMA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137581002"
    },
    "created_date": "2022-04-26T17:57:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02477432",
    "company_name": "DR. REDDY'S LABORATORIES INC",
    "atc_number": "D11AH",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "anticipated_start_date": "2022-04-27T00:00:00-04:00",
    "estimated_end_date": "2022-06-25T00:00:00-04:00",
    "actual_start_date": "2022-04-27T00:00:00-04:00",
    "actual_end_date": "2022-06-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-06-29T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Please contact customer service 1-855-550-5528 (Monday to Friday from: 9:00 am to 5:00 pm ET).",
    "fr_comments": "Veuillez contacter le service à la clientèle au 1-855-550-5528 (du lundi au vendredi de : 9h00 à 17h00 HE).",
    "en_drug_brand_name": "HANZEMA",
    "en_drug_common_name": "Alitretinoin Capsules",
    "fr_drug_brand_name": "Hanzema",
    "fr_drug_common_name": "Alitrétinoïne Capsules",
    "en_ingredients": "ALITRETINOIN",
    "fr_ingredients": "Alitrétinoïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Boxes of 3 blister strips. Each strip contains 10 capsules",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159399,
    "drug": {
      "current_status": "MARKETED",
      "id": 65778,
      "drug_code": 97284,
      "updated_date": "2025-05-15T02:36:54-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8263693,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02482371",
      "brand_name": "AURO-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072003"
    },
    "created_date": "2022-04-26T18:43:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02482371",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2022-11-30T00:00:00-05:00",
    "actual_start_date": "2022-01-26T00:00:00-05:00",
    "actual_end_date": "2022-12-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-12-08T20:11:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "AURO-AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "200MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "15mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159402,
    "drug": {
      "current_status": "MARKETED",
      "id": 57805,
      "drug_code": 95957,
      "updated_date": "2025-05-15T02:36:12-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262914,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470586",
      "brand_name": "AURO-CEPHALEXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105911003"
    },
    "created_date": "2022-04-26T18:45:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470586",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-09-28T20:13:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CEPHALEXIN",
    "en_drug_common_name": "CEPHALEXIN",
    "fr_drug_brand_name": "Auro-Cephalexin",
    "fr_drug_common_name": "Cephalexin",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159405,
    "drug": {
      "current_status": "MARKETED",
      "id": 57805,
      "drug_code": 95957,
      "updated_date": "2025-05-15T02:36:12-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262914,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470586",
      "brand_name": "AURO-CEPHALEXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105911003"
    },
    "created_date": "2022-04-26T18:50:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470586",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2022-01-26T00:00:00-05:00",
    "actual_end_date": "2022-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-09-28T20:14:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CEPHALEXIN",
    "en_drug_common_name": "CEPHALEXIN",
    "fr_drug_brand_name": "Auro-Cephalexin",
    "fr_drug_common_name": "Cephalexin",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159408,
    "drug": {
      "current_status": "MARKETED",
      "id": 100409,
      "drug_code": 98755,
      "updated_date": "2020-06-16T22:21:12-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8264963,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02497743",
      "brand_name": "AURO-CEPHALEXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105911001"
    },
    "created_date": "2022-04-26T18:51:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02497743",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2023-10-01T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2023-09-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-14T20:46:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CEPHALEXIN",
    "en_drug_common_name": "CEPHALEXIN",
    "fr_drug_brand_name": "Auro-Cephalexin",
    "fr_drug_common_name": "Cephalexin",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "125MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159411,
    "drug": {
      "current_status": "MARKETED",
      "id": 15504,
      "drug_code": 76121,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8255552,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02275570",
      "brand_name": "AURO-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243002"
    },
    "created_date": "2022-04-26T18:53:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02275570",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-06-17T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-06-15T18:40:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CITALOPRAM",
    "en_drug_common_name": "CITALOPRAM",
    "fr_drug_brand_name": "Auro-Citalopram",
    "fr_drug_common_name": "Citalopram",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "Citalopram",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159414,
    "drug": {
      "current_status": "MARKETED",
      "id": 99766,
      "drug_code": 97637,
      "updated_date": "2020-04-03T06:54:03-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8263926,
          "ingredient": {
            "id": 3538,
            "ingredient_code": 19793,
            "en_name": "DARUNAVIR",
            "fr_name": "Darunavir (Propylène glycolate de Darunavir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02486148",
      "brand_name": "AURO-DARUNAVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151656006"
    },
    "created_date": "2022-04-26T18:55:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02486148",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J05AE",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2022-07-06T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-07-04T14:50:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-DARUNAVIR",
    "en_drug_common_name": "DARUNAVIR",
    "fr_drug_brand_name": "Auro-Duloxetine",
    "fr_drug_common_name": "Duloxetine",
    "en_ingredients": "DARUNAVIR",
    "fr_ingredients": "Darunavir",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159417,
    "drug": {
      "current_status": "MARKETED",
      "id": 17474,
      "drug_code": 78517,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8256159,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299828",
      "brand_name": "AURO-MIRTAZAPINE OD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928002"
    },
    "created_date": "2022-04-26T18:56:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299828",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-05-30T00:00:00-04:00",
    "actual_start_date": "2021-04-26T00:00:00-04:00",
    "actual_end_date": "2022-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-05-30T20:41:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-MIRTAZAPINE OD",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "Auro-Mirtazapine OD",
    "fr_drug_common_name": "Mirtazapine",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "5X6'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159420,
    "drug": {
      "current_status": "MARKETED",
      "id": 17476,
      "drug_code": 78518,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8256160,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299836",
      "brand_name": "AURO-MIRTAZAPINE OD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928003"
    },
    "created_date": "2022-04-26T18:58:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299836",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-05-30T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-05-30T20:41:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-MIRTAZAPINE OD",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "Auro-Mirtazapine OD",
    "fr_drug_common_name": "Mirtazapine",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "45MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "5X6'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159423,
    "drug": {
      "current_status": "MARKETED",
      "id": 67236,
      "drug_code": 98357,
      "updated_date": "2020-04-03T06:03:03-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8264550,
          "ingredient": {
            "id": 848,
            "ingredient_code": 7554,
            "en_name": "PROGESTERONE",
            "fr_name": "Progestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02493578",
      "brand_name": "AURO-PROGESTERONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106327002"
    },
    "created_date": "2022-04-26T19:06:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02493578",
    "company_name": "AURO PHARMA INC",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-09-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-09-28T20:24:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-PROGESTERONE",
    "en_drug_common_name": "PROGESTERONE",
    "fr_drug_brand_name": "Auro-Progesterone",
    "fr_drug_common_name": "Progesterone",
    "en_ingredients": "PROGESTERONE",
    "fr_ingredients": "Progestérone",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159426,
    "drug": {
      "current_status": "MARKETED",
      "id": 67236,
      "drug_code": 98357,
      "updated_date": "2020-04-03T06:03:03-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8264550,
          "ingredient": {
            "id": 848,
            "ingredient_code": 7554,
            "en_name": "PROGESTERONE",
            "fr_name": "Progestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02493578",
      "brand_name": "AURO-PROGESTERONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106327002"
    },
    "created_date": "2022-04-26T19:11:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02493578",
    "company_name": "AURO PHARMA INC",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2022-09-30T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-09-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-09-28T20:23:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-PROGESTERONE",
    "en_drug_common_name": "PROGESTERONE",
    "fr_drug_brand_name": "Auro-Progesterone",
    "fr_drug_common_name": "Progesterone",
    "en_ingredients": "PROGESTERONE",
    "fr_ingredients": "Progestérone",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159429,
    "drug": {
      "current_status": "MARKETED",
      "id": 62809,
      "drug_code": 97034,
      "updated_date": "2025-05-15T02:36:40-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8263528,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02479672",
      "brand_name": "AURO-TRAMADOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694006"
    },
    "created_date": "2022-04-26T19:12:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02479672",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-06-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-06-29T17:27:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-TRAMADOL",
    "en_drug_common_name": "TRAMADOL",
    "fr_drug_brand_name": "Auro-Tramadol",
    "fr_drug_common_name": "Tramadol",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159434,
    "drug": {
      "current_status": "MARKETED",
      "id": 3878,
      "drug_code": 19460,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252492,
          "ingredient": {
            "id": 1564,
            "ingredient_code": 7526,
            "en_name": "FLUDROCORTISONE 21-ACETATE",
            "fr_name": "21-acétate de fludrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02086026",
      "brand_name": "FLORINEF",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81757",
      "number_of_ais": "1",
      "ai_group_no": "0106361002"
    },
    "created_date": "2022-04-26T20:21:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02086026",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "H02AA",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "anticipated_start_date": "2022-04-21T00:00:00-04:00",
    "estimated_end_date": "2022-06-22T00:00:00-04:00",
    "actual_end_date": "2022-06-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-21T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Resolved - product to remain on allocation based on historical demand until end of September to ensure fair distribution",
    "fr_comments": "Résolu - Pour s’assurer une répartition équitable, ce produit sera en allocation basée sur l’historique de ventes jusqu’à la fin septembre.",
    "en_drug_brand_name": "FLORINEF",
    "en_drug_common_name": "FLUDROCORTISONE 21-ACETATE",
    "fr_drug_brand_name": "Florinef",
    "fr_drug_common_name": "acétate de fludrocortisone",
    "en_ingredients": "FLUDROCORTISONE 21-ACETATE",
    "fr_ingredients": "21-acétate de fludrocortisone",
    "drug_strength": "0.1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159439,
    "drug": {
      "current_status": "MARKETED",
      "id": 1474,
      "drug_code": 13191,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 94,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 9307,
        "mfr_code": "AZC08",
        "name": "ASTRAZENECA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1004 MIDDLEGATE ROAD, SUITE 5000",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4Y 1M4",
        "post_office_box": "",
        "contact_information": "Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com."
      },
      "drug_ingredients": [
        {
          "id": 8251733,
          "ingredient": {
            "id": 198,
            "ingredient_code": 7581,
            "en_name": "BUDESONIDE",
            "fr_name": "Budésonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01978918",
      "brand_name": "PULMICORT NEBUAMP 0.25 MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74501",
      "number_of_ais": "1",
      "ai_group_no": "0116807004"
    },
    "created_date": "2022-04-26T21:07:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01978918",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2022-05-03T00:00:00-04:00",
    "estimated_end_date": "2022-05-19T00:00:00-04:00",
    "actual_start_date": "2022-05-03T00:00:00-04:00",
    "actual_end_date": "2022-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-05-18T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PULMICORT NEBUAMP 0.25 MG/ML",
    "en_drug_common_name": "budesonide",
    "fr_drug_brand_name": "PULMICORT NEBUAMP",
    "fr_drug_common_name": "budésonide",
    "en_ingredients": "BUDESONIDE",
    "fr_ingredients": "Budésonide",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "20 ampoules",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159486,
    "drug": {
      "current_status": "MARKETED",
      "id": 22364,
      "drug_code": 84760,
      "updated_date": "2025-12-03T00:31:44-05:00",
      "company": {
        "id": 17393,
        "created_date": "2025-12-03T00:30:14-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 22004,
        "mfr_code": "",
        "name": "JUNO PHARMA CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258008,
          "ingredient": {
            "id": 1166,
            "ingredient_code": 1076,
            "en_name": "POTASSIUM ACETATE",
            "fr_name": "Acétate de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "39.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02362597",
      "brand_name": "POTASSIUM ACETATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "POTASSIUM 4MMOL/ML. 50ML SINGLE USE VIALS.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107304002"
    },
    "created_date": "2022-04-27T20:40:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362597",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2022-07-01T00:00:00-04:00",
    "estimated_end_date": "2022-08-08T00:00:00-04:00",
    "actual_start_date": "2022-07-01T00:00:00-04:00",
    "actual_end_date": "2022-08-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2022-11-03T11:54:35-04:00",
    "status": "resolved",
    "en_comments": "Restricting sales to contracted customers only",
    "fr_comments": "Ventes de la molécule restreintes aux clients à contrat seulement",
    "en_drug_brand_name": "POTASSIUM ACETATE INJECTION USP",
    "en_drug_common_name": "Potassium Acetate Injection",
    "fr_drug_brand_name": "ACÉTATE DE POTASSIUM INJECTION USP",
    "fr_drug_common_name": "Acétate de potassium injection",
    "en_ingredients": "POTASSIUM ACETATE",
    "fr_ingredients": "Acétate de potassium",
    "drug_strength": "39.2%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 50 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159512,
    "drug": {
      "current_status": "DORMANT",
      "id": 6536,
      "drug_code": 43464,
      "updated_date": "2025-12-03T02:32:17-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367220,
          "ingredient": {
            "id": 2196,
            "ingredient_code": 7559,
            "en_name": "PREDNICARBATE",
            "fr_name": "Prednicarbate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02227517",
      "brand_name": "DERMATOP OINTMENT",
      "brand_name_fr": "DERMATOP ONGUENT",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9803",
      "number_of_ais": "1",
      "ai_group_no": "0120996001"
    },
    "created_date": "2022-04-28T13:42:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02227517",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2023-12-30T00:00:00-05:00",
    "actual_start_date": "2021-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-05-04T13:03:08-04:00",
    "status": "active_confirmed",
    "en_comments": "delay in production related to excipient",
    "fr_comments": "delai en production",
    "en_drug_brand_name": "DERMATOP OINTMENT",
    "en_drug_common_name": "DERMATOP OINTMENT",
    "fr_drug_brand_name": "DERMATOP OINTMENT",
    "fr_drug_common_name": "DERMATOP OINTMENT",
    "en_ingredients": "PREDNICARBATE",
    "fr_ingredients": "Prednicarbate",
    "drug_strength": "0.1%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60g",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159533,
    "drug": {
      "current_status": "MARKETED",
      "id": 6202,
      "drug_code": 42959,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253012,
          "ingredient": {
            "id": 2120,
            "ingredient_code": 109,
            "en_name": "TETRABENAZINE",
            "fr_name": "Tétrabénazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02199270",
      "brand_name": "NITOMAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9188",
      "number_of_ais": "1",
      "ai_group_no": "0128227001"
    },
    "created_date": "2022-04-28T13:56:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02199270",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "N07XX",
    "atc_description": "OTHER NERVOUS SYSTEM DRUGS",
    "estimated_end_date": "2022-05-26T00:00:00-04:00",
    "actual_start_date": "2022-04-21T00:00:00-04:00",
    "actual_end_date": "2022-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-26T20:51:11-04:00",
    "status": "resolved",
    "en_comments": "awaiting documents from supplier",
    "fr_comments": "en attente des documents du fournisseur",
    "en_drug_brand_name": "NITOMAN",
    "en_drug_common_name": "NITOMAN",
    "fr_drug_brand_name": "NITOMAN",
    "fr_drug_common_name": "NITOMAN",
    "en_ingredients": "TETRABENAZINE",
    "fr_ingredients": "Tétrabénazine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "N/A",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159536,
    "drug": {
      "current_status": "MARKETED",
      "id": 3454,
      "drug_code": 18742,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252365,
          "ingredient": {
            "id": 1132,
            "ingredient_code": 4179,
            "en_name": "CYCLOPENTOLATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cyclopentolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148382",
      "brand_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE",
      "brand_name_fr": "MINIMS CHLORHYDRATE DE CYCLOPENTOLATE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81016",
      "number_of_ais": "1",
      "ai_group_no": "0108675001"
    },
    "created_date": "2022-04-28T14:01:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148382",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "S01FA",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "estimated_end_date": "2022-06-07T00:00:00-04:00",
    "actual_start_date": "2022-04-25T00:00:00-04:00",
    "actual_end_date": "2022-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-06-23T17:50:39-04:00",
    "status": "resolved",
    "en_comments": "packaging issue",
    "fr_comments": "problème avec l'emballage",
    "en_drug_brand_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE",
    "en_drug_common_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE",
    "fr_drug_brand_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE",
    "fr_drug_common_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE",
    "en_ingredients": "CYCLOPENTOLATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cyclopentolate",
    "drug_strength": "1%",
    "drug_dosage_form": "SOLUTION\r\nDROPS",
    "drug_dosage_form_fr": "Solution\r\nGouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "0.5 ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159539,
    "drug": {
      "current_status": "MARKETED",
      "id": 3476,
      "drug_code": 18759,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252376,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148455",
      "brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
      "brand_name_fr": "MINIMS CHLORHYDRATE DE PHÉNYLÉPHRINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81033",
      "number_of_ais": "1",
      "ai_group_no": "0100662005"
    },
    "created_date": "2022-04-28T14:04:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148455",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "S01FB",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "estimated_end_date": "2022-05-16T00:00:00-04:00",
    "actual_start_date": "2022-04-25T00:00:00-04:00",
    "actual_end_date": "2022-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-05-26T20:43:56-04:00",
    "status": "resolved",
    "en_comments": "awaiting QA release",
    "fr_comments": "en attente relâche QA",
    "en_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "en_drug_common_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "fr_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "fr_drug_common_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de phényléphrine",
    "drug_strength": "10%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "0.5 ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159557,
    "drug": {
      "current_status": "MARKETED",
      "id": 10850,
      "drug_code": 66737,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254096,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242905",
      "brand_name": "MIDAZOLAM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "MULTI-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2022-04-28T14:21:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242905",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2022-06-03T00:00:00-04:00",
    "actual_start_date": "2022-05-01T00:00:00-04:00",
    "actual_end_date": "2022-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-01T18:31:25-04:00",
    "status": "avoided_shortage",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to production delays, we will be experiencing supply interruptions. During our supply interruption on Midazolam Injection 5 mg/mL MD Vial 2 mL, our Midazolam Injection 5 mg/mL MD Vial 10 mL will be available for substitution.",
    "fr_comments": "resenius Kabi Canada a le regret de vous informer qu’en raison de retards de production, nous allons connaître des interruptions d’approvisionnement. Au cours de l’interruption d’approvisionnement de notre présentation de Midazolam injectable à 5 mg/mL en fioles DM de 2 mL, notre préparation de Midazolam injectable à 5 mg/mL en fioles DM de 10 mL sera disponible en guise de substitut.",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "Midazolam Injection",
    "fr_drug_brand_name": "Midazolam injectable",
    "fr_drug_common_name": "Midazolam injectable",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "2mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159570,
    "drug": {
      "current_status": "MARKETED",
      "id": 3562,
      "drug_code": 18937,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252402,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "234",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139510",
      "brand_name": "SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "81223",
      "number_of_ais": "1",
      "ai_group_no": "0100053008"
    },
    "created_date": "2022-04-28T14:23:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139510",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2022-05-01T00:00:00-04:00",
    "estimated_end_date": "2022-05-19T00:00:00-04:00",
    "actual_start_date": "2022-05-01T00:00:00-04:00",
    "actual_end_date": "2022-05-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-05-24T15:51:26-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be experiencing supply interruptions. Once available, Sodium Chloride Injection, USP 4 mEq/mL Maxivial® 200 mL will be placed on allocation. Contract customers will be allocated 100% of historical monthly volumes.",
    "fr_comments": "Fresenius Kabi Canada a le regret de vous informer qu’en raison de retards d’expédition, nous allons connaître des interruptions d’approvisionnement. Au retour de sa disponibilité, le Chlorure de sodium injectable, USP à 4 mEq/mL en MaxivialMD de 200 mL sera mis sous allocation. Les clients contractuels s’en verront attribuer 100 % de leurs volumes mensuels moyens historiques.",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "Sodium Chloride Injection, USP",
    "fr_drug_brand_name": "Chlorure de sodium injectable, USP",
    "fr_drug_common_name": "Chlorure de sodium injectable, USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "234MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "200mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159578,
    "drug": {
      "current_status": "MARKETED",
      "id": 8374,
      "drug_code": 5778,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250825,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250824,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00608165",
      "brand_name": "TEVA-OXYCOCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61498",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2022-04-28T14:54:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00608165",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-07-10T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-07-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-07-20T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OXYCOCET",
    "en_drug_common_name": "OXYCOCET TABS 5MG/325MG",
    "fr_drug_brand_name": "TEVA-OXYCOCET TABS 5MG/325MG",
    "fr_drug_common_name": "OXYCOCET TABS 5MG/325MG",
    "en_ingredients": "ACETAMINOPHEN\r\nOXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate d'oxycodone",
    "drug_strength": "325MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159581,
    "drug": {
      "current_status": "MARKETED",
      "id": 12226,
      "drug_code": 7042,
      "updated_date": "2025-05-15T02:30:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250975,
          "ingredient": {
            "id": 70,
            "ingredient_code": 7617,
            "en_name": "PREDNISOLONE ACETATE",
            "fr_name": "Acétate de prednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00700401",
      "brand_name": "TEVA-PREDNISOLONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "64527",
      "number_of_ais": "1",
      "ai_group_no": "0106295001"
    },
    "created_date": "2022-04-28T14:55:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00700401",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2022-05-31T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-26T17:42:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PREDNISOLONE",
    "en_drug_common_name": "PREDNISOLONE 1.0% SUSP",
    "fr_drug_brand_name": "TEVA-PREDNISOLONE 1.0% SUSP",
    "fr_drug_common_name": "PREDNISOLONE 1.0% SUSP",
    "en_ingredients": "PREDNISOLONE ACETATE",
    "fr_ingredients": "Acétate de prednisolone",
    "drug_strength": "1%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159584,
    "drug": {
      "current_status": "MARKETED",
      "id": 972,
      "drug_code": 12262,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251606,
          "ingredient": {
            "id": 356,
            "ingredient_code": 8450,
            "en_name": "AMPICILLIN",
            "fr_name": "Ampicilline (Ampicilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00872652",
      "brand_name": "AMPICILLIN SODIUM FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73332",
      "number_of_ais": "1",
      "ai_group_no": "0105872001"
    },
    "created_date": "2022-04-28T14:56:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00872652",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2023-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-19T14:45:55-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AMPICILLIN SODIUM FOR INJECTION, USP",
    "en_drug_common_name": "AMPICILLIN SODIUM INJ 500MG",
    "fr_drug_brand_name": "AMPICILLIN SODIUM INJ 500MG",
    "fr_drug_common_name": "AMPICILLIN SODIUM INJ 500MG",
    "en_ingredients": "AMPICILLIN",
    "fr_ingredients": "Ampicilline",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10pk",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159587,
    "drug": {
      "current_status": "MARKETED",
      "id": 24820,
      "drug_code": 87363,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258969,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388065",
      "brand_name": "TEVA-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440002"
    },
    "created_date": "2022-04-28T14:57:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388065",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2022-06-20T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-17T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL 300MG TAB",
    "fr_drug_brand_name": "TEVA-CLOPIDOGREL 300MG TAB",
    "fr_drug_common_name": "CLOPIDOGREL 300MG TAB",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "P PACK 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159590,
    "drug": {
      "current_status": "MARKETED",
      "id": 6306,
      "drug_code": 43176,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253035,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02216221",
      "brand_name": "TEVA-IPRATROPIUM STERINEBS",
      "brand_name_fr": "",
      "descriptor": "1ML & 2ML SINGLE-USE VIALS",
      "pediatric_flag": false,
      "accession_number": "P9489",
      "number_of_ais": "1",
      "ai_group_no": "0115643001"
    },
    "created_date": "2022-04-28T14:59:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216221",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R03BB",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2022-06-30T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-07-01T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-IPRATROPIUM STERINEBS",
    "en_drug_common_name": "TEVA-IPRATROPIUM 250MCG/ML UDV",
    "fr_drug_brand_name": "TEVA-IPRATROPIUM 250MCG/ML UDV",
    "fr_drug_common_name": "TEVA-IPRATROPIUM 250MCG/ML UDV",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "20x1ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159593,
    "drug": {
      "current_status": "MARKETED",
      "id": 15572,
      "drug_code": 76242,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255583,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02276747",
      "brand_name": "TEVA-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2022-04-28T15:00:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02276747",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-12-30T00:00:00-05:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-22T14:00:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE 10MG TAB",
    "fr_drug_brand_name": "TEVA-OLANZAPINE 10MG TAB",
    "fr_drug_common_name": "OLANZAPINE 10MG TAB",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159596,
    "drug": {
      "current_status": "MARKETED",
      "id": 21586,
      "drug_code": 83978,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257719,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02354616",
      "brand_name": "TEVA-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2022-04-28T15:01:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02354616",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-05-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN 10MG TAB",
    "fr_drug_brand_name": "TEVA-ROSUVASTATIN 10MG TAB",
    "fr_drug_common_name": "ROSUVASTATIN 10MG TAB",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159609,
    "drug": {
      "current_status": "MARKETED",
      "id": 18438,
      "drug_code": 79700,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256454,
          "ingredient": {
            "id": 1070,
            "ingredient_code": 1810,
            "en_name": "ENALAPRIL MALEATE",
            "fr_name": "Maléate d'énalapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02311429",
      "brand_name": "PRO-ENALAPRIL - 10",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117649001"
    },
    "created_date": "2022-04-28T16:12:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02311429",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2022-07-01T00:00:00-04:00",
    "actual_start_date": "2022-04-28T00:00:00-04:00",
    "actual_end_date": "2022-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-07-01T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRO-ENALAPRIL - 10",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "PRO- ENALAPRIL-10",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL MALEATE",
    "fr_ingredients": "Maléate d'énalapril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159614,
    "drug": {
      "current_status": "MARKETED",
      "id": 22070,
      "drug_code": 84453,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257904,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359510",
      "brand_name": "HYDROMORPH CONTIN",
      "brand_name_fr": "",
      "descriptor": "CONTROLLED RELEASE CAPSULE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698019"
    },
    "created_date": "2022-04-28T18:53:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359510",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-04-27T00:00:00-04:00",
    "estimated_end_date": "2022-06-03T00:00:00-04:00",
    "actual_start_date": "2022-04-27T00:00:00-04:00",
    "actual_end_date": "2022-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-05-18T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPH CONTIN",
    "en_drug_common_name": "hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "HYDROMORPH CONTIN",
    "fr_drug_common_name": "Capsules de chlorhydrate d’HYDROmorphone* à libération contrôlée",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "9MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159619,
    "drug": {
      "current_status": "MARKETED",
      "id": 101883,
      "drug_code": 100410,
      "updated_date": "2021-06-08T05:13:06-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266232,
          "ingredient": {
            "id": 3816,
            "ingredient_code": 21466,
            "en_name": "PIRFENIDONE",
            "fr_name": "Pirfénidone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "267",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02514702",
      "brand_name": "JAMP PIRFENIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153328001"
    },
    "created_date": "2022-04-28T20:58:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02514702",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "L04AX",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_start_date": "2022-04-01T00:00:00-04:00",
    "estimated_end_date": "2022-07-29T00:00:00-04:00",
    "actual_end_date": "2022-07-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-07-19T20:17:10-04:00",
    "status": "resolved",
    "en_comments": "Demand increase for the drug.",
    "fr_comments": "Augmentation de la demande pour le médicament.",
    "en_drug_brand_name": "JAMP PIRFENIDONE",
    "en_drug_common_name": "Pirfenidone Tablets",
    "fr_drug_brand_name": "JAMP Pirfenidone",
    "fr_drug_common_name": "Comprimés de pirfénidone",
    "en_ingredients": "PIRFENIDONE",
    "fr_ingredients": "Pirfénidone",
    "drug_strength": "267MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90 (bottle)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159622,
    "drug": {
      "current_status": "MARKETED",
      "id": 10430,
      "drug_code": 65671,
      "updated_date": "2025-12-03T00:30:44-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253938,
          "ingredient": {
            "id": 718,
            "ingredient_code": 10271,
            "en_name": "MEPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mépivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242001",
      "brand_name": "CARBOCAINE 2%",
      "brand_name_fr": "",
      "descriptor": "20ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100583002"
    },
    "created_date": "2022-04-28T21:12:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242001",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2022-04-28T00:00:00-04:00",
    "actual_end_date": "2022-09-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-09-07T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CARBOCAINE 2%",
    "en_drug_common_name": "CARBOCAINE 2%",
    "fr_drug_brand_name": "CARBOCAINE 2%",
    "fr_drug_common_name": "CARBOCAINE 2%",
    "en_ingredients": "MEPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mépivacaïne",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nINTRACAUDAL\r\nEPIDURAL\r\nINTRACAUDAL",
    "drug_route_fr": "Épidurale\r\nIntracaudale\r\nÉpidurale\r\nIntracaudale",
    "drug_package_quantity": "10 x 20mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159641,
    "drug": {
      "current_status": "MARKETED",
      "id": 66526,
      "drug_code": 98405,
      "updated_date": "2025-05-15T02:39:00-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264582,
          "ingredient": {
            "id": 3044,
            "ingredient_code": 1218,
            "en_name": "BISOPROLOL FUMARATE",
            "fr_name": "Fumarate de bisoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02494035",
      "brand_name": "SANDOZ BISOPROLOL TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122418001"
    },
    "created_date": "2022-04-29T01:12:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02494035",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-04-28T00:00:00-04:00",
    "actual_end_date": "2022-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-05-25T01:39:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ BISOPROLOL TABLETS",
    "en_drug_common_name": "BISOPROLOL",
    "fr_drug_brand_name": "SANDOZ BISOPROLOL TABLETS",
    "fr_drug_common_name": "BISOPROLOL",
    "en_ingredients": "BISOPROLOL FUMARATE",
    "fr_ingredients": "Fumarate de bisoprolol",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159648,
    "drug": {
      "current_status": "MARKETED",
      "id": 25112,
      "drug_code": 87624,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259100,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390841",
      "brand_name": "SANDOZ PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121005"
    },
    "created_date": "2022-04-29T01:16:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390841",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-05-20T00:00:00-04:00",
    "actual_start_date": "2022-04-28T00:00:00-04:00",
    "actual_end_date": "2022-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-25T01:35:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "SANDOZ PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500HGC BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159676,
    "drug": {
      "current_status": "DORMANT",
      "id": 6004,
      "drug_code": 42066,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 3128,
        "created_date": "2017-08-17T01:15:06-04:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16816,
        "mfr_code": "",
        "name": "KNIGHT THERAPEUTICS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 ALEXIS-NIHON BLVD., SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367190,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00875996",
      "brand_name": "TEMPRA DOUBLE STRENGTH CHILDREN'S SYRUP",
      "brand_name_fr": "TEMPRA SIROP POUR ENFANTS CONCENTRATION DOUBLE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "M2264",
      "number_of_ais": "1",
      "ai_group_no": "0102009005"
    },
    "created_date": "2022-04-29T13:06:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00875996",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "actual_start_date": "2022-04-01T00:00:00-04:00",
    "actual_end_date": "2022-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-31T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEMPRA DOUBLE STRENGTH CHILDREN'S SYRUP",
    "en_drug_common_name": "ACETAMINOPHEN",
    "fr_drug_brand_name": "TEMPRA DOUBLE STRENGTH CHILDREN'S SYRUP",
    "fr_drug_common_name": "Acétaminophène",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "160MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159695,
    "drug": {
      "current_status": "MARKETED",
      "id": 9248,
      "drug_code": 62232,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253610,
          "ingredient": {
            "id": 1492,
            "ingredient_code": 7567,
            "en_name": "BECLOMETHASONE DIPROPIONATE",
            "fr_name": "Dipropionate de béclométhasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02238796",
      "brand_name": "APO-BECLOMETHASONE NASAL SPRAY",
      "brand_name_fr": "",
      "descriptor": "METERED DOSE SPRAY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106320002"
    },
    "created_date": "2022-04-29T14:19:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238796",
    "company_name": "APOTEX INC",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "estimated_end_date": "2022-05-27T00:00:00-04:00",
    "actual_start_date": "2022-04-25T00:00:00-04:00",
    "actual_end_date": "2022-05-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-27T12:30:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BECLOMETHASONE NASAL SPRAY",
    "en_drug_common_name": "BECLOMETHASONE",
    "fr_drug_brand_name": "APO-BECLOMETHASONE",
    "fr_drug_common_name": "BECLOMETHASONE",
    "en_ingredients": "BECLOMETHASONE DIPROPIONATE",
    "fr_ingredients": "Dipropionate de béclométhasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "200MD",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159700,
    "drug": {
      "current_status": "MARKETED",
      "id": 9562,
      "drug_code": 63180,
      "updated_date": "2025-12-03T00:30:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253707,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239699",
      "brand_name": "APO-DIVALPROEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112996001"
    },
    "created_date": "2022-04-29T14:20:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239699",
    "company_name": "APOTEX INC",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-07-29T00:00:00-04:00",
    "actual_start_date": "2022-04-25T00:00:00-04:00",
    "actual_end_date": "2022-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-28T19:01:33-04:00",
    "status": "resolved",
    "en_comments": "Limited inventory is still available",
    "fr_comments": "Limited inventory is still available",
    "en_drug_brand_name": "APO-DIVALPROEX",
    "en_drug_common_name": "DIVALPROEX",
    "fr_drug_brand_name": "APO-DIVALPROEX",
    "fr_drug_common_name": "DIVALPROEX",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)\r\nTABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)\r\nComprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159703,
    "drug": {
      "current_status": "MARKETED",
      "id": 31596,
      "drug_code": 93914,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261825,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452731",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548004"
    },
    "created_date": "2022-04-29T14:22:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452731",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2022-12-24T00:00:00-05:00",
    "actual_start_date": "2022-04-25T00:00:00-04:00",
    "actual_end_date": "2022-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2022-12-17T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHANIDATE ER",
    "fr_drug_brand_name": "APO-METHYLPHANIDATE ER",
    "fr_drug_common_name": "METHYLPHANIDATE ER",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "18MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159713,
    "drug": {
      "current_status": "MARKETED",
      "id": 98825,
      "drug_code": 93947,
      "updated_date": "2020-04-03T06:53:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261847,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261846,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453061",
      "brand_name": "APO-PERINDOPRIL-INDAPAMIDE",
      "brand_name_fr": "APO-PERINDOPRIL-INDAPAMIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0248401003"
    },
    "created_date": "2022-04-29T14:30:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453061",
    "company_name": "APOTEX INC",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2022-06-29T00:00:00-04:00",
    "actual_start_date": "2022-04-25T00:00:00-04:00",
    "actual_end_date": "2022-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PERINDOPRIL-INDAPAMIDE",
    "en_drug_common_name": "PERINDOPRIL-INDAPAMIDE",
    "fr_drug_brand_name": "APO-PERINDOPRIL-INDAPAMIDE",
    "fr_drug_common_name": "PERINDOPRIL-INDAPAMIDE",
    "en_ingredients": "PERINDOPRIL ERBUMINE\r\nINDAPAMIDE",
    "fr_ingredients": "Périndopril erbumine\r\nIndapamide",
    "drug_strength": "8MG\r\n2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159716,
    "drug": {
      "current_status": "MARKETED",
      "id": 16412,
      "drug_code": 77207,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255851,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286629",
      "brand_name": "APO-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928002"
    },
    "created_date": "2022-04-29T14:33:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286629",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-06-10T00:00:00-04:00",
    "actual_start_date": "2022-04-25T00:00:00-04:00",
    "actual_end_date": "2022-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-03T22:49:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "APO-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159719,
    "drug": {
      "current_status": "MARKETED",
      "id": 31598,
      "drug_code": 93915,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261826,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "27",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452758",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548007"
    },
    "created_date": "2022-04-29T14:52:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452758",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-06-20T00:00:00-04:00",
    "estimated_end_date": "2022-10-14T00:00:00-04:00",
    "actual_start_date": "2022-06-17T00:00:00-04:00",
    "actual_end_date": "2022-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2022-10-14T20:15:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHANIDATE ER",
    "fr_drug_brand_name": "APO-METHYLPHANIDATE ER",
    "fr_drug_common_name": "METHYLPHANIDATE ER",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "27MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159722,
    "drug": {
      "current_status": "MARKETED",
      "id": 31600,
      "drug_code": 93916,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261827,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "36",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452766",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548005"
    },
    "created_date": "2022-04-29T14:53:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452766",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-07-01T00:00:00-04:00",
    "estimated_end_date": "2022-11-04T00:00:00-04:00",
    "actual_start_date": "2022-06-03T00:00:00-04:00",
    "actual_end_date": "2022-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2022-10-22T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHANIDATE ER",
    "fr_drug_brand_name": "APO-METHYLPHANIDATE ER",
    "fr_drug_common_name": "METHYLPHANIDATE ER",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "36MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159725,
    "drug": {
      "current_status": "MARKETED",
      "id": 20168,
      "drug_code": 81611,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257152,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "54",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330377",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548006"
    },
    "created_date": "2022-04-29T15:00:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330377",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-06-10T00:00:00-04:00",
    "estimated_end_date": "2022-11-18T00:00:00-05:00",
    "actual_start_date": "2022-05-20T00:00:00-04:00",
    "actual_end_date": "2022-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2022-11-07T13:12:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHANIDATE ER",
    "fr_drug_brand_name": "APO-METHYLPHANIDATE ER",
    "fr_drug_common_name": "METHYLPHANIDATE ER",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "54MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159738,
    "drug": {
      "current_status": "MARKETED",
      "id": 7164,
      "drug_code": 48622,
      "updated_date": "2025-12-03T00:30:38-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253249,
          "ingredient": {
            "id": 2244,
            "ingredient_code": 1929,
            "en_name": "PENTOXIFYLLINE",
            "fr_name": "Pentoxifylline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230090",
      "brand_name": "APO-PENTOXIFYLLINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115837001"
    },
    "created_date": "2022-04-29T17:11:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230090",
    "company_name": "AA PHARMA INC",
    "atc_number": "C04AD",
    "atc_description": "PERIPHERALVASODILATORS",
    "anticipated_start_date": "2022-04-29T00:00:00-04:00",
    "estimated_end_date": "2022-07-18T00:00:00-04:00",
    "actual_end_date": "2022-07-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-23T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PENTOXIFYLLINE SR",
    "en_drug_common_name": "PENTOXIFYLLINE SR",
    "fr_drug_brand_name": "PENTOXIFYLLINE SR",
    "fr_drug_common_name": "PENTOXIFYLLINE SR",
    "en_ingredients": "PENTOXIFYLLINE",
    "fr_ingredients": "Pentoxifylline",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159741,
    "drug": {
      "current_status": "MARKETED",
      "id": 6844,
      "drug_code": 45324,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253192,
          "ingredient": {
            "id": 2260,
            "ingredient_code": 7991,
            "en_name": "PROCHLORPERAZINE",
            "fr_name": "Prochlorpérazine (Maléate de prochlorpérazine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "00886432",
      "brand_name": "PROCHLORAZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "W7390",
      "number_of_ais": "1",
      "ai_group_no": "0106181001"
    },
    "created_date": "2022-04-29T17:15:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00886432",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05AB",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2022-04-29T00:00:00-04:00",
    "estimated_end_date": "2022-07-27T00:00:00-04:00",
    "actual_end_date": "2022-08-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-08-11T13:09:12-04:00",
    "status": "resolved",
    "en_comments": "Prochlorazine 5MG 100BTL is available.",
    "fr_comments": "La prochlorpérazine 5 MG 100 BTL est disponible.",
    "en_drug_brand_name": "PROCHLORAZINE",
    "en_drug_common_name": "PROCHLORAZINE",
    "fr_drug_brand_name": "PROCHLORAZINE",
    "fr_drug_common_name": "PROCHLORAZINE",
    "en_ingredients": "PROCHLORPERAZINE",
    "fr_ingredients": "Prochlorpérazine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159744,
    "drug": {
      "current_status": "MARKETED",
      "id": 15590,
      "drug_code": 76280,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255589,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277158",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548002"
    },
    "created_date": "2022-04-29T17:28:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277158",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-04-27T00:00:00-04:00",
    "estimated_end_date": "2022-07-08T00:00:00-04:00",
    "actual_start_date": "2022-04-27T00:00:00-04:00",
    "actual_end_date": "2022-06-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-06-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "BIPHENTIN",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159755,
    "drug": {
      "current_status": "MARKETED",
      "id": 15600,
      "drug_code": 76285,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255594,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277204",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548012"
    },
    "created_date": "2022-04-29T17:40:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277204",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-04-26T00:00:00-04:00",
    "estimated_end_date": "2022-08-26T00:00:00-04:00",
    "actual_start_date": "2022-04-26T00:00:00-04:00",
    "actual_end_date": "2022-08-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-08-27T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "BIPHENTIN",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 159765,
    "drug": {
      "current_status": "MARKETED",
      "id": 5652,
      "drug_code": 37363,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252903,
          "ingredient": {
            "id": 54,
            "ingredient_code": 8523,
            "en_name": "GRAMICIDIN",
            "fr_name": "Gramicidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252902,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252901,
          "ingredient": {
            "id": 1292,
            "ingredient_code": 8626,
            "en_name": "FRAMYCETIN SULFATE",
            "fr_name": "Sulfate de framycétine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02224623",
      "brand_name": "SOFRACORT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4890",
      "number_of_ais": "3",
      "ai_group_no": "0305701001"
    },
    "created_date": "2022-04-29T19:29:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02224623",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "S03CA",
    "atc_description": "CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION",
    "estimated_end_date": "2022-09-07T00:00:00-04:00",
    "actual_start_date": "2022-04-29T00:00:00-04:00",
    "actual_end_date": "2022-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-08-16T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard d'approvisionnement. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "SOFRACORT",
    "en_drug_common_name": "Framycetin sulphate, Dexamethasone and Gramicidin Ophthalmic/Otic Solution",
    "fr_drug_brand_name": "SOFRACORT",
    "fr_drug_common_name": "Solution ophtalmique / otique de sulfate de framycétine, dexaméthasone, gramicidine",
    "en_ingredients": "GRAMICIDIN\r\nDEXAMETHASONE\r\nFRAMYCETIN SULFATE",
    "fr_ingredients": "Gramicidine\r\nDexaméthasone\r\nSulfate de framycétine",
    "drug_strength": "0.05MG\r\n0.5MG\r\n5MG",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OTIC\r\nOPHTHALMIC\r\nOTIC\r\nOPHTHALMIC",
    "drug_route_fr": "Otique\r\nOphtalmique\r\nOtique\r\nOphtalmique",
    "drug_package_quantity": "8 mL bottle",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]